<SEC-DOCUMENT>0001628280-19-010124.txt : 20190806
<SEC-HEADER>0001628280-19-010124.hdr.sgml : 20190806
<ACCEPTANCE-DATETIME>20190806160603
ACCESSION NUMBER:		0001628280-19-010124
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		9
CONFORMED PERIOD OF REPORT:	20190630
FILED AS OF DATE:		20190806
DATE AS OF CHANGE:		20190806

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Aurinia Pharmaceuticals Inc.
		CENTRAL INDEX KEY:			0001600620
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			A0
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36421
		FILM NUMBER:		191002081

	BUSINESS ADDRESS:	
		STREET 1:		#1203-4464 MARKHAM STREET
		CITY:			VICTORIA BC
		STATE:			A1
		ZIP:			V8Z 7X8
		BUSINESS PHONE:		250-708-4272

	MAIL ADDRESS:	
		STREET 1:		#1203-4464 MARKHAM STREET
		CITY:			VICTORIA BC
		STATE:			A1
		ZIP:			V8Z 7X8
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>auph-0630196xk.htm
<DESCRIPTION>6-K
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2019 Workiva -->
		<title>Document</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="sA5948B90D26E5FF9800C1FB4F8CC2369"></a></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;border-bottom:1px solid #000000;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;font-weight:bold;">UNITED STATES</font></div><div style="line-height:120%;text-align:center;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</font></div><div style="line-height:120%;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Washington, D.C. 20549</font><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">_________________________________________________________</font></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:16pt;"><font style="font-family:inherit;font-size:16pt;font-weight:bold;">FORM 6-K</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">_________________________________________________________</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">REPORT OF FOREIGN PRIVATE ISSUER</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">PURSUANT TO RULE 13A-16 OR 15D-16 UNDER THE</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">SECURITIES EXCHANGE ACT OF 1934</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Dated August 6, 2019</font></div><div style="line-height:120%;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Commission File Number 001-36421</font><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">_________________________________________________________</font></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:18pt;"><font style="font-family:inherit;font-size:18pt;font-weight:bold;">AURINIA PHARMACEUTICALS INC.</font></div><div style="line-height:120%;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">(Exact name of Registrant as specified in its charter)</font><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#160;</font><font style="font-family:inherit;font-size:10pt;">_________________________________________________________</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">N/A</font></div><div style="line-height:120%;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">(Translation of Registrant's Name)</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">#1203-4464 Markham Street</font></div><div style="line-height:120%;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Victoria, British Columbia</font></div><div style="line-height:120%;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">V8Z 7X8</font></div><div style="line-height:120%;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">(250) 708-4272</font></div><div style="line-height:120%;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Address and telephone number of registrant&#8217;s principal executive offices)</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#160;</font><font style="font-family:inherit;font-size:10pt;">_________________________________________________________</font></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Indicate by check mark whether the registrant files of will file annual reports under cover of Form 20-F or Form 40-F.</font></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Form 20-F&#160;&#9744;      &#160;&#160;Form 40-F&#160;&#160; &#9746;&#160;</font></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b) (1): &#9744;</font></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b) (7):  &#9744;</font></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.</font></div><div style="line-height:120%;padding-top:16px;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Yes&#160;&#160;&#9746;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;No&#160;&#160; &#9744;</font></div><div style="line-height:120%;padding-top:16px;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">This Form 6-K is hereby filed and incorporated by reference in the registrant's Registration Statement on Form F-10 (File No. 333-222413).</font></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#160;</font><font style="font-family:inherit;font-size:10pt;">_________________________________________________________</font></div><div style="line-height:120%;padding-top:16px;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div><a name="s2D2E33F6F95A5CEF9BAB724BB17E4060"></a></div><div style="line-height:120%;padding-bottom:16px;text-align:center;-sec-extract:summary;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">SIGNATURES</font></div><div style="line-height:120%;padding-top:14px;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</font></div><div style="line-height:120%;padding-bottom:16px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:47%;"></td><td style="width:8%;"></td><td style="width:45%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Date:&#160;August 6, 2019</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Aurinia Pharmaceuticals Inc.</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">By:</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">/s/ Dennis Bourgeault</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Name:</font></div><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Title:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Dennis Bourgeault</font></div><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Chief Financial Officer</font></div></td></tr></table></div></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;border-bottom:1px solid #000000;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:16px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">EXHIBIT INDEX</font></div><div style="line-height:120%;padding-bottom:16px;font-size:9pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:13%;"></td><td style="width:87%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">Exhibit No.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">Document</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="exhibit991-20190630interim.htm"><font style="font-family:inherit;font-size:9pt;">99.1</font></a></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Interim Condensed Consolidated Financial Statements for the Second Quarter ended June 30, 2019</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="exhibit992-20190630mda.htm"><font style="font-family:inherit;font-size:9pt;">99.2</font></a></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">MD&amp;A for the Second Quarter ended June 30, 2019</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="exhibit993-20190630certifi.htm"><font style="font-family:inherit;font-size:9pt;">99.3</font></a></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Certification of Interim Filings - Chief Executive Officer</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="exhibit994-20190630certifi.htm"><font style="font-family:inherit;font-size:9pt;">99.4</font></a></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Certification of Interim Filings - Chief Financial Officer</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:13px;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Exhibits 99.1, 99.2, 99.3 and 99.4 included with this report on Form 6-K are hereby incorporated by reference as exhibits to the Registration Statement on Form F-10 of Aurinia Pharmaceuticals Inc. (File No. 333-222413), as amended or supplemented.</font></div><div style="line-height:120%;padding-bottom:16px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>2
<FILENAME>exhibit991-20190630interim.htm
<DESCRIPTION>EXHIBIT 99.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2019 Workiva -->
		<title>Exhibit</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="s9E70D61752E1533EB828DD838AFC321A"></a></div><div style="line-height:120%;text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Exhibit 99.1</font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:30pt;"><font style="font-family:inherit;font-size:30pt;"><br></font></div><div style="line-height:120%;text-align:right;font-size:26pt;"><font style="font-family:Arial;font-size:26pt;color:#555659;">Financial Statements</font></div><div style="line-height:120%;text-align:justify;font-size:16pt;"><font style="font-family:Arial;font-size:16pt;"><br></font></div><div style="line-height:120%;text-align:center;"><img src="consolidatedfinancialstate01.jpg" alt="consolidatedfinancialstate01.jpg" style="height:368px;width:684px;"></div><div style="line-height:120%;text-align:justify;font-size:16pt;"><font style="font-family:Arial;font-size:16pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:20pt;"><font style="font-family:Arial;font-size:20pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:20pt;"><font style="font-family:Arial;font-size:20pt;color:#555659;">Second Quarter Ended June 30, 2019</font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><a name="s260BFD5C77BE53E0820FF9E70AAEFCE9"></a></div><div><div style="line-height:120%;text-align:center;font-size:9pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Aurinia Pharmaceuticals Inc.</font></div><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Interim Condensed Consolidated Statements of Financial Position </font><font style="font-family:inherit;font-size:9pt;font-style:italic;">(Unaudited)</font></div><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">As at June 30, 2019</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(expressed in thousands of US dollars)</font></div></td></tr></table></div></div></div><div><br></div><div style="line-height:120%;padding-bottom:16px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6"></td></tr><tr><td style="width:63%;"></td><td style="width:17%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:17%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">June 30, <br>2019<br>$</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31, <br>2018<br>$</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;background-color:#cceeff;font-weight:bold;">Assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Current assets</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;background-color:#cceeff;">Cash and cash equivalents</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">131,493</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">117,967</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Short term investments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7,889</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;background-color:#cceeff;">Accounts receivable and accrued interest receivable</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">248</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">217</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Prepaid expenses and deposits</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6,782</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6,775</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">138,523</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">132,848</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Clinical trial contract deposits</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">358</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">358</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;background-color:#cceeff;font-weight:bold;">Property and equipment</font><font style="font-family:inherit;font-size:9pt;background-color:#cceeff;">&#160;(note 12)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">425</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">41</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Acquired intellectual property and other intangible assets</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">11,931</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">12,616</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">151,237</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">145,863</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;background-color:#cceeff;font-weight:bold;">Current liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Accounts payable and accrued liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6,989</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7,071</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;background-color:#cceeff;">Lease liability (note 12)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">122</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Deferred revenue </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">118</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">118</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;background-color:#cceeff;">Contingent consideration (note 4)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">71</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">72</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7,300</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7,261</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;background-color:#cceeff;font-weight:bold;">Lease liability </font><font style="font-family:inherit;font-size:9pt;background-color:#cceeff;">(note 12)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">290</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Deferred revenue</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">265</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">324</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;background-color:#cceeff;font-weight:bold;">Contingent consideration</font><font style="font-family:inherit;font-size:9pt;background-color:#cceeff;">&#160;(note 4)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,037</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,956</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Derivative warrant liabilities</font><font style="font-family:inherit;font-size:9pt;">&#160;(note 5)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">13,477</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">21,747</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">25,369</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">33,288</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Shareholders&#8217; Equity</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;background-color:#cceeff;font-weight:bold;">Common shares </font><font style="font-family:inherit;font-size:9pt;background-color:#cceeff;">(note 6)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">543,824</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">504,650</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Contributed surplus</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">27,138</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">24,690</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;background-color:#cceeff;font-weight:bold;">Accumulated other comprehensive loss</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(805</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(805</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Deficit</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(444,289</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(415,960</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">125,868</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">112,575</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">151,237</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">145,863</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;background-color:#cceeff;font-weight:bold;">Commitments (note 10)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Subsequent events (note 13)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:16px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The accompanying notes are an integral part of these interim condensed consolidated financial statements.</font></div><div style="line-height:120%;padding-bottom:16px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><a name="s7F1F63C98FDB5A8BAE47C7B6AED2824B"></a></div><div><div style="line-height:120%;text-align:center;font-size:9pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Aurinia Pharmaceuticals Inc.</font></div><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Interim Condensed Consolidated Statements of Operations and Comprehensive Loss </font><font style="font-family:inherit;font-size:9pt;font-style:italic;">(Unaudited)</font></div><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">For the three and six month periods ended June 30, 2019 and 2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(expressed in thousands of US dollars, except per share data)</font></div></td></tr></table></div></div></div><div><br></div><div style="line-height:120%;padding-bottom:16px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="10"></td></tr><tr><td style="width:47%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three months ended</font></div></td><td style="vertical-align:bottom;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Six months ended</font></div></td><td style="vertical-align:bottom;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">June 30, <br>2019<br>$</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">June 30, <br>2018<br>$</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">June 30, <br>2019<br>$</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">June 30, <br>2018<br>$</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Revenue</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Licensing revenue</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">29</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">29</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">59</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">59</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Expenses</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Research and development</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">11,152</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">10,504</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">21,783</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">19,391</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Corporate, administration and business development</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,946</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,462</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8,847</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7,253</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Amortization of acquired intellectual property and other intangible assets </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">347</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">397</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">693</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">793</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Amortization of property and equipment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">38</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">75</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">9</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other expenses (note 7)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">720</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">720</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">17,203</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">14,369</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">32,118</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">27,446</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Loss before interest income, finance costs, change in estimated fair value of derivative warrant liabilities and income taxes</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(17,174</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(14,340</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(32,059</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(27,387</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Interest income</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">787</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">632</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,598</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">872</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Finance costs (note 7)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(123</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(66</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(189</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(106</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Loss before change in estimated fair value of derivative warrant liabilities and income taxes</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(16,510</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(13,774</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(30,650</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(26,621</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;background-color:#cceeff;">Change in estimated fair value of derivative warrant liabilities (note 5)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">625</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1,933</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,350</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(4,564</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Loss before income taxes</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(15,885</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(15,707</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(28,300</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(31,185</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;background-color:#cceeff;">Income tax expense</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">16</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">29</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Net loss and comprehensive loss for the period</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(15,901</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(15,707</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(28,329</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(31,185</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;background-color:#cceeff;font-weight:bold;">Net loss per common share</font><font style="font-family:inherit;font-size:9pt;background-color:#cceeff;">&#160;(note 8) (expressed in $ per share)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Basic and diluted loss per common share</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.17</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.19</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.31</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.37</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Certain lines in the statement of operations and comprehensive loss have been disaggregated and re-labeled as described in note 7.</font></div><div style="line-height:120%;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:120%;padding-bottom:16px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The accompanying notes are an integral part of these interim condensed consolidated financial statements.</font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><a name="s8110AD78DF785E96AE252F4822FF80FB"></a></div><div><div style="line-height:120%;text-align:center;font-size:9pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Aurinia Pharmaceuticals Inc.</font></div><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Interim Condensed Consolidated Statements of Changes in Shareholders&#8217; Equity </font><font style="font-family:inherit;font-size:9pt;font-style:italic;">(Unaudited)</font></div><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">For the six month periods ended June 30, 2019 and 2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(expressed in thousands of US dollars)</font></div></td></tr></table></div></div></div><div><br></div><div style="line-height:120%;padding-bottom:16px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="18"></td></tr><tr><td style="width:33%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Common<br>shares<br>$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Warrants<br>$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Contributed<br>surplus<br>$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Deficit<br>$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Accumulated<br>other<br>comprehensive<br>loss<br>$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Shareholders&#8217;<br>equity <br>$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Balance &#8211; January&#160;1, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">504,650</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">24,690</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(415,960</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(805</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">112,575</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Issue of common shares </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">30,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">30,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Share issue costs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1,170</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1,170</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Exercise of derivative warrants</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7,413</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7,413</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Exercise of stock options</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,931</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1,116</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,815</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Stock based compensation</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,564</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,564</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net loss and comprehensive loss for the period</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(28,329</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(28,329</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Balance - June 30, 2019</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">543,824</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">27,138</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(444,289</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(805</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">125,868</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Balance &#8211; January&#160;1, 2018</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">499,200</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">906</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">18,360</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(351,840</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(805</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">165,821</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Exercise of warrants</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,935</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(888</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,047</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Exercise of stock options</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">553</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(206</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">347</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Stock based compensation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,140</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,140</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net loss and comprehensive loss for the period</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(31,185</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(31,185</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Balance - June 30, 2018</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">503,688</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">18</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">22,294</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(383,025</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(805</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">142,170</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:16px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The accompanying notes are an integral part of these interim condensed consolidated financial statements.</font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><a name="sB0FE9E74A9D55422812CD721A68AAA19"></a></div><div><div style="line-height:120%;text-align:center;font-size:9pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Aurinia Pharmaceuticals Inc.</font></div><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Interim Condensed Consolidated Statements of Cash Flows </font><font style="font-family:inherit;font-size:9pt;font-style:italic;">(Unaudited)</font></div><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">For the three and six month periods ended June 30, 2019 and 2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(expressed in thousands of US dollars)</font></div></td></tr></table></div></div></div><div><br></div><div style="line-height:120%;padding-bottom:16px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"></td></tr><tr><td style="width:56%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three months ended</font></div></td><td style="vertical-align:bottom;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Six months ended</font></div></td><td style="vertical-align:bottom;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">June 30,<br>2019<br>$</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">June 30,<br>2018<br>$</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">June 30,<br>2019<br>$</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">June 30,<br>2018<br>$</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Cash flow provided by (used in)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Operating activities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net loss for the period</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(15,901</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(15,707</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(28,329</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(31,185</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Adjustments for</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Amortization of deferred revenue</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(29</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(29</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(59</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(59</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Amortization of property and equipment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">38</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">75</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">9</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Amortization of acquired intellectual property and other intangible assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">347</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">397</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">693</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">793</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Amortization of short term investment discount (note 11)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">11</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Revaluation of contingent consideration</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">87</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">60</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">80</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">149</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Foreign exchange impact on lease liability</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">10</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">18</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Interest expense</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">10</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">21</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Change in estimated fair value of derivative warrant liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(625</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,933</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(2,350</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,564</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Stock-based compensation</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,960</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,029</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,564</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,140</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(14,102</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(11,306</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(26,282</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(21,578</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net change in other operating assets and liabilities (note 11)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">849</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(983</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(120</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(5,091</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Net cash used in operating activities</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(13,253</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(12,289</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(26,402</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(26,669</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Investing activities</font><font style="font-family:inherit;font-size:9pt;">&#160;(note 11)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Proceeds on maturity of short term investment</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,974</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">10,001</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7,884</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">10,001</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Purchase of short term investments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(20,000</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Purchase of equipment</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(22</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(34</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(22</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Capitalized patent costs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(31</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(31</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Net cash generated from (used in) investing activities</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,952</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">9,970</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7,842</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(10,052</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Financing activities</font><font style="font-family:inherit;font-size:9pt;">&#160;(note 11)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net proceeds from issuance of common shares</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">28,830</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Proceeds from exercise of derivative warrants</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,493</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Proceeds from exercise of warrants</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,047</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,047</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Proceeds from exercise of stock options</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">464</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">347</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,815</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">347</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Principal elements of lease payments</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(29</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(52</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Net cash generated from financing activities</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">435</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,394</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">32,086</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,394</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Increase (decrease) in cash and cash equivalents during the period</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(8,866</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,075</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">13,526</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(33,327</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Cash and cash equivalents &#8211; Beginning of period</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">140,359</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">131,227</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">117,967</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">165,629</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Cash and cash equivalents &#8211; End of period</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">131,493</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">132,302</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">131,493</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">132,302</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:16px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The accompanying notes are an integral part of these interim condensed consolidated financial statements.</font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><a name="sB524EBD4C75355B1A4FEB030FEB7A9E7"></a></div><div><div style="line-height:120%;text-align:center;font-size:9pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Aurinia Pharmaceuticals Inc.</font></div><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Notes to Interim Condensed Consolidated Statements </font><font style="font-family:inherit;font-size:9pt;font-style:italic;">(Unaudited)</font></div><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">For the three and six month periods ended June 30, 2019 and 2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(expressed in US dollars, tabular amounts in thousands)</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:0px;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">1</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Corporate information</font></div></td></tr></table><div style="line-height:120%;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Aurinia Pharmaceuticals Inc. or the Company is a late clinical stage biopharmaceutical company, focused on developing and commercializing therapies to treat targeted patient populations that are suffering from serious diseases with a high unmet medical need. The Company is currently developing voclosporin, an investigational drug, for the treatment of lupus nephritis (LN), focal segmental glomerulosclerosis (FSGS) and Dry Eye Syndrome (DES). </font></div><div style="line-height:120%;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:120%;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Aurinia's head office is located at #1203-4464 Markham Street, Victoria, British Columbia, V8Z 7X8. The Company has its registered office located at #201, 17904-105 Avenue, Edmonton, Alberta, T5S 2H5 where the finance function is performed. </font></div><div style="line-height:120%;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:120%;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Aurinia Pharmaceuticals Inc. is incorporated pursuant to the Business Corporations Act (Alberta). The Company&#8217;s common shares are currently listed and traded on the NASDAQ Global Market (NASDAQ) under the symbol AUPH and on the Toronto Stock Exchange (TSX) under the symbol AUP. </font></div><div style="line-height:120%;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:120%;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">These consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries, Aurinia Pharma U.S., Inc. (Delaware incorporated) and Aurinia Pharma Limited (UK incorporated).</font></div><div style="line-height:120%;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div><a name="s7217297D18325BE8B4EB657B14F2B736"></a></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Basis of preparation</font></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;text-indent:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Statement of compliance</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">These interim condensed consolidated financial statements of the Company have been prepared in accordance with International Financial Reporting Standards (IFRS), as applicable to interim financial reports including IAS 34, Interim Financial Reporting, and should be read in conjunction with the annual financial statements of the Company for the year ended December 31, 2018 which have been prepared in accordance with IFRS, as issued by International Accounting Standards Board (IASB).</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">These interim condensed consolidated financial statements were authorized for issue by the Board of Directors on August 6, 2019.</font></div><div style="line-height:120%;padding-bottom:8px;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Basis of measurement</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The interim condensed consolidated financial statements have been prepared on a going concern and historical cost basis, other than certain financial instruments recognized at fair value.</font></div><div style="line-height:120%;padding-bottom:8px;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Functional and presentation currency</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">These interim condensed consolidated financial statements are presented in United States (US) dollars, which is the Company&#8217;s functional currency.</font></div><div><a name="s9EBC434B90F95CBB83554219369397A1"></a></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:0px;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">3</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Accounting Policy</font></div></td></tr></table><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">These interim condensed consolidated financial statements follow the same accounting policies and methods of their application as the December 31, 2018 annual audited consolidated financial statements except as described below for new accounting standards adopted effective January 1, 2019.</font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">New Accounting Standards Adopted During the Period</font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">IFRS 16&#8212; Leases</font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company has adopted IFRS 16 &#8212;</font><font style="font-family:inherit;font-size:9pt;font-style:italic;">Leases </font><font style="font-family:inherit;font-size:9pt;">(IFRS 16) with the date of initial application of January 1, 2019 using the modified retrospective approach. In accordance with the transitional provisions in IFRS 16 comparative figures have not been restated, rather the reclassifications and adjustments arising from the adoption of this standard are recognized in the opening Statement of Financial Position on January 1, 2019. The impact of adoption of IFRS 16 is disclosed in Note 11.</font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The following policies are applicable from January 1, 2019. In the comparative period, leases were accounted for in accordance with the accounting policy for leases disclosed in the Company&#8217;s December 31, 2018 annual audited consolidated financial statements. </font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">Policy applicable from January 1, 2019:</font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">At inception of a contract, the Company assesses whether a contract is, or contains, a lease. A contract contains a lease if the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration. The Company assesses whether:</font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8226; the contract involves the use of an explicitly or implicitly identified asset;</font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8226; the Company has the right to obtain substantially all of the economic benefits from the use of the asset throughout the contract term;</font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8226; the Company has the right to direct the use of the asset.</font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(</font><font style="font-family:inherit;font-size:10pt;">1</font><font style="font-family:inherit;font-size:10pt;">)</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:center;font-size:9pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Aurinia Pharmaceuticals Inc.</font></div><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Notes to Interim Condensed Consolidated Statements </font><font style="font-family:inherit;font-size:9pt;font-style:italic;">(Unaudited)</font></div><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">For the three and six month periods ended June 30, 2019 and 2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(expressed in US dollars, tabular amounts in thousands)</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company recognizes a right-of-use asset and a lease liability at the commencement date of the lease, the date the underlying asset is available for use. Right-of-use assets are measured at cost, less any accumulated depreciation and impairment losses, and adjusted for any re-measurement of lease liabilities. The cost of right-of-use assets includes the initial amount of lease liabilities recognized, initial direct costs incurred, restoration costs, and lease payments made at or before the commencement date less any lease incentive received, if any.</font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Unless the Company is reasonably certain to obtain ownership of the leased asset at the end of the lease term, the right-of-use assets are depreciated on a straight-line basis over the shorter of the estimated useful life and the lease term. Right-of-use assets are subject to impairment. </font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">At the commencement date of the lease, the Company recognizes lease liabilities measured at the present value of lease payments to be made over the lease term, discounted using the interest rate implicit in the lease or, if that rate cannot be readily determined, the Company&#8217;s incremental borrowing rate. The lease payments include fixed payments, variable lease payments that depend on an index or a rate, amounts expected to be paid under residual value guarantees and the exercise price of a purchase option reasonably certain to be exercised by the Company. </font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">After the commencement date, the amount of lease liabilities is increased to reflect the accretion of interest and reduced for the lease payments made. In addition, the carrying amount of lease liabilities is remeasured if there is a modification, a change in the lease term, a change in the fixed lease payments or a change in the assessment to purchase the underlying asset.</font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company presents right-of-use assets in the property and equipment line and lease liabilities in the lease liability line on the interim condensed statement of financial position.</font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">Short-term leases and leases of low value assets</font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company has elected to use the practical expedient permitted by the standard and not to recognize right-of-use assets and lease liabilities for leases that have a lease term of 12 months or less and do not contain a purchase option or for leases related to low value assets. Lease payments on short-term leases and leases of low value assets are recognized as an expense in the interim condensed statement of operations and comprehensive loss.</font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">Critical Judgements in determining the lease term</font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">In determining the lease term, management considers all facts and circumstances that create economic incentive to exercise an extension option, or not exercise a termination option. Extension options (or periods after termination options) are only included in the lease term if the lease is reasonably certain to be extended (or not terminated).</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div><a name="s94CF1184EA555B2890A18E125B4CD7E3"></a></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:0px;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">4</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Contingent consideration</font></div></td></tr></table><div style="line-height:120%;padding-bottom:16px;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The outstanding fair value of contingent consideration payable to ILJIN an affiliated shareholder and related party, is the result of an Arrangement Agreement (the Agreement) completed on September 20, 2013 between the Company, Aurinia Pharma Corp. and ILJIN. Pursuant to the Agreement, the remaining payments of up to $7,850,000 may be paid dependent on the achievement of pre-defined clinical and marketing milestones.</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Previously, in 2017 the Company paid ILJIN $2,150,000 upon the achievement of two specific milestones reducing the original $10,000,000 contingent consideration to $7,850,000. </font></div><div style="line-height:120%;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">At </font><font style="font-family:inherit;font-size:9pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:9pt;">, if all of the remaining milestones are met, the timing of these payments is estimated to occur as follows:</font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:92.98245614035088%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:86%;"></td><td style="width:13%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">$   </font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2019</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">100</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2021</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6,625</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2022</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">500</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2023</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">125</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2024</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">500</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7,850</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The fair value estimates at </font><font style="font-family:inherit;font-size:9pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:9pt;">&#32;were based on a discount rate of 10% (</font><font style="font-family:inherit;font-size:9pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:9pt;">&#32;- 10%) and a presumed payment range between 50% and 74% (</font><font style="font-family:inherit;font-size:9pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:9pt;">&#32;- 50% and 74%). The fair value of this contingent consideration as at </font><font style="font-family:inherit;font-size:9pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:9pt;">&#32;&#32;was estimated to be </font><font style="font-family:inherit;font-size:9pt;">$4,108,000</font><font style="font-family:inherit;font-size:9pt;">&#32;(</font><font style="font-family:inherit;font-size:9pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:9pt;">&#32;- $4,028,000) and was determined by estimating the probability and timing of achieving the milestones and applying the income approach. </font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(</font><font style="font-family:inherit;font-size:10pt;">2</font><font style="font-family:inherit;font-size:10pt;">)</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:center;font-size:9pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Aurinia Pharmaceuticals Inc.</font></div><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Notes to Interim Condensed Consolidated Statements </font><font style="font-family:inherit;font-size:9pt;font-style:italic;">(Unaudited)</font></div><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">For the three and six month periods ended June 30, 2019 and 2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(expressed in US dollars, tabular amounts in thousands)</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The change in expected timing of milestone payments and passage of time, on revaluation, resulted in an increase in contingent consideration of $87,000 and $80,000 respectively for the three and six months ended June 30, 2019 compared to an increase in contingent consideration of $60,000 and $149,000 for the same periods in 2018.</font></div><div style="line-height:120%;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">This is a Level&#160;3 recurring fair value measurement. If the probability for success were to increase by a factor of 10% for each milestone, this would increase the net present value (NPV) of the obligation by approximately $635,000 as at </font><font style="font-family:inherit;font-size:9pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:9pt;">. If the probability for success were to decrease by a factor of 10% for each milestone, this would decrease the NPV of the obligation by approximately $635,000 as at </font><font style="font-family:inherit;font-size:9pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:9pt;">. If the discount rate were to increase to 12%, this would decrease the NPV of the obligation by approximately $158,000. If the discount rate were to decrease to 8%, this would increase the NPV of the obligation by approximately $173,000.</font></div><div><a name="s796EBFDE4C16580DA37FAF27F60887B9"></a></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:0px;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">5</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Derivative warrant liabilities</font></div></td></tr></table><div style="line-height:120%;padding-bottom:4px;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">In accordance with IFRS, a contract to issue a variable number of shares fails to meet the definition of equity and must instead be classified as a derivative liability and measured at fair value with changes in fair value recognized in the consolidated statements of operations and comprehensive loss at each period-end. The derivative liabilities will ultimately be converted into the Company&#8217;s equity (common shares) when the warrants are exercised, or will be extinguished on the expiry of the outstanding warrants, and will not result in the outlay of any cash by the Company. Immediately prior to exercise, the warrants are remeasured at their estimated fair value. Upon exercise, the intrinsic value is transferred to share capital (the intrinsic value is the share price at the date the warrant is exercised less the exercise price of the warrant) . Any remaining fair value is recorded through the statement of operations and comprehensive loss as part of the change in estimated fair value of derivative warrant liabilities.</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;padding-left:48px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:92.98245614035088%;border-collapse:collapse;text-align:left;"><tr><td colspan="18"></td></tr><tr><td style="width:32%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;28, 2016<br>Warrants</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">February&#160;14, 2014<br>Warrants</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">#&#160;of&#160;warrants<br>(in&#160;thousands)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">#&#160;of&#160;warrants<br>(in&#160;thousands)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">#&#160;of&#160;warrants<br>(in&#160;thousands)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Balance at January&#160;1, 2019</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,523</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">15,475</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,738</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6,272</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5,261</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">21,747</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Conversion to equity (common shares) upon exercise of warrants</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1,738</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(5,920</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1,738</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(5,920</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Revaluation of derivative warrant liability</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1,373</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(352</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1,725</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Balance at March 31, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,523</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">14,102</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,523</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">14,102</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Revaluation of derivative warrant liability</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(625</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(625</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Balance at June 30, 2019</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,523</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">13,477</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,523</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">13,477</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Balance at January&#160;1, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,523</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8,948</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,738</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,845</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5,261</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">11,793</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Revaluation of derivative warrant liability</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,903</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">728</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,631</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Balance at March 31, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,523</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">10,851</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,738</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,573</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5,261</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">14,424</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Revaluation of derivative warrant liability</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,231</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">702</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,933</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Balance at June 30, 2018</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,523</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">12,082</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,738</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,275</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5,261</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">16,357</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:120%;padding-bottom:4px;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Derivative warrant liability related to December&#160;28, 2016 Bought Deal public offering</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">On December&#160;28, 2016, the Company completed a </font><font style="font-family:inherit;font-size:9pt;">$28,750,000</font><font style="font-family:inherit;font-size:9pt;">&#32;Bought Deal public offering (the Offering). Under the terms of the Offering, the Company issued </font><font style="font-family:inherit;font-size:9pt;">12,778,000</font><font style="font-family:inherit;font-size:9pt;">&#32;units at a subscription price per Unit of </font><font style="font-family:inherit;font-size:9pt;">$2.25</font><font style="font-family:inherit;font-size:9pt;">, each Unit consisting of </font><font style="font-family:inherit;font-size:9pt;">one</font><font style="font-family:inherit;font-size:9pt;">&#32;common share and one-half (</font><font style="font-family:inherit;font-size:9pt;">0.50</font><font style="font-family:inherit;font-size:9pt;">) of a common share purchase warrant (a Warrant), exercisable for a period of </font><font style="font-family:inherit;font-size:9pt;">five</font><font style="font-family:inherit;font-size:9pt;">&#32;years from the date of issuance at an exercise price of </font><font style="font-family:inherit;font-size:9pt;">$3.00</font><font style="font-family:inherit;font-size:9pt;">. The holders of the Warrants issued pursuant to this offering may elect, if the Company does not have an effective registration statement registering or the prospectus contained therein is not available for the issuance of the Warrant Shares to the holder, in lieu of exercising the Warrants for cash, a cashless exercise option to receive common shares equal to the fair value of the Warrants. The fair value is determined by multiplying the number of Warrants to be exercised by the weighted average market price less the exercise price with the difference divided by the weighted average market price. If a Warrant holder exercises this option, there will be variability in the number of shares issued per Warrant.</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">At initial recognition on December&#160;28, 2016, the Company recorded a derivative warrant liability of </font><font style="font-family:inherit;font-size:9pt;">$7,223,000</font><font style="font-family:inherit;font-size:9pt;">&#32;based on the estimated fair value of the Warrants.</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">There were no derivative warrant exercises in the three and six month periods ended June 30, 2019 and June 30, 2018 for the December 28, 2016 derivate warrants. </font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company uses the Black-Scholes pricing model to estimate fair value. The Company considers expected volatility of its common shares in estimating its future stock price volatility. The risk-free interest rate for the life of the Warrants was based on the yield available on government benchmark bonds with an approximate equivalent remaining term at the time of issue. The life of warrant is based on the contractual term.</font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(</font><font style="font-family:inherit;font-size:10pt;">3</font><font style="font-family:inherit;font-size:10pt;">)</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:center;font-size:9pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Aurinia Pharmaceuticals Inc.</font></div><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Notes to Interim Condensed Consolidated Statements </font><font style="font-family:inherit;font-size:9pt;font-style:italic;">(Unaudited)</font></div><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">For the three and six month periods ended June 30, 2019 and 2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(expressed in US dollars, tabular amounts in thousands)</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">As at  </font><font style="font-family:inherit;font-size:9pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:9pt;">, the Company revalued the remaining derivative warrants at an estimated fair value of  </font><font style="font-family:inherit;font-size:9pt;">$13,477,000</font><font style="font-family:inherit;font-size:9pt;">&#32;(</font><font style="font-family:inherit;font-size:9pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:9pt;">&#32;&#32;&#8211; </font><font style="font-family:inherit;font-size:9pt;">$15,475,000</font><font style="font-family:inherit;font-size:9pt;">). The Company recorded a decrease in the estimated fair value of the derivative warrant liability of </font><font style="font-family:inherit;font-size:9pt;">$625,000</font><font style="font-family:inherit;font-size:9pt;">&#32;and $1,998,000  for the three and six months ended </font><font style="font-family:inherit;font-size:9pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:9pt;">&#32;(June 30, 2018 - increase of </font><font style="font-family:inherit;font-size:9pt;">$1,231,000</font><font style="font-family:inherit;font-size:9pt;">&#32;and $3,134,000).</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The following assumptions were used to estimate the fair value of the derivative warrant liability on </font><font style="font-family:inherit;font-size:9pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:9pt;">&#32;and </font><font style="font-family:inherit;font-size:9pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:9pt;">. </font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;padding-left:48px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:92.98245614035088%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:72%;"></td><td style="width:13%;"></td><td style="width:1%;"></td><td style="width:13%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">June 30, <br>2019<br>$</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31,<br>2018<br>$</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Annualized volatility</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">40</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">55</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Risk-free interest rate</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1.72</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2.45</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Life of warrants in years</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2.50</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2.99</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Dividend rate</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Market price</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6.58</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6.82</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Fair value per Warrant</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3.82</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4.39</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">These derivative warrant liabilities are Level&#160;3 recurring fair value measurements. The key Level&#160;3 inputs used by management to estimate the fair value are the market price and the expected volatility. If the market price were to increase by a factor of </font><font style="font-family:inherit;font-size:9pt;">10%</font><font style="font-family:inherit;font-size:9pt;">, this would increase the estimated fair value of the obligation by approximately $2,222,000 as at </font><font style="font-family:inherit;font-size:9pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:9pt;">. If the market price were to decrease by a factor of </font><font style="font-family:inherit;font-size:9pt;">10%</font><font style="font-family:inherit;font-size:9pt;">, this would decrease the estimated fair value of the obligation by approximately $2,183,000. If the volatility were to increase by </font><font style="font-family:inherit;font-size:9pt;">10%</font><font style="font-family:inherit;font-size:9pt;">, this would increase the estimated fair value of the obligation by approximately $168,000. If the volatility were to decrease by </font><font style="font-family:inherit;font-size:9pt;">10%</font><font style="font-family:inherit;font-size:9pt;">, this would decrease estimated fair value of the obligation by approximately $143,000 as at </font><font style="font-family:inherit;font-size:9pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:9pt;">.</font></div><div style="line-height:120%;padding-bottom:8px;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Derivative warrant liability related to February&#160;14, 2014 private placement offering</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">On February&#160;14, 2014, the Company completed a </font><font style="font-family:inherit;font-size:9pt;">$52,000,000</font><font style="font-family:inherit;font-size:9pt;">&#32;private placement. Under the terms of the Offering, the Company issued </font><font style="font-family:inherit;font-size:9pt;">18,919,404</font><font style="font-family:inherit;font-size:9pt;">&#32;units at a subscription price per Unit of </font><font style="font-family:inherit;font-size:9pt;">$2.7485</font><font style="font-family:inherit;font-size:9pt;">, each Unit consisting of </font><font style="font-family:inherit;font-size:9pt;">one</font><font style="font-family:inherit;font-size:9pt;">&#32;common share and one-quarter (</font><font style="font-family:inherit;font-size:9pt;">0.25</font><font style="font-family:inherit;font-size:9pt;">) of a common share purchase warrant (a Warrant), exercisable for a period of </font><font style="font-family:inherit;font-size:9pt;">five</font><font style="font-family:inherit;font-size:9pt;">&#32;years from the date of issuance at an exercise price of </font><font style="font-family:inherit;font-size:9pt;">$3.2204</font><font style="font-family:inherit;font-size:9pt;">. The holders of the Warrants issued pursuant to the February&#160;14, 2014 private placement may elect, in lieu of exercising the Warrants for cash, a cashless exercise option to receive common shares equal to the fair value of the Warrants based on the number of Warrants to be exercised multiplied by a </font><font style="font-family:inherit;font-size:9pt;">five</font><font style="font-family:inherit;font-size:9pt;">-day weighted average market price less the exercise price with the difference divided by the weighted average market price. If a Warrant holder exercises this option, there will be variability in the number of shares issued per Warrant.</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">In the three month period ended March 31, 2019, the 1,738,000 derivative warrants outstanding at December 31, 2018 related to the February 14, 2014 private placement offering, were exercised. Certain holders of these Warrants elected the cashless exercise option and the Company issued 687,000 common shares on the cashless exercise of 1,274,000 Warrants. The remaining 464,000 warrants were exercised for cash, at a price of $3.2204 per common share and the Company received cash proceeds of $1,493,000 upon the issuance of 464,000 common shares. Pursuant to the exercise of these warrants, the Company transfered $5,920,000 from derivative warrant liabilities to equity (common shares) and recorded a net adjustment of $352,000 through the Statement of Operations and Comprehensive Loss. As a result, the derivative warrant liability of $6,272,000 at December 31, 2018 related to the February 14, 2014 private placement offering has been extinguished upon the exercise of the aforementioned warrants. </font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(</font><font style="font-family:inherit;font-size:10pt;">4</font><font style="font-family:inherit;font-size:10pt;">)</font></div></div><hr style="page-break-after:always"><div><a name="s8FA1D703D48E57B89074D5BC4B6855A6"></a></div><div><div style="line-height:120%;text-align:center;font-size:9pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Aurinia Pharmaceuticals Inc.</font></div><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Notes to Interim Condensed Consolidated Statements </font><font style="font-family:inherit;font-size:9pt;font-style:italic;">(Unaudited)</font></div><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">For the three and six month periods ended June 30, 2019 and 2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(expressed in US dollars, tabular amounts in thousands)</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:0px;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">6</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Share capital</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:48px;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">a)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Common shares</font></div></td></tr></table><div style="line-height:120%;padding-bottom:4px;padding-left:48px;text-indent:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Authorized</font></div><div style="line-height:120%;padding-bottom:4px;padding-left:48px;text-indent:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;Unlimited common shares without par value</font></div><div style="line-height:120%;padding-bottom:4px;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:120%;padding-bottom:4px;padding-left:48px;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:9pt;">Issued</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:92.98245614035088%;border-collapse:collapse;text-align:left;"><tr><td colspan="6"></td></tr><tr><td style="width:71%;"></td><td style="width:13%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:13%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Common shares</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Number<br></font><font style="font-family:inherit;font-size:8pt;">(in&#160;thousands)</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Balance as at January&#160;1, 2019</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">85,500</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">504,650</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Issued pursuant to At The Market (ATM) Facility</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,608</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">28,830</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Issued pursuant to exercise of derivative liability warrants (note 5)<br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,151</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7,413</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Issued pursuant to exercise of stock options<br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">534</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,931</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Balance as at June 30, 2019</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">91,793</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">543,824</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Balance as at January 1, 2018</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">84,052</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">499,200</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Issued pursuant to exercise of warrants</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,158</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,935</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Issued pursuant to exercise of stock options</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">111</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">553</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Balance as at June 30, 2018</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">85,321</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">503,688</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:4px;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">ATM Facility</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:4px;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">On November 30, 2018 the Company entered into an Open Market Sale Agreement (the &#8220;Sale Agreement&#8221;) with Jefferies LLC (&#8220;Jefferies&#8221;) pursuant to which the Company sold, through at-the-market (&#8220;ATM&#8221;) offerings, common shares that would have an aggregate offering price of up to US$30,000,000. Aurinia filed a prospectus supplement with securities regulatory authorities in Canada in the provinces of British Columbia, Alberta and Ontario, and with the United States Securities and Exchange Commission, which supplements Aurinia&#8217;s short form base shelf prospectus dated March 26, 2018, and Aurinia&#8217;s shelf registration statement on Form F-10 dated March 26, 2018, declared effective on March 29, 2018. Sales from the ATM offering were only conducted in the United States through NASDAQ at market prices. </font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Pursuant to this agreement the ATM Facility was fully utilized in the three months ended March 31, 2019 resulting in gross proceeds of $30,000,000 upon the issuance of 4,608,000 common shares at a weighted average price of $6.51. The Company incurred share issue costs of $1,170,000 including a 3% commission of $900,000 paid to the agent and professional and filing fees of $270,000 directly related to the ATM.</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:48px;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">b)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Stock options and compensation expense</font></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;text-align:justify;padding-left:96px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">A summary of the stock options outstanding as at </font><font style="font-family:inherit;font-size:9pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:9pt;">&#32;and </font><font style="font-family:inherit;font-size:9pt;">June&#160;30, 2018</font><font style="font-family:inherit;font-size:9pt;">&#32;and changes during the periods ended on those dates is presented below:</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;padding-left:48px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:92.98245614035088%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td style="width:45%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Number</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted<br>average<br>exercise<br>price in<br>CA$</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Number</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted<br>average<br>exercise<br>price in<br>CA$</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Outstanding &#8211; Beginning of period</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7,591</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5.51</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,864</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4.80</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Granted pursuant to Stock Option Plan</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,480</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8.08</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,978</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6.53</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Granted pursuant to Section 613(c) of TSX manual</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,600</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8.45</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Exercised</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(534</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4.55</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(111</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4.08</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Forfeited</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(273</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6.74</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Outstanding &#8211; End of period</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">9,864</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6.39</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7,731</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5.48</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Options exercisable &#8211; End of period</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5,211</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5.42</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,581</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4.68</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(</font><font style="font-family:inherit;font-size:10pt;">5</font><font style="font-family:inherit;font-size:10pt;">)</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:center;font-size:9pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Aurinia Pharmaceuticals Inc.</font></div><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Notes to Interim Condensed Consolidated Statements </font><font style="font-family:inherit;font-size:9pt;font-style:italic;">(Unaudited)</font></div><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">For the three and six month periods ended June 30, 2019 and 2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(expressed in US dollars, tabular amounts in thousands)</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The maximum number of  Common Shares issuable under the Stock Option Plan is equal to </font><font style="font-family:inherit;font-size:9pt;">12.5%</font><font style="font-family:inherit;font-size:9pt;">&#32;of the issued and outstanding Common Shares at the time the Common Shares are reserved for issuance. As at </font><font style="font-family:inherit;font-size:9pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:9pt;">&#32;there were </font><font style="font-family:inherit;font-size:9pt;">91,793,000</font><font style="font-family:inherit;font-size:9pt;">&#32;Common Shares of the Company issued and outstanding, resulting in a maximum of </font><font style="font-family:inherit;font-size:9pt;">11,474,000</font><font style="font-family:inherit;font-size:9pt;">&#32;options available for issuance under the Stock Option Plan. An aggregate total of </font><font style="font-family:inherit;font-size:9pt;">8,145,000</font><font style="font-family:inherit;font-size:9pt;">&#32;options are presently outstanding in the Stock Option Plan, representing </font><font style="font-family:inherit;font-size:9pt;">8.9%</font><font style="font-family:inherit;font-size:9pt;">&#32;of the issued and outstanding Common Shares of the Company.</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">In addition, on April 29, 2019, the Company granted 1,600,000 inducement stock options to the new Chief Executive Officer pursuant to Section 613(c) of the TSX Company Manual at a price of $6.28 (CA$8.45). The first 25% of these options vest on the one year anniversary of grant, and the remaining 75% vest in equal amounts over </font><font style="font-family:inherit;font-size:9pt;">36</font><font style="font-family:inherit;font-size:9pt;">&#32;months following the one year anniversary date and are exercisable for a term of ten years. These options are recorded outside of the Company&#8217;s stock option plan. </font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Previously, on May&#160;2, 2016, the Company granted </font><font style="font-family:inherit;font-size:9pt;">200,000</font><font style="font-family:inherit;font-size:9pt;">&#32;inducement stock options to a new employee pursuant to Section 613(c) of the TSX Company Manual at a price of </font><font style="font-family:inherit;font-size:9pt;">$2.92</font><font style="font-family:inherit;font-size:9pt;">&#32;(CA</font><font style="font-family:inherit;font-size:9pt;">$3.66</font><font style="font-family:inherit;font-size:9pt;">). These options vest in equal amounts over </font><font style="font-family:inherit;font-size:9pt;">36</font><font style="font-family:inherit;font-size:9pt;">&#32;months and are exercisable for a term of </font><font style="font-family:inherit;font-size:9pt;">five years</font><font style="font-family:inherit;font-size:9pt;">. At June 30, 2019 this employee currently holds </font><font style="font-family:inherit;font-size:9pt;">119,000</font><font style="font-family:inherit;font-size:9pt;">&#32;of these options. These options are recorded outside of the Company&#8217;s stock option plan. </font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Stock Option Plan requires the exercise price of each option to be determined by the Board of Directors and not to be less than the closing market price of the Company&#8217;s stock on the day immediately prior to the date of grant. Any options which expire may be re-granted. The Board of Directors approves the vesting criteria and periods at its discretion. The options issued under the plan are accounted for as equity-settled share-based payments.</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">A summary of the stock options granted pursuant to the Stock Option Plan for the period ended </font><font style="font-family:inherit;font-size:9pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:9pt;">&#32;and </font><font style="font-family:inherit;font-size:9pt;">June&#160;30, 2018</font><font style="font-family:inherit;font-size:9pt;">&#32;is presented below:</font></div><div style="line-height:120%;padding-bottom:8px;text-align:center;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Six month period ended </font><font style="font-family:inherit;font-size:9pt;font-weight:bold;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:9pt;font-weight:bold;">&#32;</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;padding-left:48px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:92.98245614035088%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"></td></tr><tr><td style="width:58%;"></td><td style="width:13%;"></td><td style="width:1%;"></td><td style="width:13%;"></td><td style="width:1%;"></td><td style="width:13%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Grant date</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Grant&#160;price</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(6)<br></sup></font><font style="font-family:inherit;font-size:8pt;font-weight:bold;">US$</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Grant&#160;price</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(6)<br></sup></font><font style="font-family:inherit;font-size:8pt;font-weight:bold;">CA$</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Number <br></font><font style="font-family:inherit;font-size:8pt;">(in&#160;thousands)</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">January 29, 2019 - Directors</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6.06</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8.04</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">210</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">January 29, 2019 - Officers</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(4)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6.06</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8.04</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">875</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">January 29, 2019 - Employees</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6.06</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8.04</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">260</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">January 29, 2019 - Employees</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;background-color:transparent; font-size:6pt">(3)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6.06</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8.04</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">20</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;background-color:#cceeff;">March 29, 2019 - Employees</font><font style="font-family:inherit;font-size:9pt;background-color:#cceeff;"><sup style="vertical-align:top;line-height:120%;background-color:#cceeff; font-size:6pt">(3)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6.42</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8.62</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">10</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">April 2, 2019 - Employees</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;background-color:transparent; font-size:6pt">(3)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6.72</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8.97</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">30</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;background-color:#cceeff;">April 24, 2019 - Employees</font><font style="font-family:inherit;font-size:9pt;background-color:#cceeff;"><sup style="vertical-align:top;line-height:120%;background-color:#cceeff; font-size:6pt">(3)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6.29</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8.48</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">April 29, 2019 - Chief Executive Officer </font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;background-color:transparent; font-size:6pt">(5)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6.28</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8.45</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,600</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;background-color:#cceeff;">April 29, 2019 - Directors</font><font style="font-family:inherit;font-size:9pt;background-color:#cceeff;"><sup style="vertical-align:top;line-height:120%;background-color:#cceeff; font-size:6pt">(1)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6.28</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8.45</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">60</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">April 29, 2019 - Employees</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;background-color:transparent; font-size:6pt">(3)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6.28</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8.45</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">10</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,080</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;text-align:center;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Six month period ended </font><font style="font-family:inherit;font-size:9pt;font-weight:bold;">June&#160;30, 2018</font><font style="font-family:inherit;font-size:9pt;font-weight:bold;">&#32;</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;padding-left:48px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:92.98245614035088%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"></td></tr><tr><td style="width:58%;"></td><td style="width:13%;"></td><td style="width:1%;"></td><td style="width:13%;"></td><td style="width:1%;"></td><td style="width:13%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Grant date</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Grant&#160;price</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(6)<br></sup></font><font style="font-family:inherit;font-size:8pt;font-weight:bold;">US$</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Grant&#160;price</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(6)<br></sup></font><font style="font-family:inherit;font-size:8pt;font-weight:bold;">CA$</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Number <br></font><font style="font-family:inherit;font-size:8pt;">(in&#160;thousands)</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">February 1, 2018 - Employees</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5.30</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6.52</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">503</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">February 1, 2018 - Officers</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5.30</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6.52</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,675</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">February 5, 2018 - Chief Executive Officer</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5.19</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6.42</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">400</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">February 5, 2018 - Directors</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;background-color:transparent; font-size:6pt">(1)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5.19</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6.42</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">150</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;background-color:#cceeff;">February 9, 2018 - Director</font><font style="font-family:inherit;font-size:9pt;background-color:#cceeff;"><sup style="vertical-align:top;line-height:120%;background-color:#cceeff; font-size:6pt">(1)<br></sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5.09</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6.40</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">50</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">February 22, 2018 - Director</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;background-color:transparent; font-size:6pt">(1)<br></sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5.46</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6.92</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">50</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;background-color:#cceeff;">March 21, 2018 - Officer </font><font style="font-family:inherit;font-size:9pt;background-color:#cceeff;"><sup style="vertical-align:top;line-height:120%;background-color:#cceeff; font-size:6pt">(3)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5.40</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7.06</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">150</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,978</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:7pt;padding-left:72px;"><font style="font-family:inherit;font-size:7pt;">1.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">These options vest in equal amounts over </font><font style="font-family:inherit;font-size:7pt;">12</font><font style="font-family:inherit;font-size:7pt;">&#32;months and are exercisable for a term of </font><font style="font-family:inherit;font-size:7pt;">ten years</font><font style="font-family:inherit;font-size:7pt;">.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:7pt;padding-left:72px;"><font style="font-family:inherit;font-size:7pt;">2.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">These options vest in equal amounts over </font><font style="font-family:inherit;font-size:7pt;">36</font><font style="font-family:inherit;font-size:7pt;">&#32;months and are exercisable for a term of </font><font style="font-family:inherit;font-size:7pt;">ten years</font><font style="font-family:inherit;font-size:7pt;">.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:7pt;padding-left:72px;"><font style="font-family:inherit;font-size:7pt;">3.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">These options vest 12/36</font><font style="font-family:inherit;font-size:7pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt"> </sup></font><font style="font-family:inherit;font-size:7pt;">on the 12-month anniversary date and thereafter 1/36 per month over the next 24 months and are exercisable for a term of ten years.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:7pt;padding-left:72px;"><font style="font-family:inherit;font-size:7pt;">4.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">These options vest in equal amounts over 24 months and are exercisable for a term of </font><font style="font-family:inherit;font-size:7pt;">ten years</font><font style="font-family:inherit;font-size:7pt;">.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:7pt;padding-left:72px;"><font style="font-family:inherit;font-size:7pt;">5.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">These options vest 25% on the 12-month anniversary date and thereafter 75% vest 1/36 per month over the next 36 months and are exercisable for a term of ten years.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:7pt;padding-left:72px;"><font style="font-family:inherit;font-size:7pt;">6.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Stock options are granted at a Canadian Dollar (CA$) exercise price, and converted to US Dollars (US$) based on the exchange rate when these stock options are granted. </font></div></td></tr></table><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(</font><font style="font-family:inherit;font-size:10pt;">6</font><font style="font-family:inherit;font-size:10pt;">)</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:center;font-size:9pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Aurinia Pharmaceuticals Inc.</font></div><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Notes to Interim Condensed Consolidated Statements </font><font style="font-family:inherit;font-size:9pt;font-style:italic;">(Unaudited)</font></div><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">For the three and six month periods ended June 30, 2019 and 2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(expressed in US dollars, tabular amounts in thousands)</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;padding-left:96px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br></font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Dr. Glickman and the Company entered into a transition agreement whereby upon his retirement as Chairman of the Board and Chief Executive Officer of the Company Dr. Glickman will continue to provide substantive services as an adviser, to the Company for a period of 12 months commencing May 6, 2019. Management applied judgment in assessing if the services to be provided are substantive. Unvested stock options at May 6, 2019 were modified such that they will vest in equal installments over the next 12 months , subject to Dr. Glickman remaining an adviser to the Company at each of the vesting dates.</font></div><div style="line-height:120%;padding-bottom:8px;text-align:left;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The transition agreement resulted in 100,000 stock options that would have been</font><font style="font-family:inherit;font-size:9pt;font-weight:bold;">&#160;</font><font style="font-family:inherit;font-size:9pt;">forfeited</font><font style="font-family:inherit;font-size:9pt;font-weight:bold;">&#160;</font><font style="font-family:inherit;font-size:9pt;">at May 6, 2020 vesting on an accelerated timeline. Therefore, the Company considered that the amount expensed for such awards to date should be reversed. The Company recognized these 100,000 stock options as a new grant based on the fair value at the date of the transition agreement which will be expensed as they vest over the transition period.The Company also revised the allocation over the remaining vesting period to reflect the graded nature of the vesting over the transition period, at one twelfth per month.</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Application of the fair value method resulted in charges to stock-based compensation expense of </font><font style="font-family:inherit;font-size:9pt;">$1,960,000</font><font style="font-family:inherit;font-size:9pt;">&#32;and $3,564,000 for the three and six months ended </font><font style="font-family:inherit;font-size:9pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:9pt;">&#32;(2018 &#8211; </font><font style="font-family:inherit;font-size:9pt;">$2,029,000</font><font style="font-family:inherit;font-size:9pt;">&#32;and $4,140,000) with corresponding credits to contributed surplus. For the three and six month periods ended </font><font style="font-family:inherit;font-size:9pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:9pt;">, stock compensation expense has been allocated to research and development expense in the amount of </font><font style="font-family:inherit;font-size:9pt;">$749,000</font><font style="font-family:inherit;font-size:9pt;">&#32;and $1,611,000 respectively  (2018 &#8211; </font><font style="font-family:inherit;font-size:9pt;">$770,000</font><font style="font-family:inherit;font-size:9pt;">&#32;and $1,554,000) and corporate, administration and business development expense in the amount of </font><font style="font-family:inherit;font-size:9pt;">$1,211,000</font><font style="font-family:inherit;font-size:9pt;">&#32;and $1,953,000 (2018 &#8211; </font><font style="font-family:inherit;font-size:9pt;">$1,259,000</font><font style="font-family:inherit;font-size:9pt;">&#32;and $2,586,000).</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">If the stock price volatility was higher by a factor of 10% on the option grant dates in 2019, this would have increased annual stock compensation expense by approximately $</font><font style="font-family:inherit;font-size:9pt;">158,000</font><font style="font-family:inherit;font-size:9pt;">. If the stock price volatility was lower by a factor of 10% on the grant date, this would have decreased annual stock compensation expense by approximately $</font><font style="font-family:inherit;font-size:9pt;">162,000</font><font style="font-family:inherit;font-size:9pt;">.</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company used the Black-Scholes option pricing model to estimate the fair value of the options granted in 2019 and 2018.</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company considers historical volatility of its common shares in estimating its future stock price volatility. The risk-free interest rate for the expected life of the options was based on the yield available on government benchmark bonds with an approximate equivalent remaining term at the time of the grant. The expected life is based upon the contractual term, taking into account expected employee exercise and expected post-vesting employment termination behavior.</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The following weighted average assumptions were used to estimate the fair value of the options granted during the six months ended </font><font style="font-family:inherit;font-size:9pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:9pt;">:   </font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;padding-left:48px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:92.98245614035088%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"></td></tr><tr><td style="width:72%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">June 30, <br>2019</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">June 30, <br>2018</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Annualized volatility</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">52</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">55</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Risk-free interest rate</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1.68</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2.04</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Expected life of options in years</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4.0 years</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4.0 years</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Estimated forfeiture rate</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">16.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">22.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Dividend rate</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Exercise price</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6.19</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5.28</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Market price on date of grant</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6.19</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5.28</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Fair value per common share option</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2.60</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2.33</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:120%;padding-bottom:8px;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:9pt;">The following table summarizes information on stock options outstanding as at </font><font style="font-family:inherit;font-size:9pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:9pt;">:</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:92.20272904483431%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:23%;"></td><td style="width:24%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:25%;"></td><td style="width:1%;"></td><td style="width:24%;"></td><td style="width:1%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Options outstanding</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Options exercisable</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Range&#160;of exercise prices CA$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Number outstanding<br></font><font style="font-family:inherit;font-size:8pt;">(in&#160;thousands)</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted average remaining contractual life&#160;(years)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Number outstanding<br></font><font style="font-family:inherit;font-size:8pt;">(in&#160;thousands)</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3.39 - 3.96</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">666</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3.15</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">660</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4.21 - 5.19</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,770</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5.28</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,422</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6.40 - 6.92</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,575</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8.30</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,256</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7.06 - 7.70</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">240</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8.65</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">100</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8.04 - 8.62</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,270</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">9.55</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">525</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8.97 - 9.45</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">343</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7.99</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">248</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">9,864</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7.52</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5,211</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(</font><font style="font-family:inherit;font-size:10pt;">7</font><font style="font-family:inherit;font-size:10pt;">)</font></div></div><hr style="page-break-after:always"><div><a name="s9935911227E552DE809673DBFB623B98"></a></div><div><div style="line-height:120%;text-align:center;font-size:9pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Aurinia Pharmaceuticals Inc.</font></div><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Notes to Interim Condensed Consolidated Statements </font><font style="font-family:inherit;font-size:9pt;font-style:italic;">(Unaudited)</font></div><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">For the three and six month periods ended June 30, 2019 and 2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(expressed in US dollars, tabular amounts in thousands)</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:0px;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">7</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Other expenses and finance costs</font></div></td></tr></table><div style="line-height:120%;padding-bottom:16px;text-align:justify;padding-left:48px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:93.17738791423001%;border-collapse:collapse;text-align:left;"><tr><td colspan="10"></td></tr><tr><td style="width:51%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three months ended</font></div></td><td style="vertical-align:bottom;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Six months ended</font></div></td><td style="vertical-align:bottom;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">June 30,<br>2019<br>$</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">June 30,<br>2018<br>$</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">June 30,<br>2019<br>$</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">June 30,<br>2018<br>$</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other expenses</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Proxy contest costs</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">720</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">720</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Finance costs</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Interest expense</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">10</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">21</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Revaluation adjustment on contingent consideration (note 4)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">87</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">60</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">80</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">149</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Foreign exchange loss (gain) and other</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">26</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">88</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(43</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">123</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">66</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">189</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">106</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other expenses is comprised of proxy contest costs related to a dissident shareholder's challenge of the Company's 2019 annual general meeting proxy. </font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Previously, finance income and costs were labeled on the statement of operations and comprehensive loss as other income. In the current period they have been disaggregated and re-labeled as interest income and finance costs.</font></div><div><a name="sEE3EEE9E56AB534B84C069F01798AC3D"></a></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:0px;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">8</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Net loss per common share</font></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Basic and diluted net loss per common share is computed by dividing net loss by the weighted average number of common shares outstanding for the period. In determining diluted net loss per common share, the weighted average number of common shares outstanding is adjusted for stock options and warrants eligible for exercise where the average market price of common shares for the three and six months ended </font><font style="font-family:inherit;font-size:9pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:9pt;">&#32;exceeds the exercise price. Common shares that could potentially dilute basic net loss per common share in the future that could be issued from the exercise of stock options and warrants were not included in the computation of the diluted loss per common share for the three and six months ended </font><font style="font-family:inherit;font-size:9pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:9pt;">&#32;because to do so would be anti-dilutive.</font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The numerator and denominator used in the calculation of historical basic and diluted net loss amounts per common share are as follows:</font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:92.98245614035088%;border-collapse:collapse;text-align:left;"><tr><td colspan="10"></td></tr><tr><td style="width:59%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three months ended</font></div></td><td style="vertical-align:bottom;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Six months ended</font></div></td><td style="vertical-align:bottom;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">June 30,<br>2019<br>$</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">June 30,<br>2018<br>$</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">June 30,<br>2019<br>$</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">June 30,<br>2018<br>$</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net loss for the period</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(15,901</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(15,707</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(28,329</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(31,185</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Number</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Number</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Weighted average common shares outstanding</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">91,768</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">84,350</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">90,961</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">84,833</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net loss per common share (expressed in $ per share)</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.17</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.19</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.31</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.37</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The outstanding number and type of securities that would potentially dilute basic loss per common share in the future and which were not included in the computation of diluted loss per share, because to do so would have reduced the loss per common share (anti-dilutive) for the periods presented, are as follows:</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;padding-left:48px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:92.98245614035088%;border-collapse:collapse;text-align:left;"><tr><td colspan="10"></td></tr><tr><td style="width:55%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three months ended</font></div></td><td style="vertical-align:bottom;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Six months ended</font></div></td><td style="vertical-align:bottom;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">June 30,<br>2019<br>$</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">June 30,<br>2018<br>$</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">June 30,<br>2019<br>$</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">June 30,<br>2018<br>$</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Stock options</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,954</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,374</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,954</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,296</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Warrants (derivative liabilities)</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,875</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,359</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,887</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,262</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Warrants (equity)</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">10</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">10</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,829</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,743</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,841</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,568</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(</font><font style="font-family:inherit;font-size:10pt;">8</font><font style="font-family:inherit;font-size:10pt;">)</font></div></div><hr style="page-break-after:always"><div><a name="s373AD47DCC9C51F58CADFF936BB13857"></a></div><div><div style="line-height:120%;text-align:center;font-size:9pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Aurinia Pharmaceuticals Inc.</font></div><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Notes to Interim Condensed Consolidated Statements </font><font style="font-family:inherit;font-size:9pt;font-style:italic;">(Unaudited)</font></div><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">For the three and six month periods ended June 30, 2019 and 2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(expressed in US dollars, tabular amounts in thousands)</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:0px;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">9</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Segment disclosures</font></div></td></tr></table><div style="line-height:120%;padding-bottom:16px;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company&#8217;s operations comprise a single reporting segment engaged in the research, development and commercialization of therapeutic drugs. As the operations comprise a single reporting segment, amounts disclosed in the consolidated financial statements represent those of the single reporting unit. The Company&#8217;s long-lived assets are located in Canada. The reported licensing revenue was generated in China. </font></div><div><a name="s0590BC147A2A535D8C3C1E4D8DA2D2B5"></a></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">10. &#160;&#160;&#160;&#160;Commitments</font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company has entered into contractual obligations for services and materials required for its clinical trial program, drug manufacturing and other operational activities. Future minimum payments to exit the Company&#8217;s contractual commitments are as follows:</font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:92.78752436647173%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td style="width:41%;"></td><td style="width:13%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:13%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:13%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:13%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total<br>(in&#160;thousands)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Less than<br>one year<br>(in&#160;thousands)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">One&#160;to&#160;three<br>years<br>(in&#160;thousands)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Four to&#160;five <br>years<br>(in&#160;thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;background-color:#cceeff;">Short-term lease and variable payment obligations</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">304</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">122</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">182</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Purchase obligations</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;background-color:transparent; font-size:6pt">&#160;</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">17,161</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">16,911</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">242</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;background-color:#cceeff;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">17,465</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">17,033</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">424</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s558956AE22C95FA2AC4C1F667A21C8BA"></a></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:0px;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">11</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Supplementary cash flow information</font></div></td></tr></table><div style="line-height:120%;padding-bottom:16px;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:9pt;">Net change in other operating assets and liabilities</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:92.98245614035088%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td style="width:45%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="4" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three months ended</font></div></td><td style="vertical-align:bottom;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="4" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Six months ended</font></div></td><td style="vertical-align:bottom;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">June 30,<br>2019<br>$</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">June 30,<br>2018<br>$</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">June 30,<br>2019<br>$</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">June 30,<br>2018<br>$</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Accounts receivable</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">128</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(82</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(31</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(198</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Prepaid expenses and deposits</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(68</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(666</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1,610</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Clinical trial contract deposits</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(210</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Accounts payable and accrued liabilities</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">789</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(235</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(82</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(3,073</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">849</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(983</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(120</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(5,091</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Interest received</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">908</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">601</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,556</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">673</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(</font><font style="font-family:inherit;font-size:10pt;">9</font><font style="font-family:inherit;font-size:10pt;">)</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:center;font-size:9pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Aurinia Pharmaceuticals Inc.</font></div><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Notes to Interim Condensed Consolidated Statements </font><font style="font-family:inherit;font-size:9pt;font-style:italic;">(Unaudited)</font></div><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">For the three and six month periods ended June 30, 2019 and 2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(expressed in US dollars, tabular amounts in thousands)</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:16px;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:9pt;">Cash flows from financing and investing activities:</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:92.98245614035088%;border-collapse:collapse;text-align:left;"><tr><td colspan="21"></td></tr><tr><td style="width:20%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Short term investments<br>$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Contingent consideration<br>$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Derivative warrants December 28, 2016<br>$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Derivative warrants February 14, 2014<br>$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Common shares<br>$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Warrants<br>$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Contributed surplus<br>$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;background-color:#cceeff;font-weight:bold;">Balance at <br>January 1, 2019</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7,889</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(4,028</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(15,475</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(6,272</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(504,650</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(24,690</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Cash flow - Proceeds from short term investment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(7,884</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;background-color:#cceeff;">Cash flow - Net proceeds from ATM</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(28,830</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Cash flow - Proceeds from exercise of derivative warrants </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1,493</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;background-color:#cceeff;">Cash flow - Proceeds from exercise of options</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1,815</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Non-cash changes - Conversion to common shares</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5,920</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(7,036</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,116</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;background-color:#cceeff;">Non-cash changes - Fair value adjustments</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(80</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,998</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">352</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Non-cash changes - Stock Based Compensation </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(3,564</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;background-color:#cceeff;">Non-cash changes - Other<br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Balance at <br>June 30, 2019</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(4,108</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(13,477</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(543,824</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(27,138</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:28px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:28px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:28px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:28px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:28px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:28px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:28px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:28px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:28px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:28px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:28px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:28px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:28px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:28px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Balance at <br>January 1, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7,833</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(3,792</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(8,948</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(2,845</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(499,200</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(906</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(18,360</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;background-color:#cceeff;">Cash flow - Purchases</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">20,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Cash flow - Proceeds from short term investment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(10,001</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;background-color:#cceeff;">Cash flow - Proceeds from exercise of warrants</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(3,047</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Cash flow - Proceeds from exercise of options</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(347</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;background-color:#cceeff;">Non-cash changes - Conversion to common shares</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1,094</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">888</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">206</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Non-cash changes - Fair value adjustments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(149</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(3,134</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1,430</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;background-color:#cceeff;">Non-cash changes - Stock Based Compensation </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(4,140</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Non-cash changes - opening adjustment on change in accounting policy<br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">78</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;background-color:#cceeff;">Non-cash changes - Other</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(11</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Balance at <br>June 30, 2018</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">17,899</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(3,941</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(12,082</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(4,275</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(503,688</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(18</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(22,294</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr></table></div></div><div><a name="s7571DFF8A925520BA7F23ECB35A537AB"></a></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:0px;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">12</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Leases</font></div></td></tr></table><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company adopted IFRS 16 using the modified retrospective method with the date of initial application of January 1, 2019. Under this method, the standard is applied retrospectively with the cumulative effect of initially applying the standard recognized at the date of initial application. The Company also elected to use the practical expedients permitted by the standard for lease contracts that, at the commencement date, have a lease term of 12 months or less and do not contain a purchase option and lease contracts for which the underlying asset is of low value. The Company has also elected not to reassess whether a contract is, or contains a lease at the date of initial application.</font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(</font><font style="font-family:inherit;font-size:10pt;">10</font><font style="font-family:inherit;font-size:10pt;">)</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:center;font-size:9pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Aurinia Pharmaceuticals Inc.</font></div><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Notes to Interim Condensed Consolidated Statements </font><font style="font-family:inherit;font-size:9pt;font-style:italic;">(Unaudited)</font></div><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">For the three and six month periods ended June 30, 2019 and 2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(expressed in US dollars, tabular amounts in thousands)</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">On adoption the Company was required to analyze all current commitments and determine which agreements were within the scope of  IFRS 16 Leases. The Company determined that its three facility agreements, previously classified as operating leases under the principles of IAS 17 Leases, were within the scope of the new standard. </font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">For the lease of our head office facility in Victoria, British Columbia the Company recognized a right-of-use asset and a corresponding lease liability as at January 15, 2019 at which time a modification to an existing, and almost expired, lease agreement was signed. The modification extended the lease term an additional 36 months rendering the practical expedient not applicable to the Victoria facility lease. The right-of-use asset was recognized based on the amount equal to the lease liability, adjusted for any related prepaid and accrued lease payments previously recognized. The lease liability was measured at the present value of the remaining lease payments and was discounted using the Company's estimated incremental borrowing rate as at January 15, 2019, over the term of the lease. </font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">For the two other facility leases identified, the Company was able to apply a practical expedient permitted by the standard, which allowed the Company to account for operating leases with a remaining lease term of  12 months or less as at January 1, 2019 as short term leases. For the three and six month period ended June 30, 2019, the Company incurred short-term lease expense of $15,000 and $31,000 and variable lease expense of  $17,000 and $31,000 respectively.</font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">A reconciliation of the operating lease commitments disclosed applying IAS 17 in the December 31, 2018 annual audited financial statements and the least liability recognized at the date of initial application of IFRS 16 is as follows:</font></div><div style="line-height:120%;text-align:center;padding-left:48px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:92.98245614035088%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:79%;"></td><td style="width:20%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Operating lease commitments disclosed at December 31, 2018</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">800</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Less: adjustment resulting from lease modification made in January 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(497</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Less: operating costs not included in measurement of lease liability</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(287</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Less: short-term leases recognized on a straight-line basis as expense</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(16</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;background-color:#cceeff;">Lease liability recognized as at January 1, 2019</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">On January 15, 2019 the Company recognized a $425,000 right-of-use asset and a $425,000 lease liability. When measuring the lease liability, the Company discounted lease payments using its incremental borrowing rate at January 15, 2019. The incremental borrowing rate applied to the lease liability on January 15, 2019 was 10%. </font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The change in accounting policy resulted in the following adjustments to the  Statement of Financial Position and Statement of  Operations and Comprehensive Loss:</font></div><div style="line-height:120%;text-align:center;padding-left:48px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:92.98245614035088%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:83%;"></td><td style="width:16%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">January 15, 2019 - Recognition of lease liability</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">425</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Lease liability payments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(52</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Interest expense</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">21</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Foreign exchange impact on lease liability<br><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">18</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">June 30, 2019 - Lease liability</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">412</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Current portion of lease liability</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">122</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Non-current portion of lease liability</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">290</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Lease Liability </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">412</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">January 15, 2019 - Recognition right-of-use asset</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">425</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Right-of-use asset amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(62</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">June 30, 2019 - Right-of-use asset</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">363</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div><a name="s0B6A4EEFEAE259B9AE5663C7BC6EA7E4"></a></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:0px;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">13</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Subsequent Events</font></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Subsequent to June 30, 2019, the Company issued 36,800 common shares upon the exercise of 36,800 stock options for proceeds of $112,000. The Company also granted 165,000 stock options to new employees at a weighted average exercise price of $6.42 (CA $8.39).</font></div><div style="line-height:120%;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(</font><font style="font-family:inherit;font-size:10pt;">11</font><font style="font-family:inherit;font-size:10pt;">)</font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.3
<SEQUENCE>3
<FILENAME>exhibit992-20190630mda.htm
<DESCRIPTION>EXHIBIT 99.3
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2019 Workiva -->
		<title>Exhibit</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="sFB53DC96A999524CA4B0BFE8B5B15E65"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Exhibit 99.2</font></div><div style="line-height:120%;text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:120%;text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:120%;text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:120%;text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:120%;text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:120%;text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:120%;text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:120%;text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:120%;text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:120%;text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:120%;text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:120%;text-align:right;font-size:26pt;"><font style="font-family:Arial;font-size:26pt;color:#555659;">Management's Discussion and Analysis</font></div><div style="line-height:120%;text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:120%;text-align:center;"><img src="consolidatedfinancialstate02.jpg" alt="consolidatedfinancialstate02.jpg" style="height:368px;width:682px;"></div><div style="line-height:120%;text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:120%;text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:120%;text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:120%;text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:20pt;"><font style="font-family:Arial;font-size:20pt;color:#555659;">Second Quarter Ended June 30, 2019</font></div><div style="line-height:120%;text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div><br></div><hr style="page-break-after:always"><div><a name="s12A65FD1365C590483A6280375795BD3"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;font-weight:bold;">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF </font></div><div style="line-height:120%;text-align:center;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;font-weight:bold;">FINANCIAL CONDITION AND RESULTS OF OPERATIONS FOR </font></div><div style="line-height:120%;text-align:center;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;font-weight:bold;">THE SECOND QUARTER ENDED JUNE 30, 2019</font></div><div style="line-height:120%;text-align:center;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;"><br></font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">In this Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations ("MD&amp;A"), unless the context otherwise requires, references to "</font><font style="font-family:inherit;font-size:9pt;font-style:italic;font-weight:bold;">we</font><font style="font-family:inherit;font-size:9pt;font-style:italic;">", "</font><font style="font-family:inherit;font-size:9pt;font-style:italic;font-weight:bold;">us</font><font style="font-family:inherit;font-size:9pt;font-style:italic;">", "</font><font style="font-family:inherit;font-size:9pt;font-style:italic;font-weight:bold;">our</font><font style="font-family:inherit;font-size:9pt;font-style:italic;">" or similar terms, as well as references to "</font><font style="font-family:inherit;font-size:9pt;font-style:italic;font-weight:bold;">Aurinia</font><font style="font-family:inherit;font-size:9pt;font-style:italic;">" or the "</font><font style="font-family:inherit;font-size:9pt;font-style:italic;font-weight:bold;">Company</font><font style="font-family:inherit;font-size:9pt;font-style:italic;">", refer to Aurinia Pharmaceuticals Inc., together with our subsidiaries.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">The following MD&amp;A provides information on the activities of Aurinia on a consolidated basis and should be read in conjunction with our unaudited interim condensed consolidated financial statements and accompanying notes for the three and six months ended June 30, 2019 and our annual MD&amp;A and audited financial statements for the year ended December&#160;31, 2018. All amounts are expressed in United States (US) dollars unless otherwise stated. Dollar amounts in tabular columns are expressed in thousands of US dollars. This document is current in all material respects as of August 6, 2019.</font></div><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The financial information contained in this MD&amp;A and in our unaudited interim condensed consolidated financial statements has been prepared in accordance with International Financial Reporting Standards ("</font><font style="font-family:inherit;font-size:9pt;font-weight:bold;">IFRS</font><font style="font-family:inherit;font-size:9pt;">") as issued by the International Accounting Standards Board ("</font><font style="font-family:inherit;font-size:9pt;font-weight:bold;">IASB</font><font style="font-family:inherit;font-size:9pt;">") applicable to the preparation of interim financial statements including International Accounting Standard 34: </font><font style="font-family:inherit;font-size:9pt;font-style:italic;">Interim Financial Reporting</font><font style="font-family:inherit;font-size:9pt;">. The unaudited interim condensed consolidated financial statements and MD&amp;A have been reviewed and approved by our Audit Committee on August 1, 2019. This MD&amp;A has been prepared with reference to National Instrument 51-102 "Continuous Disclosure Obligations" of the Canadian Securities Administrators. Under the US/Canada Multijurisdictional Disclosure System, Aurinia is permitted to prepare this MD&amp;A in accordance with the disclosure requirements of Canada, which are different from those in the United States.</font></div><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div><a name="s73F3E6DC38BB5387A19B6C7F509F2AEE"></a></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">FORWARD-LOOKING STATEMENTS</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">A statement is forward-looking when it uses what we know and expect today to make a statement about the future. Forward-looking statements may include words such as "anticipate", "believe", "intend", "expect", "goal", "may", "outlook", "plan", "seek", "project", "should", "strive", "target", "could", "continue", "potential" and "estimated", or the negative of such terms or comparable terminology.  You should not place undue reliance on the forward-looking statements, particularly those concerning anticipated events relating to the development, clinical trials, regulatory approval, and marketing of our products and the timing or magnitude of those events, as they are inherently risky and uncertain.</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Securities laws encourage companies to disclose forward-looking information so that investors can get a better understanding of our future prospects and make informed investment decisions.  These statements, made in this MD&amp;A, may include, without limitation:</font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">our belief that we have sufficient cash resources to adequately fund operations;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">our belief that the Phase 2b lupus nephritis ("</font><font style="font-family:inherit;font-size:9pt;font-weight:bold;">LN</font><font style="font-family:inherit;font-size:9pt;">") AURA- LV ("</font><font style="font-family:inherit;font-size:9pt;font-weight:bold;">AURA</font><font style="font-family:inherit;font-size:9pt;">") clinical trial had positive results;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:9pt;">our belief that the totality of data from both the Phase 3 LN ("</font><font style="font-family:inherit;font-size:9pt;font-weight:bold;">AURORA</font><font style="font-family:inherit;font-size:9pt;">") and AURA clinical trials can potentially serve as the basis for a New Drug Application ("</font><font style="font-family:inherit;font-size:9pt;font-weight:bold;">NDA</font><font style="font-family:inherit;font-size:9pt;">") submission with the U.S. Food and Drug Administration ("</font><font style="font-family:inherit;font-size:9pt;font-weight:bold;">FDA</font><font style="font-family:inherit;font-size:9pt;">") following a successful completion of the AURORA clinical trial;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">our belief that confirmatory data generated from the single AURORA clinical trial and the completed AURA clinical trial should support regulatory submissions in the United States, Europe and Japan and the timing of such, including the NDA submission in the United States;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">our belief that granted formulation patents regarding the delivery of voclosporin to the ocular surface for conditions such as dry eye have the potential to be of therapeutic value;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">our belief in the duration of patent exclusivity for voclosporin and that the patents owned by us are valid;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">our belief in receiving extensions to patent life based on certain events or classifications;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">our plans and expectations and the timing of commencement, enrollment, completion and release of results of clinical trials;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">our current forecast for the cost of the AURORA clinical trial and the AURORA 2 extension trial;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">our intention to demonstrate that voclosporin possesses pharmacologic properties with the potential to demonstrate best-in-class differentiation with first-in-class status for the treatment of LN outside of Japan;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">our belief of the key potential benefits of voclosporin in the treatment of LN and other podocytopathies;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">our belief that voclosporin has the potential to improve near and long-term outcomes in LN when added to mycophenolate mofetil ("</font><font style="font-family:inherit;font-size:9pt;font-weight:bold;">MMF</font><font style="font-family:inherit;font-size:9pt;">");</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">our belief that the confirmatory drug-drug interaction study (a "</font><font style="font-family:inherit;font-size:9pt;font-weight:bold;">DDI study</font><font style="font-family:inherit;font-size:9pt;">") between voclosporin and MMF will add to our knowledge of voclosporin in a multi-targeted therapeutic approach and should have no impact on the potential approval of voclosporin;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">our belief that there is precedent for the AUDREY (as defined below) study to act as one of the two pivotal clinical studies that would support approval by the FDA for the treatment of DES;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">our belief that this voclosporin modification may result in a more predictable pharmacokinetic and pharmacodynamic relationship, an increase in potency, an altered metabolic profile, and easier dosing without the need for therapeutic drug monitoring;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">our target launch date for voclosporin as a treatment for LN in the United States, if approved, in early 2021;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">our belief in voclosporin being potentially a best-in-class CNI (as defined below) with robust intellectual property exclusivity and the benefits over existing commercially available CNIs;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">our belief that CNIs are a mainstay of treatment for DES;</font></div></td></tr></table><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">our belief that voclosporin has further potential to be effectively used across a range of therapeutic autoimmune areas including keratoconjunctivitis sicca ("</font><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Dry Eye Syndrome</font><font style="font-family:inherit;font-size:9pt;">" or "</font><font style="font-family:inherit;font-size:9pt;font-weight:bold;">DES</font><font style="font-family:inherit;font-size:9pt;">") and focal segmental glomerulosclerosis ("</font><font style="font-family:inherit;font-size:9pt;font-weight:bold;">FSGS</font><font style="font-family:inherit;font-size:9pt;">");</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">the timing for completion of enrollment and for data availability for our Phase 2 clinical study for voclosporin in FSGS patients; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">statements concerning the anticipated commercial potential of voclosporin for the treatment of LN, DES and FSGS;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">our plan to expand the voclosporin renal franchise to include FSGS;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">our belief that the expansion of the renal franchise could create significant value for shareholders; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">our belief that voclosporin has the potential to significantly improve complete renal response rates in LN versus current standard of care;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">our expectation to have top-line data for the AURORA Phase 3 trial in late 2019 and our belief that this trial will provide additional data regarding voclosporin benefit and risk in LN;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">our intention to use the net proceeds from financings for various purposes; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">our belief that we will have a positive pre-NDA meeting with the FDA, which we anticipate will occur in the first quarter of 2020;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">our belief that our current financial resources are sufficient to fund our existing LN program including the AURORA trial and the NDA submission to the FDA, conduct the current Phase 2 study for FSGS, commence additional studies for DES and fund operations into mid-2020; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">our current plan to complete the NDA, including the clinical module, in the second quarter of 2020;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">our expectation that the AURORA 2 extension trial will be completed by the end of 2021 with estimated costs left to be incurred of approximately $22 million;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">our plans to generate future revenues from products licensed to pharmaceutical and biotechnology companies;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">statements concerning partnership activities and health regulatory discussions; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">statements concerning the potential market for voclosporin;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">our ability to take advantage of financing opportunities if and when needed;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">our belief that voclosporin ophthalmic solution ("</font><font style="font-family:inherit;font-size:9pt;font-weight:bold;">VOS</font><font style="font-family:inherit;font-size:9pt;">") has the potential to compete in the multi-billion-dollar human prescription dry eye market;  </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">our intention, if needed, to seek additional corporate alliances and collaborative agreements to support the commercialization and development of our products;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">our estimation that corresponding expenses to our contractual obligations, excluding purchase obligations, will be in the range of $25-$30 million over the next twelve months;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">our belief that additional patents may be granted worldwide based on our filings under the Patent Cooperation Treaty ("</font><font style="font-family:inherit;font-size:9pt;font-weight:bold;">PCT</font><font style="font-family:inherit;font-size:9pt;">");</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">our belief that patents corresponding to United States Patent No. 10,286,036 issued to Aurinia on May 14, 2019 and covering dosing protocol, with corresponding FDA granted label, for voclosporin in LN with a patent term extending to 2037, could grant with similar claims in major global pharmaceutical markets;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">our strategy to become a global biopharmaceutical company;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">our plan to conduct a Phase 2/3 DES clinical trial with VOS with patient enrollment commencing in the fourth quarter of 2019; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">our plan to conduct a study with pediatric patients.</font></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Such statements reflect our current views with respect to future events and are subject to risks and uncertainties and are necessarily based on a number of estimates and assumptions that, while considered reasonable by management, as at the date of such statements, are inherently subject to significant business, economic, competitive, political, regulatory, legal, scientific and social uncertainties and contingencies, many of which, with respect to future events, are subject to change. The factors and assumptions used by management to develop such forward-looking statements include, but are not limited to:</font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:50px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:26px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">the assumption that we will be able to obtain approval from regulatory agencies on executable development programs with parameters that are satisfactory to us;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:50px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:26px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">the assumption that recruitment to clinical trials will occur as projected;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:50px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:26px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">the assumption that we will successfully complete our clinical programs on a timely basis, including conducting the required AURORA clinical trial and meet regulatory requirements for approval of marketing authorization applications and new drug approvals, as well as favourable product labelling;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:50px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:26px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">the assumption that the planned studies will achieve positive results;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:50px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:26px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">the assumptions regarding the costs and expenses associated with our clinical trials;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:50px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:26px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">the assumption that regulatory requirements and commitments will be maintained; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:50px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:26px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">the assumption that we will be able to meet Good Manufacturing Practice ("</font><font style="font-family:inherit;font-size:9pt;font-weight:bold;">GMP</font><font style="font-family:inherit;font-size:9pt;">") standards and manufacture and secure a sufficient supply of voclosporin on a timely basis to successfully complete the development and commercialization of voclosporin; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:50px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:26px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">the assumptions on the market value for the LN program;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:50px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:26px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">the assumption that our patent portfolio is sufficient and valid;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:50px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:26px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">the assumption that we will be able to extend our patents to the fullest extent allowed by law, on terms most beneficial to us;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:50px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:26px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">the assumptions on the market; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:50px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:26px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">the assumption that there is a potential commercial value for other indications for voclosporin;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:50px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:26px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">the assumption that market data and reports reviewed by us are accurate;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:50px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:26px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">the assumption that another company will not create a substantial competitive product for Aurinia&#8217;s LN business without violating Aurinia&#8217;s intellectual property rights;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:50px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:26px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">the assumptions on the burn rate of Aurinia&#8217;s cash for operations;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:50px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:26px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">the assumption that our current good relationships with our suppliers, service providers and other third parties will be maintained;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:50px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:26px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">the assumption that we will be able to attract and retain a sufficient amount of skilled staff; and/or</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:50px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:26px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">the assumptions relating to the capital required to fund operations through AURORA clinical trial results and regulatory submission.</font></div></td></tr></table><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">It is important to know that:</font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">actual results could be materially different from what we expect if known or unknown risks affect our business, or if our estimates or assumptions turn out to be inaccurate.  As a result, we cannot guarantee that any forward-looking statement will materialize and, accordingly, you are cautioned not to place undue reliance on these forward-looking statements.</font></div></td></tr></table><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">forward-looking statements do not take into account the effect that transactions or non-recurring or other special items announced or occurring after the statements are made may have on our business.  For example, they do not include the effect of mergers, acquisitions, other business combinations or transactions, dispositions, sales of assets, asset write-downs or other charges announced or occurring after the forward-looking statements are made.  The financial impact of such transactions and non-recurring and other special items can be complex and necessarily depend on the facts particular to each of them.  Accordingly, the expected impact cannot be meaningfully described in the abstract or presented in the same manner as known risks affecting our business.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The factors discussed below and other considerations discussed in the </font><font style="font-family:inherit;font-size:9pt;font-style:italic;">Risk Factors</font><font style="font-family:inherit;font-size:9pt;">&#32;section of this MD&amp;A could cause our actual results to differ significantly from those contained in any forward-looking statements. </font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Such forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause our actual results, performance, or achievements to differ materially from any assumptions, further results, performance or achievements expressed or implied by such forward-looking statements.  Important factors that could cause such differences include, among other things, the following:</font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">the need for additional capital in the future to continue to fund our development programs and commercialization activities, and the effect of capital market conditions and other factors on capital availability;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">competition;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:9pt;">difficulties, delays, or failures we may experience in the conduct of and reporting of results of our clinical trials for voclosporin;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">difficulties in meeting GMP standards and the manufacturing and securing of a sufficient supply of voclosporin on a timely basis to successfully complete the development and commercialization of voclosporin;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">difficulties, delays or failures in obtaining regulatory approvals for the initiation of clinical trials;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">difficulties in gaining alignment among the key regulatory jurisdictions, European Medicines Agency, FDA and Pharmaceutical and Medical Devices Agency, which may require further clinical activities;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">difficulties, delays or failures in obtaining regulatory approvals to market voclosporin;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">not being able to extend our patent portfolio for voclosporin;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">our patent portfolio not covering all of our proposed uses of voclosporin;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">the uncertainty that the FDA will approve the use of voclosporin for LN and that the label for such use will follow the dosing protocol pursuant to US Patent No. 10,286,036 granted on May 14, 2019;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">difficulties we may experience in completing the development and commercialization of voclosporin;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">the market for the LN business may not be as we have estimated;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">insufficient acceptance of and demand for voclosporin;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">difficulties obtaining adequate reimbursements from third party payors;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">difficulties obtaining formulary acceptance; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">competitors may arise with similar products;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:9pt;">product liability, patent infringement and other civil litigation;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">injunctions, court orders, regulatory and other enforcement actions;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">we may have to pay unanticipated expenses, and/or estimated costs for clinical trials or operations may be underestimated, resulting in our having to make additional expenditures to achieve our current goals;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">difficulties, restrictions, delays, or failures in obtaining appropriate reimbursement from payors for voclosporin; and/or</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">difficulties we may experience in identifying and successfully securing appropriate vendors to support the development and commercialization of our product.</font></div></td></tr></table><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements. These forward-looking statements are made as of the date hereof and we disclaim any intention and have no obligation or responsibility, except as require by law, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. </font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">For additional information on risks and uncertainties in respect of the Company and its business, please see the "Risks and Uncertainties" section of this MD&amp;A. Although we believe that the expectations reflected in such forward-looking statements and information are reasonable, undue reliance should not be placed on forward-looking statements or information because we can give no assurance that such expectations will prove to be correct.</font></div><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">Additional information related to Aurinia, including its most recent Annual Information Form ("</font><font style="font-family:inherit;font-size:9pt;font-style:italic;font-weight:bold;">AIF</font><font style="font-family:inherit;font-size:9pt;font-style:italic;">"), is available by accessing the Canadian Securities Administrators&#8217; System for Electronic Document Analysis and Retrieval ("</font><font style="font-family:inherit;font-size:9pt;font-style:italic;font-weight:bold;">SEDAR</font><font style="font-family:inherit;font-size:9pt;font-style:italic;">") website at </font><font style="font-family:inherit;font-size:9pt;color:#0000ff;font-style:italic;text-decoration:underline;">www.sedar.com</font><font style="font-family:inherit;font-size:9pt;font-style:italic;">&#32;or the U.S. Securities and Exchange Commission&#8217;s ("</font><font style="font-family:inherit;font-size:9pt;font-style:italic;font-weight:bold;">SEC</font><font style="font-family:inherit;font-size:9pt;font-style:italic;">") Electronic Document Gathering and Retrieval System ("</font><font style="font-family:inherit;font-size:9pt;font-style:italic;font-weight:bold;">EDGAR</font><font style="font-family:inherit;font-size:9pt;font-style:italic;">") website at </font><font style="font-family:inherit;font-size:9pt;color:#0000ff;font-style:italic;text-decoration:underline;">www.sec.gov/edgar</font><font style="font-family:inherit;font-size:9pt;font-style:italic;">.</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></div><hr style="page-break-after:always"><div><a name="s72AF7A4E4D0E5D27B449C79F349C3A35"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;font-weight:bold;">OVERVIEW</font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">THE COMPANY</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;color:#282828;">Aurinia is a late clinical stage biopharmaceutical company focused on developing and commercializing therapies to treat targeted patient populations that are suffering from serious diseases with a high unmet medical need.  We are currently developing voclosporin, an investigational drug, for the potential treatment of LN, DES and FSGS.</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Our head office is located at #1203-4464 Markham Street, Victoria, British Columbia V8Z 7X8.  Aurinia has its registered office located at #201, 17904-105 Avenue, Edmonton, Alberta T5S 2H5 where the finance function is performed.</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Aurinia Pharmaceuticals Inc. is organized under the </font><font style="font-family:inherit;font-size:9pt;font-style:italic;">Business Corporations Act</font><font style="font-family:inherit;font-size:9pt;">&#32;(Alberta). Our common shares (the "</font><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Common Shares</font><font style="font-family:inherit;font-size:9pt;">") are currently listed and traded on the NASDAQ Global Market ("</font><font style="font-family:inherit;font-size:9pt;font-weight:bold;">NASDAQ</font><font style="font-family:inherit;font-size:9pt;">") under the symbol "AUPH" and on the Toronto Stock Exchange under the symbol "AUP". </font></div><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">We have two wholly-owned subsidiaries:  Aurinia Pharma U.S., Inc., (Delaware incorporated) and Aurinia Pharma Limited (United Kingdom incorporated). </font></div><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div><a name="sB2289FE139A25303A6E9EE1E37F25CED"></a></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">BUSINESS OF THE COMPANY</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">We are currently developing voclosporin, an investigational drug, for the potential treatment of LN, DES and FSGS. Voclosporin is novel and potentially best-in-class calcineurin inhibitor ("CNI") with clinical data in over 2,600 patients across various indications. It has been studied in kidney rejection following transplantation, psoriasis and in various forms of uveitis (an ophthalmic disease). </font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The topical formulation of voclosporin, VOS, is an aqueous, preservative free nanomicellar solution intended for use in the treatment of DES. A Phase 2a study was recently completed with results released in January of 2019. Previously, a Phase 1 study with healthy volunteers and patients with DES was also completed as were studies in rabbit and dog models.</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Voclosporin is an immunosuppressant, with a synergistic and dual mechanism of action that has the potential to improve near and long-term outcomes in LN when added to MMF although not approved for such, the current standard of care for LN. By inhibiting calcineurin, voclosporin reduces cytokine activation and blocks interleukin IL-2 expression and T-cell mediated immune responses.  Voclosporin also potentially stabilizes disease modifying podocytes, which protects against proteinuria.  Voclosporin is made by a modification of a single amino acid of the cyclosporine molecule.  This modification may result in a more predictable pharmacokinetic and pharmacodynamic relationship, an increase in potency, an altered metabolic profile, and easier dosing without the need for therapeutic drug monitoring. Clinical doses of voclosporin studied to date range from 13 - 70 mg administered twice a day ("</font><font style="font-family:inherit;font-size:9pt;font-weight:bold;">BID</font><font style="font-family:inherit;font-size:9pt;">"). The mechanism of action of voclosporin has been validated with certain first generation CNIs for the prevention of rejection in patients undergoing solid organ transplants and in several autoimmune indications, including dermatitis, keratoconjunctivitis sicca, psoriasis, rheumatoid arthritis, and for LN in Japan. We believe that voclosporin possesses pharmacologic properties with the potential to demonstrate best-in-class differentiation with first-in-class regulatory approval status for the treatment of LN outside of Japan.</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Based on our Phase 2 trial, AURA-LV, we believe voclosporin has the potential to significantly improve complete renal response rates in LN versus current standard of care.  Complete renal response is a required regulatory endpoint in LN as well as being extremely clinically meaningful.  Our fully recruited Phase 3 trial, AURORA, will provide additional data regarding voclosporin benefit/risk in LN.</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Legacy CNIs have demonstrated efficacy for a number of conditions, including transplant, DES and other autoimmune diseases; however, side effects exist which can limit their long-term use and tolerability.  Some clinical complications of legacy CNIs include hypertension, hyperlipidemia, diabetes, and both acute and chronic nephrotoxicity.</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Based on published data, we believe the key potential benefits of voclosporin in the treatment of LN versus marketed CNIs are:</font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">increased potency compared to cyclosporine A, allowing lower dosing requirements and potentially fewer off target effects;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">limited inter and intra patient variability, allowing for easier dosing without the need for therapeutic drug monitoring;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">less cholesterolemia and triglyceridemia than cyclosporine A; and</font></div></td></tr></table><div style="line-height:120%;padding-left:0px;padding-bottom:12px;text-align:justify;text-indent:24px;"><font style="padding-bottom:12px;text-align:justify;font-family:inherit;font-size:9pt;padding-right:24px;">&#8226;</font><font style="font-family:inherit;font-size:9pt;">limited incidence of glucose intolerance and diabetes at therapeutic doses compared to tacrolimus.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Our target launch date for voclosporin as a treatment for LN in the United States, if approved, is early 2021.    </font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">LN </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">LN is an inflammation of the kidney caused by systemic lupus erythematosus ("</font><font style="font-family:inherit;font-size:9pt;font-weight:bold;">SLE</font><font style="font-family:inherit;font-size:9pt;">") and represents a serious progression of SLE. SLE is a chronic, complex and often disabling disorder. The disease is highly heterogeneous, affecting a wide range of organs and tissue systems. Unlike SLE, LN has straightforward disease outcomes (measuring proteinuria) where an early response correlates with long-term outcomes. In patients with LN, renal damage results in proteinuria and/or hematuria and a decrease in renal function as evidenced by reduced estimated glomerular filtration rate ("</font><font style="font-family:inherit;font-size:9pt;font-weight:bold;">eGFR</font><font style="font-family:inherit;font-size:9pt;">"), and increased serum creatinine levels. eGFR is assessed through the Chronic Kidney Disease Epidemiology Collaboration equation.  In 2004, a study indicated rapid control and reduction of proteinuria in LN patients measured at six months showed a reduction in the </font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">need for dialysis at 10 years. LN can be debilitating and costly and if poorly controlled, can lead to permanent and irreversible tissue damage within the kidney. Recent literature suggests severe LN progresses to end-stage renal disease ("</font><font style="font-family:inherit;font-size:9pt;font-weight:bold;">ESRD</font><font style="font-family:inherit;font-size:9pt;">") within 15 years of diagnosis in 10%-30% of patients, thus making LN a serious and potentially life-threatening condition.  SLE patients with renal damage have a 14-fold increased risk of premature death, while SLE patients with ESRD have a greater than 60-fold increased risk of premature death. In 2009, mean annual cost for patients (both direct and indirect) with SLE (with no nephritis) have been estimated to exceed $20,000 per patient, while the mean annual cost for patients (both direct and indirect) with LN who progress to intermittent ESRD have been estimated to exceed $60,000 per patient.</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">DES</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">DES is characterized by irritation and inflammation that occurs when the eye&#8217;s tear film is compromised by reduced tear production, imbalanced tear composition, or excessive tear evaporation.  The impact of DES ranges from subtle, yet constant eye irritation to significant inflammation and scarring of the eye&#8217;s surface. Discomfort and pain resulting from DES can reduce quality of life and cause difficulty reading, driving, using computers and performing daily activities. DES is a chronic disease. There are currently three FDA approved prescription therapies for the treatment of dry eye, two of which are CNI's; however, there is opportunity for potential improvement in the effectiveness of therapies by enhancing tolerability, onset of action and alleviating the need for repetitive dosing.  A 2017 publication estimated there were approximately 16 million diagnosed patients with DES in the United States.</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">FSGS</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">FSGS is a rare disease that attacks the kidney&#8217;s filtering units (glomeruli) causing serious scarring which leads to permanent kidney damage and even renal failure. FSGS is one of the leading causes of Nephrotic Syndrome ("</font><font style="font-family:inherit;font-size:9pt;font-weight:bold;">NS</font><font style="font-family:inherit;font-size:9pt;">") and is identified by biopsy and proteinuria.  NS is a collection of signs and symptoms that indicate kidney damage, including large amounts of protein in urine; low levels of albumin and higher than normal fat and cholesterol levels in the blood, and edema.  Similar to LN, early clinical response, (measured by reduction of proteinuria) is thought to be critical to long-term kidney health in patients with FSGS.  </font></div><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">FSGS is likely the most common primary glomerulopathy leading to ESRD. The incidence of FSGS and ESRD due to FSGS are increasing as time goes on. Precise estimates of incidence and prevalence are difficult to determine.  According to NephCure Kidney International, more than 5,400 patients are diagnosed with FSGS every year; however, this is considered an underestimate because a limited number of biopsies are performed. The number of FSGS cases are rising more than any other cause of NS and the incidence of FSGS is increasing through disease awareness and improved diagnosis. &#160;FSGS occurs more frequently in adults than in children and is most prevalent in adults 45 years or older. FSGS is most common in people of African American and Asian descent. It has been shown that the control of proteinuria is important for longterm dialysis-free survival of these patients. Currently, there are no approved therapies for FSGS in the United States or the European Union. </font></div><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div><a name="s2CB91680CB97538E9FCD3DD042AFBAF8"></a></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">STRATEGY</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Our business strategy is to optimize the clinical and commercial value of voclosporin and become a global biopharma company with a focused renal and immune related franchise.&#160; This includes the expansion of a potential renal franchise with additional renal indications and the exploitation of voclosporin in novel formulations for treatment of autoimmune related disorders.&#160; </font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">We have strategically developed a plan to expand our voclosporin renal franchise to include FSGS. Additionally, we are also furthering development of VOS for the treatment of DES. The advancement of these new indications, in addition to LN, represents an expansion of our pipeline and commercial opportunities.</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The key elements of our corporate strategy include:</font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:9pt;">advancing voclosporin through the AURORA Phase 3 clinical trial with anticipated completion of this trial in the fourth quarter of 2019;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:9pt;">conducting a Phase 2 proof of concept study for the additional renal indication of FSGS; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">conducting a Phase 2/3 study of VOS for the treatment of DES. </font></div></td></tr></table><div style="line-height:120%;text-align:justify;padding-left:48px;text-indent:-24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div><a name="s41060C52F0BA56CAAF4E3A6C33C13219"></a></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">CLINICAL AND CORPORATE DEVELOPMENTS IN 2019</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Appointment of New Officers and Directors</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">On April 29, 2019, Aurinia appointed Peter Greenleaf as Chief Executive Officer and as a Director on the Aurinia Board of Directors (the "</font><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Board</font><font style="font-family:inherit;font-size:9pt;">").  We also announced the elevation of George M. Milne, Jr., Ph.D, to Chairman of the Board.  Dr. Richard M. Glickman, who previously announced his plans to retire on November 6, 2018, stepped down from his role as Chairman and CEO concurrent with Mr. Greenleaf's appointment on April 29, 2019, and remains an advisor to Aurinia for a period of 12 months commencing May 6, 2019.</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">With more than 20 years of experience leading pharmaceutical and biotech firms, Mr. Greenleaf most recently served as the CEO of Cerecor, Inc. a leading U.S. pediatric orphan and rare disease pharmaceutical company. Prior to that, Mr. Greenleaf was the Chairman and CEO of Sucampo Pharmaceuticals Inc. which he led through the successful sale to Mallinckrodt Pharmaceuticals, PLC for $1.2B. Previously, Mr. Greenleaf served as the CEO and board member of Histogenics Corporation, a regenerative medicine company. Prior to that he was the President of MedImmune, Inc, the global biologics arm of AstraZeneca, and President of MedImmune Ventures, a wholly owned venture capital fund within the AstraZeneca Group, where he led investment in emerging biopharmaceutical, medical device, and diagnostic companies. </font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">On April 30, 2019, we announced the appointment of Dr. Daniel Billen to the Board.  Dr. Billen has more than four decades of experience leading the commercialization of pharmaceutical and biotech products in North America and Europe. Prior to his retirement, Dr. Billen served as Vice President and General Manager, Inflammation and Nephrology at Amgen, from 2011 until 2018. Prior to that, Dr. Billen was General Manager, Amgen Canada, from 1991 until 2011. Dr. Billen previously served in roles of escalating responsibility at Janssen from 1979 until 1991. Dr. Billen received his Ph.D. in Chemistry from the University of Louvain, Belgium. </font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">On June 26, 2019, Mr. R. Hector MacKay-Dunn, J.D., Q.C. was elected to the Board at the Annual General Meeting of Shareholders.  Mr. MacKay-Dunn has over 30 years of practice experience providing legal advice to high growth public and private companies, many of which achieving valuations exceeding CA$1 billion over a broad range of industry sectors including life sciences, health, and technology, advising on corporate domestic and cross-border public and private securities offerings, mergers and acquisitions and international partnering and licensing transactions, and boards of directors and independent board committees on corporate governance matters.  Mr. MacKay-Dunn is recognized by Lexpert, as being among the Top 100 Canada/US Cross-Border Corporate Lawyers in Canada, has consistently been named among The Leading 500 Lawyers in Canada, and is recognized among Canada&#8217;s leading lawyers in mergers &amp; acquisitions, technology and biotechnology. </font></div><div style="line-height:120%;padding-bottom:13px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">On July 22, 2019, we announced the appointments of Mr. Max Donley, MBA as Executive Vice President of Internal Operations and Strategy and Glenn Schulman, PharmD, MPH as Senior Vice President of Corporate Communications and Investor Relations. </font></div><div style="line-height:120%;padding-bottom:13px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Mr. Donley most recently led Human Resources, Information Technology and Facilities at Senseonics. Prior to that, Mr. Donley was Executive Vice President of Global Human Resources, Information Technology, and Corporate Strategy at Sucampo Pharmaceuticals until its acquisition in February 2018. Prior to that, Mr. Donley served as Executive Vice President, Human Resources and Corporate Affairs at MedImmune, where he provided business-integrated leadership and delivered professional tools, programs and services to optimize MedImmune&#8217;s human capital investments worldwide. </font></div><div style="line-height:120%;padding-bottom:13px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Dr. Glenn Schulman is a healthcare professional with nearly 20 years of advising biotech and life science companies. Prior to joining Aurinia, Dr. Schulman led Corporate Communications and Investor Relations at Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN). Prior to Achillion, Dr. Schulman held positions of increasing responsibility at CuraGen Corp. where he was ultimately responsible for all aspects of corporate and medical communications, investor and public relations. </font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Patents and Notice of Allowance</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">On February 25, 2019, we announced that we had received a notice of allowance (the "</font><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Notice of Allowance</font><font style="font-family:inherit;font-size:9pt;">") from the US Patent and Trademark Office (the "</font><font style="font-family:inherit;font-size:9pt;font-weight:bold;">USPTO</font><font style="font-family:inherit;font-size:9pt;">") for claims directed at our novel voclosporin dosing protocol for LN (US patent application 15/835,219, entitled </font><font style="font-family:inherit;font-size:9pt;font-style:italic;">"PROTOCOL FOR TREATMENT OF LUPUS NEPHRITIS"</font><font style="font-family:inherit;font-size:9pt;">). </font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The allowed claims broadly cover the novel voclosporin </font><font style="font-family:inherit;font-size:9pt;font-style:italic;">individualized flat-dosed pharmacodynamic treatment protocol</font><font style="font-family:inherit;font-size:9pt;">&#32;adhered to and required in both the previously reported Phase 2 AURA-LV trial and our ongoing Phase 3 confirmatory AURORA trial.  Notably, the allowed claims cover a method of modifying the dose of voclosporin in patients with LN based on patient specific pharmacodynamic parameters.</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">This Notice of Allowance concluded a substantive examination of the patent application at the USPTO. After administrative processes were completed and fees were paid, on May 14, 2019 Aurinia was granted US Patent No. 10,286,036 with a term extending to December 2037.  If the FDA approves the use of voclosporin for LN and the label for such use follows the dosing protocol, the issuance of this patent will expand the scope of intellectual property protection for voclosporin, which already includes manufacturing, formulation, synthesis and composition of matter patents. </font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">We have also filed for protection of this subject matter under the PCT and have the option of applying for similar protection in the member countries thereof. This may lead to the granting of corresponding claims in the treaty countries which include all the major global pharmaceutical markets. </font></div><div style="line-height:120%;padding-bottom:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">DES</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">On January 22, 2019 we released results for our exploratory Phase 2a head-to-head study evaluating the efficacy, safety and tolerability of VOS versus cyclosporine ophthalmic emulsion 0.05% (Restasis&#174;) for the treatment of DES. The study was initiated in July of 2018 and full enrollment was achieved in the fourth quarter of 2018. We believe CNI's are a mainstay of treatment for DES. The goal of this program is to develop a best-in class treatment option.</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">In this exploratory Phase 2a study:</font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;">&#9642;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">VOS showed statistical superiority to cyclosporine ophthalmic emulsion 0.05% on FDA-accepted objective signs of DES.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;">&#9642;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">42.9% of VOS subjects vs 18.4% of cyclosporine ophthalmic emulsion 0.05% subjects (p=.0055) demonstrated &#8805; 10mm improvement in Schirmer Tear Test ("</font><font style="font-family:inherit;font-size:9pt;font-weight:bold;">STT</font><font style="font-family:inherit;font-size:9pt;">") at Week 4.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;">&#9642;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Primary endpoint of drop discomfort at 1-minute on Day 1 was not met.  No statistical difference between VOS and Restasis&#174; was shown, as both exhibited low drop discomfort scores. Both drugs were well-tolerated.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">On the key pre-specified secondary endpoints of STT (an objective measure of tear production), and Fluorescein Corneal Staining ("</font><font style="font-family:inherit;font-size:9pt;font-weight:bold;">FCS</font><font style="font-family:inherit;font-size:9pt;">") (an objective measure of structural damage to the cornea), which are FDA-accepted efficacy endpoints, VOS showed rapid and statistically significant improvements over cyclosporine ophthalmic emulsion 0.05% at Week 4 (STT: p=.0051; FCS: p=.0003). </font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">This 100-patient, double-masked, head-to-head study was designed to evaluate the efficacy, safety and tolerability of VOS versus cyclosporine ophthalmic emulsion 0.05% in subjects with DES. Both arms of the study received either VOS or cyclosporine ophthalmic emulsion 0.05% (1:1) administered twice daily, in both eyes, for 28 days. Key pre-specified secondary endpoints, which are FDA-accepted endpoints, include STT, FCS, and assessments of dry eye symptoms.  Improvements in STT and FCS are considered by regulators to be two of the most clinically meaningful measures of efficacy in this disease.</font></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:9pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:82.421875%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:60%;"></td><td style="width:14%;"></td><td style="width:13%;"></td><td style="width:13%;"></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">4-Week Pre-Specified Efficacy Endpoints (Signs)*</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">VOS</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Restasis&#174;</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">p-value vs. Restasis&#174;</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="padding-bottom:13px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Schirmer Tear Test (STT) </font></div><div style="padding-bottom:13px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">(mm LS mean increase from baseline)</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8.6</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3.3</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">.0051</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="padding-bottom:13px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">% of subjects showing &#8805; 10mm improvement in STT </font></div><div style="padding-bottom:13px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">(basis of FDA approval for other CNIs and an improvement is considered to be clinically significant)</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">42.9%</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">18.4%</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">.0055</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="padding-bottom:13px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Fluorescein Corneal Staining (FCS)</font></div><div style="padding-bottom:13px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">(reduction in staining is clinically significant)</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">-2.2</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">-0.2</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">.0003</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:left;padding-left:60px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">*worst eye</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Both treatment arms also demonstrated substantial and statistically significant improvements on the Symptom Assessment in Dry Eye score from baseline to Week 4. </font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">No serious adverse events (SAEs) were reported in the study, and there were no unexpected safety signals. All adverse events (AEs) were mild to moderate and the majority of patients had no AEs. </font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Phase 2/3 Clinical Study ("AUDREY") in DES</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Based upon the exploratory Phase 2a results generated with VOS, Aurinia has initiated plans for a Phase 2/3 study which is expected to enroll its first patient in the 4th quarter of 2019.  This study will include certain critical regulatory requirements that the FDA has traditionally required for DES product approval, these requirements include both dose-optimization requirements along with a comparison versus the nanomicellar vehicle. </font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">AUDREY ("</font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">Au</font><font style="font-family:inherit;font-size:9pt;">rinia </font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">Dr</font><font style="font-family:inherit;font-size:9pt;">y </font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">E</font><font style="font-family:inherit;font-size:9pt;">ye Stud</font><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">y</font><font style="font-family:inherit;font-size:9pt;">") will be a United States based randomized, Double-Masked, Vehicle-Controlled, Dose Ranging Study to Evaluate the Efficacy and Safety of Voclosporin Ophthalmic Solution (VOS) in Subjects with Dry Eye Syndrome and will enroll approximately 480 subjects. The study will consist of four arms and encompass a 1:1:1:1 randomization schedule to either 0.2% VOS, 0.1% VOS, 0.05% VOS or vehicle, subjects will be dosed twice daily for 12 weeks.</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The primary outcome measure for the study is the proportion of subjects with &#8805;10mm improvement in STT at 4 weeks. </font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Secondary outcome measures will include STT at multiple time points, including at 12 weeks, FCS at multiple time points, change in Eye Dryness, burning/stinging, itching, photophobia, eye pain and foreign body sensation&#160; at multiple time points, change in Symptom Assessment in Dry Eye ("SANDE") score at multiple time points etc. and additional safety endpoints.</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">We believe there is precedent for the AUDREY study to act as one of the two pivotal clinical studies that would support approval by the FDA for the treatment of DES.</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">With the results seen in our Phase 2a exploratory study in terms of efficacy, we believe that VOS has a differentiated product profile with a long patent life that has the potential to compete favorably in the billion dollar human prescription dry eye market.</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Animal safety toxicology studies were previously completed in rabbit and dog models, and additional longer-term animal safety toxicology studies are also currently being conducted.</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">AURORA Phase 3 Clinical Trial in LN</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">We achieved a significant milestone on September 25, 2018 with the completion of enrollment for our AURORA Phase 3 clinical trial. The target enrollment of 324 patients was surpassed due to high patient demand with 358 LN patients randomized in sites across 27 countries. AURORA is a 56-week trial (52-week primary endpoint and a four-week follow-up period).  As previously indicated, we expect to have top-line data for this trial in late 2019.</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">We believe the totality of data from both the AURORA and AURA clinical trials can potentially serve as the basis for an NDA submission with the FDA following a successful completion of the AURORA clinical trial. Under voclosporin&#8217;s fast-track designation we intend to utilize a rolling NDA process which will allow us to begin the submission process following a positive pre-NDA meeting with the FDA, which we anticipate will occur in the first quarter of 2020.  To that end we are actively preparing the non-clinical and chemistry, manufacturing and controls modules required for the NDA submission. Our current plan is to complete the NDA, including the clinical module, in the second quarter of 2020.</font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The AURORA clinical trial is a global double-blind, placebo-controlled study (designed with target enrollment of 324 patients) to evaluate whether voclosporin added to background therapy of MMF can increase overall renal response rates in the presence of low dose steroids. </font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Patients were randomized 1:1 to either of: (i) 23.7 mg voclosporin BID and MMF, or (ii) MMF and placebo, with both arms receiving a rapid oral corticosteroid taper. As in the AURA clinical trial, the study population in AURORA is comprised of patients with biopsy proven active LN who will be evaluated on the primary efficacy endpoint of complete remission, or renal response, at 52 weeks, a composite which includes:</font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">urine protein-creatinine ratio of &#8804;0.5mg/mg;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">normal, stable renal function (&#8805;60 mL/min/1.73m2 or no confirmed decrease from baseline in eGFR of &gt;20%);</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">presence of sustained, low dose steroids (&#8804;10mg prednisone from week 44-52); and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">no administration of rescue medications.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Patients completing the AURORA trial have the option to roll over into a 104-week blinded extension trial (the "</font><font style="font-family:inherit;font-size:9pt;font-weight:bold;">AURORA 2 extension trial</font><font style="font-family:inherit;font-size:9pt;">").   During the second quarter ended June 30, 2018, the first patients commenced rolling over into the AURORA 2 extension trial.  Enrollment in this study continues to increase as additional patients complete AURORA.  The data from the AURORA 2 extension trial will allow us to assess the long-term benefit/risk of voclosporin in LN patients, however, this study is not a requirement for potential regulatory approval for voclosporin.  Data from the AURORA 2 extension trial assessing long-term outcomes in LN patients should be valuable in a post-marketing setting and for future interactions with various regulatory authorities. </font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">In order to enhance and complete the clinical dossier, we commenced a confirmatory DDI study between voclosporin and MMF in the second half of 2018.  A legacy CNI, cyclosporin A, impacts MPA (the active moiety of MMF) concentrations, and our goal with this short study (patients monitored for a period of two weeks) is to confirm the lack of impact of voclosporin upon MPA concentrations in lupus patients. No clinically significant interaction has been observed to date in other indications.  Full enrollment of patients was achieved towards the end of the second quarter of 2019.&#160;&#160;Results from this study, anticipated in the third quarter of 2019, will be modeled together with the abundance of PK data already available to support the NDA. We believe the results of this study will add to our knowledge of voclosporin in a multi-targeted therapeutic approach and should have no impact on the potential approval of voclosporin. </font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">We also plan to evaluate voclosporin in pediatric patients after a potential FDA approval of an indication for adults with LN.</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:4px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Additional Voclosporin Indication - FSGS </font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">As with other proteinuric kidney diseases, loss of podocyte function is a key feature of disease progression in FSGS. The disease has straightforward metrics where an early clinical response, determined by reduction in proteinuria, correlates with favorable long-term outcomes. Based on our clinical data in LN which demonstrated that voclosporin decreased proteinuria and the beneficial effects of CNIs on podocytes, we believe voclosporin has the potential to benefit patients with FSGS. In addition, voclosporin has a favorable metabolic profile and consistent predictable dose response potentially eliminating the need for therapeutic drug monitoring which are substantial advantages over legacy CNIs which are used off label primarily as second line immunotherapy in FSGS.  Our Phase 2 proof-of-concept study in FSGS, which was designed as an open-label study of approximately 20 treatment-naive United States patients, was initiated in June 2018.  The target population is newly diagnosed and steroid naive patients in a rare disease. </font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Enrollment in this study, primarily due to the target population patients available, has been slower than originally expected.  Two activities have been recently implemented to enhance enrollment into the study. We have opened up additional sites outside of the United States and amended the protocol to permit entry of subjects who have received limited corticosteroid exposure in the past. We believe enrollment could take up to an additional twelve months and anticipate interim data readouts in 2020. </font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">As we have been focused on LN and with the potential extended expansion of our intellectual property until 2037, expanding our scope to include other proteinuric renal diseases is synergistic with our current strategy and long-term vision.</font></div><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div><a name="sE06C5161EEE15DD5B6AE3EFC6FBD9556"></a></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">RESULTS OF OPERATIONS</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">For the three months ended June 30, 2019, we reported a consolidated net loss of $15.90&#160;million or $0.17 loss per common share, as compared to a consolidated net loss of $15.71&#160;million or $0.19 loss per common share for the three months ended June 30, 2018.</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">On a year-to-date basis, we recorded a consolidated net loss of $28.33 million or $0.31 per share for the six months ended June 30, 2019, compared to a consolidated net loss of $31.19 million or $0.37 per share for the six months ended June 30, 2018.  The lower consolidated net loss for the six months ended June 30, 2019 was due primarily to recording a non-cash decrease in estimated fair value of derivative warrant liabilities on revaluation of $2.35 million for the six month ended June 30, 2019 compared to recording an increase of $4.56 million for the same period in 2018, a swing of $6.91 million.</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">We record the non-cash changes in derivative warrant liabilities based on fair value revaluation each quarter.  These revaluations fluctuate based primarily on the market price of our Common Shares. An increase in the market price of our shares results in an increase in estimated fair value of derivative warrant liabilities (increase in loss) on revaluation while a decrease results in a decrease in the estimated fair value of derivative warrant liabilities (decrease in loss) on revaluation. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">After adjusting for the non-cash impact of the revaluation of the derivative warrant liabilities, the net losses before the changes in estimated fair value of derivative warrant liabilities and income taxes  for the three and six month periods ended June 30, 2019 were $16.51 million and $30.65  </font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">million respectively compared to $13.77  million and $26.62 million for the same periods in 2018. </font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Research and Development expenses </font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">R&amp;D expenses increased to $11.15 million and $21.78 million respectively for the three and six month periods ended June 30, 2019 compared to $10.50 million and $19.39 million respectively for the three and six month periods ended June 30, 2018.</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The increase in R&amp;D expenses primarily reflected additional costs incurred for the AURORA 2 extension trial, the DDI study, the FSGS Phase 2a study and preparation activities for the DES Phase 2/3 clinical trial.</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The most significant portion of R&amp;D expenses related to the AURORA trial.  AURORA trial costs were $4.36 million and $9.31 million respectively for the three and six months ended June 30, 2019 compared to $5.87 million and $11.64 million respectively for the three and six months ended June 30, 2018.</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">R&amp;D expenses by type of expense were as follows:</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Clinical Research Organization ("</font><font style="font-family:inherit;font-size:9pt;font-weight:bold;">CRO</font><font style="font-family:inherit;font-size:9pt;">") and other third party clinical trial expenses were $7.07&#160;million and $14.07 million respectively for the three and six month periods ended June 30, 2019 compared to $6.45 million and $12.44 million respectively for the three and six month periods ended June 30, 2018.  The increased costs primarily reflected higher CRO costs, including service fees and pass-through costs related to the AURORA 2 extension trial, the DDI study and the Phase 2a FSGS study. </font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">We incurred drug manufacturing and supply costs of $1.53 million and $2.68 million respectively for the three and six month periods ended June 30, 2019 compared to $1.74 million and $2.45 million respectively for the three and six month periods ended June 30, 2018. These costs included packaging and distribution of the drug supply for the AURORA trials and manufacturing VOS drug supply. </font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Salaries, annual incentive pay accruals and employee benefits increased to $1.30 million and $2.54 million respectively for the three and six month periods ended June 30, 2019 compared to $1.05 million and $2.13 million respectively for the three and six month periods ended June 30, 2018.  The increase reflected the hiring of eight additional R&amp;D employees since January 1, 2018, and annual salary increases.</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">We recorded a non-cash stock compensation expense of $749,000 and $1.61million respectively for the three and six month periods ended June 30, 2019 compared to $770,000 and $1.55 million for the three and six month periods ended June 30, 2018 for stock options granted to R&amp;D personnel. </font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other expenses, which included items such as travel, clinical trial insurance, patent annuity and legal fees, phone and publications were $501,000 and $883,000 respectively for the three and six month periods ended June 30, 2019 compared to $494,000 and $822,000 respectively for the three and six month periods ended June 30, 2018. </font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Corporate, administration and business development expenses</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Corporate, administration and business development expenses were $4.95 million and $8.85 million respectively for the three and six month periods ended June 30, 2019 compared to $3.46 million and $7.25 million respectively for the three and six month periods ended June 30, 2018.</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Corporate, administration and business development expenses included non-cash stock option expense of $1.21 million and $1.95 million respectively for the three and six month periods ended June 30, 2019 compared to $1.26 million and $2.59 million respectively for the three and six month periods ended June 30, 2018. </font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Salaries, payroll accruals and employee benefits (excluding stock compensation expense noted above) were $1.65 million and $2.99 million respectively for the three and six month periods ended June 30, 2019 compared to $1.11 million and $2.33 million respectively for the three and six month periods ended June 30, 2018.  The increases primarily reflected the hiring of nine additional staff since January 1, 2018, a signing bonus paid to the new Chief Executive Officer and annual salary increases.</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Professional and consulting fees were $1.03 million and $1.99 million respectively for the three and six month periods ended June 30, 2019 compared to $472,000 and $974,000 respectively for the three and six month periods ended June 30, 2018. The increase primarily reflected higher consulting fees in 2019 for recruiting, market research and other pre-commercial activities, </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Rent, insurance, information technology, communications and other public company operating costs were $465,000 and $1.03 million respectively for the three and six month periods ended June 30, 2019 compared to $433,000 and $915,000 respectively for the three and six month periods ended June 30, 2018.  The increases reflected overall higher activity levels, higher staff numbers, and higher director and officer insurance costs commensurate with conducting a Phase 3 clinical trial.</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Travel, tradeshows and sponsorships expense increased to $595,000 and $890,000 respectively for the three and six month periods ended June 30, 2019 compared to $188,000 and $451,000 respectively for the three and six month periods ended June 30, 2018. The increase reflected higher tradeshow, conference and sponsorship activity levels in 2019 compared to the same periods in 2018.</font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Finance Costs</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">We incurred finance costs of $123,000 and $189,000 for the three and six month periods ended June 30, 2019 compared to $66,000 and $106,000 for the three and six month periods ended June 30, 2018. Finance costs are comprised of interest expense related to the lease liability, revaluation adjustment on the contingent consideration and foreign exchange loss or gain. </font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Other Expenses</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">We incurred costs of $720,000 in the second quarter ended June 30, 2019 associated with the successful defense of a proxy contest in connection with our annual general meeting held on June 26, 2019.  There was no similar type of expense in 2018.  These costs included legal and consulting fees and additional printing, mailing and meeting costs. </font></div><div style="line-height:120%;padding-bottom:12px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Stock-based Compensation expense</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">For stock option plan information, stock option grants and outstanding stock option details refer to note 6 of the unaudited interim condensed consolidated financial statements for the three and six months ended June 30, 2019.</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">We granted 1.70 million and  3.08 million stock options for the three and six month periods ended June 30, 2019 respectively at weighted average exercise prices of $6.29 and $6.19 per common share respectively compared to Nil and 2.98 million stock options at weighted average exercise prices of $Nil and $5.28 respectively for the same periods in 2018. For the six month period ended June 30, 2019 the granted stock options were allocated 2.37 million to corporate, administration and business development personnel, and 707,000 to R&amp;D personnel compared to 1.66 million to corporate, administration and business development personnel, and 1.32 million to R&amp;D personnel for the same periods in 2018.</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Application of the fair value method resulted in charges to stock-based compensation expense of $1.96 million and $3.56 million respectively for the three and six month periods ended June 30, 2019 (2018 - $2.03 million and $4.14 million) with corresponding credits to contributed surplus.  For the three and six month periods ended June 30, 2019, stock-based compensation expense was allocated to R&amp;D expense in the amounts of $749,000 and $1.61 million respectively (2018 - $770,000 and $1.55 million) and corporate and administration expense in the amount of $1.21 million and $1.95 million respectively (2018 - $1.26 million and $2.59 million). The  decrease in stock option expense primarily reflected a reduction in the number of options granted in 2019 compared to the same period in 2018, and the reversal of  stock option expense previously recorded related to stock options forfeited in 2019 upon the resignation of our previous Vice President of Public Affairs and the modification as noted below. </font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">In 2019, Dr. Richard Glickman and Aurinia entered into a transition agreement whereby upon his retirement as Chairman of the Board and Chief Executive Officer of Aurinia, Dr. Glickman would continue to provide substantive services as an adviser to the Company for a period of 12 months commencing May 6, 2019.  Management applied judgment in assessing if the services to be provided are substantive. Unvested stock options at May 6, 2019 were modified such that they will vest in equal installments over the next 12 months, subject to Dr. Glickman remaining an adviser to the Company at each of the vesting dates. The transition agreement resulted in 100,000 stock options that would have been&#160;forfeited&#160;at May 6, 2020 vesting on an accelerated timeline. Therefore, we determined that the amount expensed for such awards to date should be reversed. We recognized these 100,000 stock options as a new grant based on the fair value at the date of the transition agreement which will be expensed as they vest over the transition period. We also revised the allocation over the remaining vesting period (on the basis of one-twelfth per month) to reflect the graded nature of the vesting over the transition period. </font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Amortization of acquired intellectual property and other intangible assets</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Amortization of acquired intellectual property and other intangible assets was $347,000 and $693,000 respectively for the three and six month periods ended June 30, 2019 compared to $397,000 and $793,000 recorded for the same periods in 2018, with no significant change to acquired intellectual property and other intangible assets. </font></div><div style="line-height:120%;padding-bottom:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Interest income </font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">We recorded interest income of $787,000 and $1.60 million for the three month and six month periods ended June 30, 2019 compared to other income of $632,000 and $872,000 for the same periods in 2018.  The increase was primarily the result of larger amounts invested in interest-bearing instruments and higher average interest rates earned on these instruments. </font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Change in estimated fair value of derivative warrant liabilities</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">We recorded a non-cash decrease in estimated fair value of derivative warrant liabilities of $625,000 and $2.35 million for the three and six month periods ended June 30, 2019 compared to a non-cash increase of $1.93 million and $4.56 million for the three and six month periods ended June 30,  2018. These revaluations fluctuate based primarily on the market price of our Common Shares and to a lesser degree on the annualized volatility calculation. Derivative warrant liabilities are more fully discussed in the section </font><font style="font-family:inherit;font-size:9pt;font-style:italic;">Critical estimates in applying the Company&#8217;s accounting policies</font><font style="font-family:inherit;font-size:9pt;">&#32;and note 5 (Derivative Warrant Liabilities) to the unaudited interim condensed consolidated financial statements for the three and six month periods ended June 30, 2019.</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">I</font><font style="font-family:inherit;font-size:9pt;">n accordance with IFRS, a contract to issue a variable number of shares fails to meet the definition of equity and must instead be classified as a derivative liability and measured at fair value with changes in fair value recognized in the consolidated statements of operations and comprehensive loss at each period-end. To clarify, while we will settle these warrants only in shares in the future, accounting rules require that </font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">we show a liability because of the potential variability in the number of shares which may be issued if the cashless exercise option is used by the holder of the warrants under the specific situations discussed below. </font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The derivative warrant liabilities will ultimately be eliminated on the exercise or forfeiture of the warrants and will not result in any cash outlay by the Company.</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Derivative warrant liability related to December 28, 2016 bought deal public offering</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">On December 28, 2016, we completed a $28.75 million bought deal public offering (the "</font><font style="font-family:inherit;font-size:9pt;font-weight:bold;">December Offering</font><font style="font-family:inherit;font-size:9pt;">"). Under the terms of the December Offering, we issued 12.78 million units at a subscription price per unit of $2.25, each unit consisting of one common share and one-half (0.50) of a common share purchase warrant (a "</font><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Warrant</font><font style="font-family:inherit;font-size:9pt;">"), exercisable for a period of five years from the date of issuance at an exercise price of $3.00.  Therefore, we issued 6.39 million Warrants. The holders of the Warrants issued pursuant to the December Offering may elect, if we do not have an effective registration statement registering the Common Shares underlying the Warrants, or the prospectus contained therein is not available for the issuance of the Common Shares underlying the Warrants to the holder, in lieu of exercising the Warrants for cash, a cashless exercise option to receive Common Shares equal to the fair value of the Warrants. This calculation is based on the number of Warrants to be exercised multiplied by the weighted average market price less the exercise price with the difference divided by the weighted average market price. If a Warrant holder exercises this option, there will be variability in the number of shares issued per Warrant.  There can be no certainty that we will have an effective registration statement in place over the entire life of the Warrants and therefore, under IFRS we are required to record these Warrants as derivative warrant liabilities.</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">There were no warrant exercises for the three or six months ended June 30, 2019 related to these December 28, 2019 warrants.</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">At June 30, 2019, there were 3.52 million of the December 28, 2016 Warrants outstanding at an exercise price of $3.00.</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Derivative warrant liability related to February 14, 2014 private placement offering</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">On February 14, 2014, we completed a $52 million private placement (the "</font><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Private Placement</font><font style="font-family:inherit;font-size:9pt;">"). Under the terms of the Private Placement, we issued 18.92 million units at a subscription price per unit of $2.7485, each unit consisting of one common share and one-quarter (0.25) of a common share purchase warrant (the "</font><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2014 Warrants</font><font style="font-family:inherit;font-size:9pt;">"), exercisable for a period of five years from the date of issuance at an exercise price of $3.2204. The holders of the 2014 Warrants issued pursuant to the Private Placement may elect, in lieu of exercising the 2014 Warrants for cash, a cashless exercise option to receive Common Shares equal to the fair value of the 2014 Warrants based on the number of 2014 Warrants to be exercised multiplied by a five-day weighted average market price less the exercise price with the difference divided by the weighted average market price. If a 2014 Warrant holder exercises this option, there will be variability in the number of shares issued per Warrant.  </font></div><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">During the three months ended March 31, 2019, the 1.74 million 2014 Warrants outstanding at December 31, 2018 were exercised.  Certain holders of the 2014 Warrants elected the cashless exercise option and as a result we issued 687,000 Common Shares upon the cashless exercise of 1.27 million 2014 Warrants.  The remaining 464,000 warrants were exercised for cash, at a price of $3.2204 per common share, and as a result we received cash proceeds of $1.49 million upon the issuance of 464,000 Common Shares. Pursuant to the exercise of the 2014 Warrants, we transferred $5.92 million from derivative warrant liability to equity (Common Shares) and recorded an adjustment of $352,000 through the statement of operations and comprehensive loss related to the change in estimated fair value of derivative warrant liabilities for the three months ended March 31, 2019. As a result, the derivative warrant liability related to the February 14, 2014 private placement offering was extinguished upon the exercise of the aforementioned warrants.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s89C3FD0936915B63A011D7F11779417D"></a></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">LIQUIDITY AND CAPITAL RESOURCES</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">As at June 30, 2019, we had cash and cash equivalents on hand of $131.49 million compared to $144.33 million as at March 31, 2019 and $125.86 million at December 31, 2018. </font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">We are in the development stage and are devoting the majority of our operational efforts and financial resources towards the clinical development and potential commercialization of our late stage drug, voclosporin, which includes the completion of the AURORA trial.  For the six months ended June 30, 2019, we reported a net loss of $28.33 million for the period and a cash outflow from operating activities of $26.40 million.  As at June 30, 2019, we had an accumulated deficit of $444.29 million.</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">We believe we have sufficient cash to fund the existing LN program, including the AURORA and AURORA 2 extension trials, complete the NDA submission to the FDA, conduct the ongoing Phase 2 study for FSGS, commence the Phase 2/3  DES  study and fund supporting and corporate operations into the second half of 2020.  </font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:10px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Costs to complete the AURORA trial are estimated to be approximately $13 million. We are also conducting the AURORA 2 extension trial which will be completed by the end of 2021 with estimated costs left to be incurred of approximately $22 million.  </font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Sources and Uses of Cash:</font></div><div style="line-height:120%;padding-bottom:4px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="10"></td></tr><tr><td style="width:47%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Three months ended June 30</font></div></td><td style="vertical-align:bottom;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Six months ended June 30</font></div></td><td style="vertical-align:bottom;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Cash used in operating activities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(13,253</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(12,289</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(26,402</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(26,669</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Cash generated from (used in) investing activities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,952</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">9,970</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7,842</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(10,052</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Cash generated from financing activities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">435</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,394</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">32,086</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,394</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Net increase (decrease) in cash and cash equivalents</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">(8,866</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">)</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">1,075</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">13,526</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">(33,327</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">)</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Cash used in operating activities was $13.25&#160;million and $26.40 million respectively for the three and six month periods ended June 30, 2019 compared to cash used in operating activities of $12.29 million and $26.67 million for the same periods in 2018.  Cash used in operating activities was composed of net loss, add-backs or adjustments not involving cash, such as stock-based compensation and change in estimated fair value of derivative warrant liabilities and net change in other operating assets and liabilities including prepaid expenses, deposits and other and accounts payable and accrued liabilities. </font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Cash generated from (used in) investing activities primarily related to movements within our short term investment portfolio which was comprised of bonds and treasury notes. As at June 30, 2019, there were no short term investments.</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Cash generated from financing activities was $435,000 and $32.09 million respectively for the three and six month periods ended June 30, 2019 compared to cash generated from financing activities of $3.39 million for both the three and six month periods ended June 30, 2018. We received net proceeds of $28.83 million from the ATM discussed below, $1.49 million from the exercise of derivative warrants and $1.82 million from the exercise of stock options for the six month period ended June 30, 2019.  Cash generated from financing activities for the three and six months ended June 30, 2018 was composed of $3.05 million from the exercise of warrants and $347,000 from the exercise of stock options.</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Use of Financing Proceeds </font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">November 30, 2018 At-the-Market (ATM) facility</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">On November 30, 2018, we entered into an open market sale agreement with Jefferies LLC pursuant to which Aurinia would be able to, from time to time, sell, through&#160;at-the-market&#160;offerings, such common shares as would have an aggregate offering amount of up to $30 million. We filed a prospectus supplement with securities regulatory authorities in Canada in the provinces of British Columbia, Alberta and Ontario, and with the United States Securities and Exchange Commission, which supplemented Aurinia&#8217;s short form base shelf prospectus dated March&#160;26, 2018, and Aurinia&#8217;s shelf registration statement on Form&#160;F-10&#160;dated March&#160;26, 2018, declared effective on March&#160;29, 2018. </font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">During the first quarter ended March 31, 2019, we sold 4.61 million Common Shares and received gross proceeds of $30 million at a weighted average price of $6.51 pursuant this agreement.  We incurred share issue costs of $1.17 million including a 3% commission of $900,000 and professional and filing fees of $270,000 directly related to the ATM offering.  Sales in the ATM offering were only conducted in the United States through NASDAQ at market prices. </font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">March 20, 2017 Offering</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">On March 20, 2017, we completed an underwritten public offering of 25.64 million Common Shares, which included 3.35 million Common Shares issued pursuant to the full exercise of the underwriters' overallotment option to purchase additional Common Shares, for net proceeds of $162.32 million, which are to be used for R&amp;D activities and for working capital and corporate purposes. </font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">A summary of the anticipated and actual use of net proceeds used to date from the above financings is set out in the table below.  </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:52%;"></td><td style="width:23%;"></td><td style="width:1%;"></td><td style="width:23%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Allocation of net proceeds</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Total net proceeds from financings</font></div><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">(in thousands) </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Net proceeds used to date</font></div><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">&#160;(in thousands)  </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">March 20, 2017 Offering:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">R&amp;D activities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">123,400</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">67,217</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Working capital and corporate purposes</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">38,924</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">13,063</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Subtotal:</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">162,324</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">80,280</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">November 30, 2018 ATM offerings</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">28,830</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Total: </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">191,154</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">80,280</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">To June 30, 2019, there have been no material variances from how we disclosed we were going to use the proceeds from the above noted offerings and thus, no material impact on the ability to achieve our business objectives and milestones. </font></div><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div><a name="s3267122C18C65ABA8E7AD7DED324CDAA"></a></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">CONTRACTUAL OBLIGATIONS</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">We have the following contractual obligations as at June 30, 2019:</font></div><div style="line-height:120%;padding-bottom:16px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="15"></td></tr><tr><td style="width:41%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(in&#160;thousands)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Less than</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">one year</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(in&#160;thousands)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">One&#160;to&#160;three</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">years</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(in&#160;thousands)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Four to&#160;five </font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">years</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(in&#160;thousands)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">More than five years</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(in&#160;thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Lease liability</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">412</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">122</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">290</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Lease obligations</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">304</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">122</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">182</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Purchase obligations</font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#160;(2)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">17,161</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">16,911</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">242</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Accounts payable and accrued liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6,989</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6,989</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Contingent consideration to ILJIN </font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(3)</sup></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,108</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">71</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,561</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">476</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">28,974</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">24,215</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">4,275</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">484</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:7pt;padding-left:0px;"><font style="font-family:inherit;font-size:7pt;">(1)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Lease obligations consist of short term facility lease and variable lease payments.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:7pt;padding-left:0px;"><font style="font-family:inherit;font-size:7pt;">(2)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">We have entered into contractual obligations for services and materials required for the AURORA clinical trial, drug supply and other R&amp;D projects activities. The purchase obligations presented represent the minimum amount to exit our contractual commitments.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:7pt;padding-left:0px;"><font style="font-family:inherit;font-size:7pt;">(3)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Contingent consideration to ILJIN is described in note 4 to the unaudited interim condensed financial statements for the three months ended June 30, 2019.</font></div></td></tr></table><div style="line-height:120%;padding-left:4px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">As at June 30, 2019, we are also party to agreements with CROs and a central laboratory, and other third party service providers providing services to us for our clinical trials and studies, and other research and development activities.  Corresponding anticipated expenses, excluding purchase obligations noted above, are estimated to be in the range of $25-$30 million over the next twelve months.</font></div><div style="line-height:120%;padding-left:4px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div><a name="sEA3D699041275C0AA3AC359FA619C216"></a></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">RELATED PARTY TRANSACTIONS</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Stephen P. Robertson, a partner at Borden Ladner Gervais ("</font><font style="font-family:inherit;font-size:9pt;font-weight:bold;">BLG</font><font style="font-family:inherit;font-size:9pt;">") acts as our corporate secretary. We incurred legal fees in the normal course of business to BLG of $265,000 and $333,000 respectively for the three and six months ended June 30, 2019 compared to $31,000 and $92,000 respectively for the same periods in 2018. The amount charged by BLG is based on standard hourly billing rates for the individuals working on our account. We have no ongoing contractual or other commitments as a result of engaging Mr. Robertson to act as our corporate secretary. Mr. Robertson receives no additional compensation for acting as the corporate secretary beyond his standard hourly billing rate. </font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The outstanding fair value of contingent consideration payable to ILJIN, an affiliated shareholder and related party, is the result of an Arrangement Agreement (the "</font><font style="font-family:inherit;font-size:9pt;font-weight:bold;">ILJIN Agreement</font><font style="font-family:inherit;font-size:9pt;">") completed on September 20, 2013 between the Company, Aurinia Pharma Corp. and ILJIN.</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Pursuant to the terms of the ILJIN Agreement, $10 million in contingent consideration would potentially be owed to ILJIN based on the achievement of future pre-defined clinical and marketing milestones.  During 2017, we paid to ILJIN $2.15 million of the $10 million upon the achievement of </font><font style="font-family:inherit;font-size:9pt;">two</font><font style="font-family:inherit;font-size:9pt;">&#32;specific milestones pursuant to this contingent consideration.  As such, at June 30, 2019, there is $7.85 million of contingent consideration milestones remaining which we may pay out in the future dependent upon the achievement of the specific pre-defined milestones being met. </font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The contingent consideration payable to ILJIN is more fully discussed in note 4 of the unaudited interim condensed consolidated financial statements for the three and six month periods ended June 30, 2019.</font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div><a name="sB75AC8590049584CBA8EE99207462F44"></a></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">OFF-BALANCE SHEET ARRANGEMENTS</font></div><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other than as described in the </font><font style="font-family:inherit;font-size:9pt;font-style:italic;">Contractual Obligations</font><font style="font-family:inherit;font-size:9pt;">&#32;and </font><font style="font-family:inherit;font-size:9pt;font-style:italic;">Contingencies</font><font style="font-family:inherit;font-size:9pt;">&#32;sections of this MD&amp;A, there are no material undisclosed off-balance sheet arrangements that have or are reasonably likely to have, a current or future effect on our results of operations or financial condition.</font></div><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div><a name="sF2A372E5FD265FE5A80EB4076D0FFBFF"></a></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">CRITICAL ACCOUNTING ESTIMATES AND JUDGMENTS</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The preparation of consolidated financial statements in accordance with IFRS often requires management to make estimates about, and apply assumptions or subjective judgment to, future events and other matters that affect the reported amounts of our assets, liabilities, revenues, expenses and related disclosures. Assumptions, estimates and judgments are based on historical experience, expectations, current trends and other factors that management believes to be relevant at the time at which our consolidated financial statements are prepared. Management reviews, on a regular basis, our accounting policies, assumptions, estimates and judgments in order to ensure the consolidated financial statements are presented fairly and in accordance with IFRS.</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Critical accounting estimates and judgments are those that have a significant risk of causing material adjustment and are often applied to matters or outcomes that are inherently uncertain and subject to change. As such, management cautions that future events often vary from forecasts and expectations and that estimates routinely require adjustment.</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Management considers the following areas to be those where critical accounting policies affect the significant judgments and estimates used in the preparation of our consolidated financial statements.</font></div><div style="line-height:120%;padding-bottom:12px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Critical estimates in applying Aurinia's accounting policies</font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Contingent consideration</font></div></td></tr></table><div style="line-height:120%;padding-bottom:12px;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Contingent consideration is a financial liability recorded at fair value. The amount of contingent consideration to be paid is based on the occurrence of future events, such as the achievement of certain development, regulatory and sales milestones. Accordingly, the estimate of fair value contains uncertainties as it involves judgment about the likelihood and timing of achieving these milestones as well as the discount rate used. Changes in fair value of the contingent consideration obligation result from changes to the assumptions used to estimate the probability of success for each milestone, the anticipated timing of achieving the milestones and the discount period and rate to be applied. A change in any of these assumptions could produce a different fair value, which could have a material impact on the results from operations. </font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The fair value estimates at June 30, 2019 were based on a discount rate of 10% (June 30, 2018 - 10%) and a presumed payment range between 50% and 74% (2018 - 50% and 75%). The fair value of this contingent consideration as at June 30, 2019 was estimated to be $4.11 million (June 30, 2018 - $3.94 million) and was determined by estimating the probability and timing of achieving the milestones and applying the income approach. </font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The change in expected timing of milestone payments and passage of time, on revaluation, resulted in a increase in contingent consideration of $87,000 and $80,000 respectively for the three and six month periods ended June 30, 2019 compared to an increase in contingent consideration of $60,000 and $149,000 respectively for the three and six month periods ended June 30, 2018.</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">This is a Level&#160;3 recurring fair value measurement. If the probability for success were to increase by a factor of 10% for each milestone, this would increase the net present value ("</font><font style="font-family:inherit;font-size:9pt;font-weight:bold;">NPV</font><font style="font-family:inherit;font-size:9pt;">") of the obligation by approximately $635,000 as at June 30, 2019. If the probability for success were to decrease by a factor of 10% for each milestone, this would decrease the NPV of the obligation by approximately $635,000 as at June 30, 2019. If the discount rate were to increase to 12%, this would decrease the NPV of the obligation by approximately $158,000. If the discount rate were to decrease to 8%, this would increase the NPV of the obligation by approximately $173,000.</font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Derivative warrant liabilities</font></div></td></tr></table><div style="line-height:120%;padding-bottom:12px;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Warrants issued pursuant to equity offerings that are potentially exercisable in cash or on a cashless basis resulting in a variable number of shares being issued are considered derivative liabilities and therefore measured at fair value.</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">We use the Black-Scholes pricing model to estimate fair value at each exercise and period end date. The key assumptions used in the model are the expected future volatility in the price of our shares and the expected life of the warrants. The impact of changes in key assumptions are noted below.</font></div><div style="line-height:120%;padding-bottom:12px;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">These derivative warrant liabilities are Level&#160;3 recurring fair value measurements.</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The key Level&#160;3 inputs used by management to estimate the fair value are the market price and the expected volatility. If the market price were to increase by a factor of 10%, this would increase the estimated fair value of the obligation by approximately $2.22 million as at June 30, 2019. If the market price were to decrease by a factor of 10%, this would decrease the estimated fair value of the obligation by approximately $2.18 million. If the volatility were to increase by 10%, this would increase the estimated fair value of the obligation by approximately $168,000. If the volatility were to decrease by 10%, this would decrease estimated fair value of the obligation by approximately $143,000 as at June 30, 2019.</font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Fair value of stock options</font></div></td></tr></table><div style="line-height:120%;padding-bottom:12px;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Determining the fair value of stock options on the grant date requires judgment related to the choice of a pricing model, the estimation of stock price volatility and the expected term of the underlying instruments. Any changes in the estimates or inputs utilized to determine fair value could result in a significant impact on our reported operating results, liabilities or other components of shareholders&#8217; equity. The key assumptions used by management is the stock price volatility. </font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">If the stock price volatility was higher by a factor of 10% on the option grant dates for the three months ended June 30, 2019, this would have increased annual stock compensation expense by approximately $158,000. If the stock price volatility was lower by a factor of 10% on the grant date, this would have decreased annual stock compensation expense by approximately $162,000.</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">We used the Black-Scholes option pricing model to estimate the fair value of options granted.</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">We consider historical volatility of our Common Shares in estimating its future stock price volatility. The risk-free interest rate for the expected life of the options was based on the yield available on government benchmark bonds with an approximate equivalent remaining term at the time of the grant. The expected life is based upon the contractual term, taking into account expected employee exercise and expected post-vesting employment termination behavior.</font></div><div style="line-height:120%;padding-bottom:12px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Critical judgments in applying Aurinia's accounting policies</font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Revenue recognition</font></div></td></tr></table><div style="line-height:120%;padding-bottom:16px;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Our assessments related to the recognition of revenues for arrangements containing multiple elements are based on estimates and assumptions. Judgment is necessary to identify separate performance obligations and to allocate related consideration to each separate performance obligation. Where deferral of license fees is deemed appropriate, subsequent revenue recognition is often determined based on certain assumptions and estimates, our continuing involvement in the arrangement, the benefits expected to be derived by the customer and expected patent lives. The estimate of variable consideration requires significant judgment and an assessment of their potential reversal. We also use judgment in assessing if a license is a right to use or a right to access intellectual property. Factors that are considered include whether the customer reasonably expects (arising from the entity's customary business practices) that the entity will undertake activities that will significantly affect the intellectual property, the rights granted by the license directly expose the customer to any positive or negative effects of the entity's activities and whether those activities transfer a separate good or service to the customer. To the extent that any of the key assumptions or estimates change, future operating results could be affected.</font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Impairment of intangible assets</font></div></td></tr></table><div style="line-height:120%;padding-bottom:12px;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">We follow the guidance of IAS 36 to determine when impairment indicators exist for its intangible assets. When impairment indicators exist, we are required to make a formal estimate of the recoverable amount of its intangible assets. This determination requires significant judgment. In making this judgment, management evaluates external and internal factors, such as significant adverse changes in the technological, market, economic or legal environment in which we operate as well as the results of our ongoing development programs. Management also considers the carrying amount of our net assets in relation to our market capitalization as a key indicator. In making a judgment as to whether impairment indicators exist as at June&#160;30, 2019, management concluded there were none.</font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Derivative warrant liabilities</font></div></td></tr></table><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Management has determined that derivative warrant liabilities are classified as long term as these derivative warrant liabilities will ultimately be settled for Common Shares and therefore the classification is not relevant.</font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div><a name="s9A14E6AFDA83558B8B77F2407B3E7457"></a></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">RECENT CHANGE IN ACCOUNTING STANDARDS </font></div><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">New Accounting Standard Adopted in 2019</font></div><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">IFRS 16&#8212; Leases</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">We adopted IFRS 16 &#8212;</font><font style="font-family:inherit;font-size:9pt;font-style:italic;">Leases </font><font style="font-family:inherit;font-size:9pt;">("</font><font style="font-family:inherit;font-size:9pt;font-weight:bold;">IFRS 16</font><font style="font-family:inherit;font-size:9pt;">") with the date of initial application of January 1, 2019 using the modified retrospective. In accordance with the transitional provisions in IFRS 16 comparative figures have not been restated, rather the reclassifications and adjustments arising from the adoption of this standard are recognized in the opening Statement of Financial Position on January 1, 2019. The impact of adoption of IFRS 16 is disclosed in Note 13 to the unaudited interim consolidated financial statements.</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The following policies are applicable from January 1, 2019. In the comparative period, leases were accounted for in accordance with the accounting policy for leases disclosed in our December 31, 2018 annual audited consolidated financial statements. </font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">Policy applicable from January 1, 2019:</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">At inception of a contract, we assess whether a contract is, or contains, a lease. A contract contains a lease if the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration. </font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">We assess whether:</font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">the contract involves the use of an explicitly or implicitly identified asset;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">the Company has the right to obtain substantially all of the economic benefits from the use of the asset throughout the contract term;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">the Company has the right to direct the use of the asset.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">We recognize a right-of-use asset and a lease liability at the commencement date of the lease, the date the underlying asset is available for use. Right-of-use assets are measured at cost, less any accumulated depreciation and impairment losses, and adjusted for any remeasurement of lease liabilities. The cost of right-of-use assets includes the initial amount of lease liabilities recognized, initial direct costs incurred, restoration costs and lease payments made at or before the commencement date less any lease incentive received, if any.</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Unless we are reasonably certain to obtain ownership of the leased asset at the end of the lease term, the right-of-use assets are depreciated on a straight-line basis over the shorter of the estimated useful life and the lease term. Right-of-use assets are subject to impairment. </font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">At the commencement date of the lease, we recognize lease liabilities measured at the present value of lease payments to be made over the lease term, discounted using the interest rate implicit in the lease or, if that rate cannot be readily determined, our incremental borrowing rate. The lease payments include fixed payments, variable lease payments that depend on an index or a rate, amounts expected to be paid under residual value guarantees and the exercise price of a purchase option reasonably certain to be exercised by us. </font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">After the commencement date, the amount of lease liabilities is increased to reflect the accretion of interest and reduced for the lease payments made. In addition, the carrying amount of lease liabilities is remeasured if there is a modification, a change in the lease term, a change in the fixed lease payments or a change in the assessment to purchase the underlying asset.</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">We present right-of-use assets in the property and equipment line and lease liabilities in the lease liability line on the interim condensed statement of financial position.</font></div><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">Short term leases and leases of low value assets</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">We have elected to use the practical expedient permitted by the standard and not to recognize right-of-use assets and lease liabilities for leases that have a lease term of 12 months or less and do not contain a purchase option or for leases related to low value assets. Lease payments on short term leases and leases of low value assets are recognized as an expense in the interim condensed statement of operations and comprehensive loss.</font></div><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">Critical Judgments in determining the lease term</font></div><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">In determining the lease term, management considers all facts and circumstances that create economic incentive to exercise an extension option, or not to exercise a termination option. Extension options (or periods after termination options) are only included in the lease term if the lease is reasonably certain to be extended (or not terminated).</font></div><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div><a name="s501D74466D875733BD455BDD581C3D17"></a></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">RISKS AND UNCERTAINTIES</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">We have invested a significant portion of our time and financial resources in the development of voclosporin.  We anticipate that our ability to generate revenues and meet expectations will depend primarily on the successful development, regulatory approval and commercialization of voclosporin. </font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The successful development and commercialization of voclosporin will depend on several factors, including the following:</font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">successful and timely completion of our clinical program in LN, including the AURORA trial which is anticipated to be completed in late 2019;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">receipt of marketing approvals from the FDA and other regulatory authorities with a commercially viable label;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">securing and maintaining sufficient expertise and resources to help in the continuing development and eventual commercialization of voclosporin;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">maintaining suitable manufacturing and supply arrangements to ensure commercial quantities of the product through validated processes;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">acceptance and adoption of the product by the medical community and third-party payers; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">our ability to raise future financial resources when required (future additional sources of capital could include payments from equity financings, debt financings, potential new licensing partners, and/or the monetization of our intangible assets).  </font></div></td></tr></table><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">A more detailed list of the risks and uncertainties affecting us can be found in our AIF which is filed on the SEDAR website at www.sedar.com or the EDGAR website at www.sec.gov/edgar.</font></div><div style="line-height:120%;padding-bottom:16px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Capital management</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Our objective in managing capital, consisting of shareholders' equity, with cash, cash equivalents and short term investments being its primary components, is to ensure sufficient liquidity to fund R&amp;D activities, corporate, administration and business development expenses and working capital requirements.  This objective has remained the same from that of the previous year.</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Over the past two years, we have raised capital via a public offering, the exercise of warrants and stock options and draw-downs under our November 30, 2018 ATM facility, as our primary sources of liquidity.</font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">As our policy is to retain cash to keep funds available to finance the activities required to advance our product development, we do not currently pay dividends. </font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">We are not subject to any capital requirements imposed by any regulators or by any other external source.</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Financial instruments and Risks</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">We are exposed to credit risks and market risks related to changes in interest rates and foreign currency exchange, each of which could affect the value of our current assets and liabilities. </font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">We invest our cash reserves in US dollar denominated, fixed rate, highly liquid and highly rated financial instruments such as treasury notes, banker acceptances, bank bonds, and term deposits.  We do not believe that the results of operations or cash flows would be affected to any significant degree by a sudden change in market interest rates relative to our investment portfolio, as all of our funds were held in cash or cash equivalents. </font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Financial risk factors</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Our activities can expose us to a variety of financial risks: market risk (including currency risk, interest rate risk and other price risk), credit risk and liquidity risk. Risk management is carried out by management under policies approved by the Board of Directors. Management identifies and evaluates the financial risks. Our overall risk management program seeks to minimize adverse effects on our financial performance.</font></div><div style="line-height:120%;padding-left:4px;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;font-weight:bold;">Liquidity risk</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Liquidity risk is the risk we will not be able to meet our financial obligations as they fall due. We manage our liquidity risk through the management of our capital structure and financial leverage, as discussed above in </font><font style="font-family:inherit;font-size:9pt;font-style:italic;">Capital Management</font><font style="font-family:inherit;font-size:9pt;">. We also manage liquidity risk by continuously monitoring actual and projected cash flows. The Board reviews and approves our budget, as well as any material transactions out of the ordinary course of business. We invest our cash equivalents in US denominated term deposits with 30 to 90-day maturities, and US denominated short term investments consisting of bonds and treasury notes issued by banks and/or United States or Canadian governments with maturities not exceeding two years to ensure our liquidity needs are met. </font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">All of our financial liabilities are due within one year except for the contingent consideration, as described in note 4 to the unaudited interim condensed consolidated financial statements for the three months ended June 30, 2019 and the derivative warrant liability, as described in note 5 to the unaudited interim condensed consolidated financial statements for the three months ended June 30, 2019, and the lease liability as described in note 12 to the unaudited interim consolidated financial statements for the three months ended June 30, 2019.</font></div><div style="line-height:120%;padding-left:4px;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;font-weight:bold;">Interest rate risk</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;padding-left:48px;text-indent:-48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Interest rate risk is the risk the fair value or future cash flows of a financial instrument will fluctuate because of changes in market interest rates.</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Financial assets and financial liabilities with variable interest rates expose us to cash flow interest rate risk. Our cash and cash equivalents are comprised of highly liquid investments that earn interest at market rates and the short term investments are comprised of bank or government bonds with a maturity of two years or less. Accounts receivable, accounts payable and accrued liabilities bear no interest.</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">We manage our interest rate risk by maintaining the liquidity necessary to conduct operations on a day-to-day basis. Our exposure to interest rate risk as at June&#160;30, 2019 was considered minimal as the majority of our financial resources were held as cash and cash equivalents.</font></div><div style="line-height:120%;padding-left:4px;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;font-weight:bold;">Credit risk</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Financial instruments that potentially subject us to significant concentrations of credit risk consist principally of cash, cash equivalents and short term investments which were held at three major Canadian banks. We regularly monitor the credit risk exposure and take steps to mitigate the likelihood of these exposures resulting in expected loss.</font></div><div style="line-height:120%;padding-left:4px;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;font-weight:bold;">Foreign currency risk</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">We are exposed to financial risk related to the fluctuation of foreign currency exchange rates. Foreign currency risk is the risk variations in exchange rates between the US dollars and foreign currencies, primarily with the Canadian dollar, will affect our operating and financial results.</font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The following table presents our exposure to the Canadian dollar:</font></div><div style="line-height:120%;padding-bottom:4px;padding-left:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6"></td></tr><tr><td style="width:73%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(in thousands)</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">June 30,</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2019<br>$</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">June 30,</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018<br>$</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Cash and cash equivalents</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">84</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,006</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Accounts receivable</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">70</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">21</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Accounts payable and accrued liabilities</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(2,141</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1,666</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net exposure</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1,987</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(639</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6"></td></tr><tr><td style="width:73%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="4" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Reporting<br>date rate</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">June 30, </font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2019<br>$</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">June 30,</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018<br>$</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">CA$ &#8211; US$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.764</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.759</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Based on our foreign currency exposure noted above, varying the foreign exchange rates to reflect a ten percent strengthening of the CA$ would have increased the net loss by $151,000 assuming all other variables remained constant. An assumed </font><font style="font-family:inherit;font-size:9pt;">10%</font><font style="font-family:inherit;font-size:9pt;">&#32;weakening of the CA$ would have had an equal but opposite effect to the amounts shown above, on the basis all other variables remain constant.</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:6px;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Intellectual Property</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Patents and other proprietary rights are essential to our business.  Our policy has been to file patent applications to protect technology, inventions, and improvements to our inventions that are considered important to the development of our business.  We are pursuing certain avenues to expand the voclosporin intellectual property portfolio, including a use patent strategy (which involves potential development of use patents driven by AURA Phase 2b data) and a potential manufacturing patent and trade secret strategy.</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company has an extensive granted patent portfolio covering voclosporin, including granted United States patents, for composition of matter, methods of use, formulations and synthesis. The corresponding Canadian, South African and Israeli patents are owned by Paladin Labs Inc. We anticipate that upon regulatory approval, patent protection for voclosporin will be extended in the United States (Patent Term Extension) and certain other major markets, including Europe and Japan, until at least October 2027 under the Hatch-Waxman Act in the United States and comparable patent extension laws in other countries (including the Supplementary Protection Certificate program in Europe).  Opportunities may also be available to add an additional six months of exclusivity related to pediatric studies which are currently in the planning process. In addition to patent rights, we also expect to receive "new chemical entity" exclusivity for voclosporin in certain countries, which provides from five years in the United States to up to ten years in Europe.</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Further, pursuant to the Notice of Allowance from the USPTO for claims directed at our novel voclosporin dosing protocol for LN as more fully discussed in the </font><font style="font-family:inherit;font-size:9pt;font-style:italic;">Clinical and Corporate Developments in 2019</font><font style="font-family:inherit;font-size:9pt;">&#32;section of this MD&amp;A, after administrative processes were completed and fees were paid, on May 14, 2019 Aurinia was granted US Patent No. 10,286,036 with a term extending to December 2037.  If the FDA approves the use of voclosporin for LN and the label for such use follows the dosing protocol, the issuance of this patent will expand the scope of intellectual property protection for voclosporin, which already includes robust manufacturing, formulation, synthesis and composition of matter patents.  We have also filed for protection of this subject matter under the PCT and have the option of applying for similar protection in the member countries thereof. This may lead to the granting of corresponding claims in the treaty countries which include all the major global pharmaceutical markets. </font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">We are also continuing to work on developing potential further intellectual property protection based on our AURA data. </font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">We have licensed the development and distribution rights to voclosporin for China, Hong Kong and Taiwan to 3SBio, Inc. This license is royalty bearing and we will also supply finished product to 3SBio on a cost-plus basis. We do not expect to receive any royalty revenue pursuant to this license in the foreseeable future.</font></div><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">We have patent protection for VOS as we own three granted United States patents, including U.S. Patent No. 10,265,375 granted in 2019, with claims directed to pharmaceutical compositions comprising a calcineurin inhibitor or mTOR inhibitor, as well as methods for treating ocular disease using such compositions&#160;and 14 patents in other jurisdictions related to ophthalmic formulations of calcineurin inhibitors or mTOR inhibitors, including voclosporin. We also have one granted United States patent and 10 patents in other jurisdictions related to topical drug delivery system for ophthalmic use. These patents expire between 2028 and 2031. </font></div><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18</font></div></div><hr style="page-break-after:always"><div><a name="sA8C983E5E78C5F8A92CE69CA79C76C84"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">CONTINGENCIES</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">We may, from time to time, be subject to claims and legal proceedings brought against us in the normal course of business. Such matters are subject to many uncertainties. Management believes that the ultimate resolution of such contingencies will not have a material adverse effect on our consolidated financial position.</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">We have entered into indemnification agreements with our officers and directors. The maximum potential amount of future payments required under these indemnification agreements is unlimited. However, we do maintain liability insurance to limit our exposure.</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">We have entered into an agreement dated February 14, 2014 whereby we are required to pay a third party a royalty equivalent to </font><font style="font-family:inherit;font-size:9pt;">2%</font><font style="font-family:inherit;font-size:9pt;">&#32;of royalties received on the sale of voclosporin by licensees and/or </font><font style="font-family:inherit;font-size:9pt;">0.3%</font><font style="font-family:inherit;font-size:9pt;">&#32;of net sales of voclosporin sold directly by the Company.  Should we sell substantially all of the assets of voclosporin to a third party or transfer those assets to another party in a merger in a manner such that this payment obligation is no longer operative, then we would be required to pay </font><font style="font-family:inherit;font-size:9pt;">0.3%</font><font style="font-family:inherit;font-size:9pt;">&#32;of the value attributable to voclosporin in the transaction.</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">We are required to pay the third party originator of the VOS formulation a 2% royalty on net sales of VOS.</font></div><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">We have entered into license and research and development agreements with third parties that include indemnification and obligation provisions that are customary in the industry. These guarantees generally require us to compensate the other party for certain damages and costs incurred as a result of third party claims or damages arising from these transactions. These provisions may survive termination of the underlying agreement. The nature of the obligations prevents us from making a reasonable estimate of the maximum potential amount we could be required to pay. Historically, we have not made any payments under such agreements and no amount has been accrued in the accompanying unaudited interim condensed consolidated financial statements.</font></div><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div><a name="s3CBACF4FFF925D0B8E56691C0CF40747"></a></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">DISCLOSURE CONTROLS AND PROCEDURES AND INTERNAL CONTROL OVER FINANCIAL REPORTING</font></div><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Aurinia's management is responsible for establishing and maintaining adequate internal control over financial reporting ("</font><font style="font-family:inherit;font-size:9pt;font-weight:bold;">ICFR</font><font style="font-family:inherit;font-size:9pt;">") and disclosure controls and procedures ("</font><font style="font-family:inherit;font-size:9pt;font-weight:bold;">DC&amp;P</font><font style="font-family:inherit;font-size:9pt;">"). </font></div><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">ICFR is a framework designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with IFRS. Management has used the Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) in order to assess the effectiveness of the Company's</font></div><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">ICFR.</font></div><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">DC&amp;P form a broader framework designed to provide reasonable assurance the information required to be disclosed by Aurinia in its annual and interim filings and other reports filed under securities legislation is recorded, processed, summarized and reported within the time frame specified in securities legislation and includes controls and procedures designed to ensure that information required to be disclosed by Aurinia in its annual and interim filings and other reports submitted under securities legislation is accumulated and communicated to our management to allow timely decisions regarding required disclosure.  </font></div><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Together, the ICFR and DC&amp;P frameworks provide internal control over financial reporting and disclosure. We maintain disclosure controls and procedures that are designed to provide reasonable assurance that information, which is required to be disclosed in our annual and interim filings and other reports filed under securities legislation, is accumulated and communicated in a timely fashion. Due to their inherent limitations, Aurinia acknowledges that, no matter how well designed, ICFR and DC&amp;P can provide only reasonable assurance of achieving the desired control objectives and as such may not prevent or detect all misstatements. Further, the effectiveness of ICFR is subject to the risk that controls may become inadequate because of changes in conditions or that the degree of compliance with policies or procedures may change.</font></div><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">There have been no significant changes to our disclosure controls nor to our internal controls over financial reporting for the second quarter ended June 30, 2019 that have materially affected, or are reasonably likely to materially affect, the reliability of financial reporting.</font></div><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div><a name="s4D2ED407C0A85F469CC81A292CC12BB7"></a></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">UPDATED SHARE INFORMATION</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">As at August 6, 2019, the following class of shares and equity securities potentially convertible into Common Shares were outstanding:</font></div><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:81%;"></td><td style="width:18%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(in thousands)</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Common Shares</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">91,830</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Convertible equity securities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Derivative liability warrants</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,523</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Stock options</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">9,992</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Subsequent to June 30, 2019, the Company issued 36,800 Common Shares upon the exercise of 36,800 stock options for proceeds of $112,000. The Company also granted 165,000 stock options to directors and new employees at a weighted average exercise price of $6.42 (CA $8.39).</font></div><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19</font></div></div><hr style="page-break-after:always"><div><a name="s703FDACA3C04501E9CD3A6BD107BBA90"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">SUPPLEMENTAL INFORMATION</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Quarterly Information </font></div><div style="line-height:120%;padding-bottom:12px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">(expressed in thousands except per share data)</font></div><div style="line-height:120%;padding-bottom:4px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Set forth below is selected unaudited consolidated financial data for each of the last eight quarters:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="17"></td></tr><tr><td style="width:30%;"></td><td style="width:7%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="16" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Three months ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="4" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2019</font></div></td><td colspan="8" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</font></div></td><td colspan="4" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">June 30</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Mar 31</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-right:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Dec 31</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Sept 30</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Jun 30</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Mar 31</font></div></td><td style="vertical-align:bottom;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Dec 31</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Sept 30</font></div></td><td style="vertical-align:bottom;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Revenues  </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">29</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">30</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">29</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">375</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">29</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">30</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">30</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">29</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Expenses:</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;padding-left:12px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">R&amp;D</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">11,152</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">10,631</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">10,839</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">11,152</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">10,504</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8,887</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8,691</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">10,807</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;padding-left:12px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Corporate, administration and business development</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,946</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,901</font></div></td><td style="vertical-align:bottom;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,498</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,923</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,462</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,791</font></div></td><td style="vertical-align:bottom;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,118</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,650</font></div></td><td style="vertical-align:bottom;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;padding-left:12px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Amortization of tangible and intangible assets</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">385</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">383</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">355</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">408</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">403</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">399</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">361</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">362</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other expenses</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">720</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-right:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-right:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-right:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Total expenses</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">17,203</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">14,915</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-right:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">14,692</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">14,483</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">14,369</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">13,077</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-right:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">12,170</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">13,819</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-right:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Interest income</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">787</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">800</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-right:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">671</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">691</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">632</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">240</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-right:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">147</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">399</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-right:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Finance costs</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(123</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(55</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">65</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(128</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(66</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(40</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(343</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(84</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net loss before change in estimated fair value of derivative warrant liabilities and income tax</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">(16,510</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">(14,140</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">(13,927</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">(13,545</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">(13,774</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">(12,847</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">(12,336</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">(13,475</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">)</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Change in estimated fair value of derivative warrant liabilities</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">625</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,725</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-right:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(593</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(4,797</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1,933</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(2,631</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-right:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">9,004</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">355</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-right:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Income tax expense</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(16</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(13</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(73</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Net loss for the period</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(15,901</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(12,428</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(14,593</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(18,342</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(15,707</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(15,478</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(3,332</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(13,120</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Per Common Share ($)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net loss per common share - basic and diluted</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.17</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.14</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-right:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.17</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.21</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.19</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.18</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-right:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.04</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.16</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-right:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Common Shares outstanding</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">91,793</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">91,646</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">85,500</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">85,323</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">85,321</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">84,052</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">84,052</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">83,973</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Weighted average number of Common Shares outstanding</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">91,768</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">90,146</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">85,384</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">85,321</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">84,350</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">84,052</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-left:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">84,038</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">83,608</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Summary of Quarterly Results</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The primary factors affecting the magnitude of our losses in the various quarters are noted below and include the timing of R&amp;D costs associated with the clinical development program, timing and amount of stock compensation expense, and fluctuations in the non-cash change in estimated fair value of derivative warrant liabilities.  </font></div><div style="line-height:120%;padding-bottom:10px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Corporate, administration and business development costs included non-cash stock-based compensation expense of  $1.21 million  for the three months ended June 30, 2019,  $742,000 for the three months ended March 31, 2019, $686,000 for the three months ended December 31, 2018, $887,000 for the three months ended September 30, 2018, $1.26 million for the three months ended June 30, 2018, $1.33 million for the three months ended March 31, 2018, $656,000 for the three months ended December 31, 2017, $795,000 for the three months ended September 30, 2017, and $718,000 for the three months ended June 30, 2017.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other expenses represent the costs associated with the successful defense of a proxy contest for our June 26, 2019 Annual General Meeting.</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">We record non-cash adjustments each quarter resulting from the fair value revaluation of the derivative warrant liabilities.  These revaluations fluctuate based primarily on the market price of our Common Shares. An increase in the market price of our Common Shares results in a loss on revaluation while a decrease results in a gain on revaluation.  </font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The change in the estimated fair value of the derivative warrant liabilities for the three months ended June 30, 2019 of  $625,000 reflected  a decrease in the annualized volatility from 53% at March 31, 2018 to 40% at June 30, 2019, offset to a lesser degree by an increase in our share price to $6.58 per share at June 30, 2019 compared to $6.50 at March 31, 2019. The change in the estimated fair value of the derivative warrant liabilities for the three months ended March 31, 2019 of $1.73 million reflected a decrease in our share price to $6.50 per share at March 31, 2019 compared to $6.82 per share at December 31, 2018. The change in the estimated fair value of the derivative warrant liabilities for the three months ended December 31, 2018 of $593,000 reflected an increase in our share price to $6.82 per share at December 31, 2018 compared to $6.64 per share at September 30, 2018. The change in the estimated fair value of the derivative warrant liabilities for the three months ended September 30, 2018 of $4.80 million primarily reflected an increase in our share price to $6.64 per share at September 30, 2018 compared to </font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$5.63 per share at June 30, 2018. The change in the estimated fair value of the derivative warrant liabilities for the three months ended June 30, 2018 of $1.93 million primarily reflected an increase in our share price to $5.63 per share at June 30, 2018 compared to $5.19 per share at March 31, 2018. The change in the estimated fair value of the derivative warrant liabilities for the three months ended March 31, 2018 of $2.63 million primarily reflected an increase in our share price to $5.19 per share at March 31, 2018 compared to $4.53 per share at December 31, 2017.  The change in the estimated fair value of the derivative warrant liabilities for the three months ended December 31, 2017 of $9.01 million primarily reflected a decrease in our share price to $4.53 per common share at December 31, 2017 compared to $6.27 per share at September 30, 2017. </font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:120%;padding-bottom:12px;text-align:center;"><img src="aurinialogoweb700pxa06.jpg" alt="aurinialogoweb700pxa06.jpg" style="height:72px;width:186px;"></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Aurinia Pharmaceuticals Inc.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">1203 - 4464 Markham Street</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Victoria, BC  V8Z 7X8</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">www.auriniapharma.com</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21</font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.4
<SEQUENCE>4
<FILENAME>exhibit993-20190630certifi.htm
<DESCRIPTION>EXHIBIT 99.4
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2019 Workiva -->
		<title>Exhibit</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="sFCFF6B37746A53CEA029BB858DB9C1BB"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Exhibit 99.3</font></div><div style="line-height:120%;text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:120%;text-align:center;"><img src="auroralogoa01.jpg" alt="auroralogoa01.jpg" style="height:60px;width:154px;"></div><div style="line-height:120%;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">FORM 52-109F2</font></div><div style="line-height:120%;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">CERTIFICATION OF INTERIM FILINGS</font></div><div style="line-height:120%;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">FULL CERTIFICATE</font></div><div style="line-height:120%;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">I, PETER GREENLEAF, </font><font style="font-family:inherit;font-size:9pt;font-style:italic;">Chief Executive Officer of AURINIA PHARMACEUTICALS Inc.</font><font style="font-family:inherit;font-size:9pt;">, certify the following:</font></div><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:0px;"><font style="font-family:inherit;font-size:9pt;">1.</font><font style="font-family:inherit;font-size:9pt;font-style:italic;font-weight:bold;">&#32;&#32;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;font-weight:bold;">Review:  </font><font style="font-family:inherit;font-size:9pt;">I have reviewed the interim financial report and interim MD&amp;A, (together, the &#8220;interim filings&#8221;) of </font><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Aurinia Pharmaceuticals Inc.</font><font style="font-family:inherit;font-size:9pt;">&#32;(the &#8220;issuer&#8221;) for the interim period ended </font><font style="font-family:inherit;font-size:9pt;font-weight:bold;">June 30, 2019</font><font style="font-family:inherit;font-size:9pt;">.</font></div></td></tr></table><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:0px;"><font style="font-family:inherit;font-size:9pt;">2.  </font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;font-weight:bold;">No misrepresentations:</font><font style="font-family:inherit;font-size:9pt;">&#32;&#32;Based on my knowledge, having exercised reasonable diligence, the interim filings do not contain any untrue statement of a material fact or omit to state a material fact required to be stated or that is necessary to make a statement not misleading in light of the circumstances under which it was made, with respect to the period covered by the interim filings.</font></div></td></tr></table><div style="line-height:120%;text-align:justify;padding-left:48px;text-indent:-48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:0px;"><font style="font-family:inherit;font-size:9pt;">3. </font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;font-weight:bold;">Fair presentation:</font><font style="font-family:inherit;font-size:9pt;">&#32;&#32;Based on my knowledge, having exercised reasonable diligence, the interim financial report together with the other financial information included in the interim filings fairly present in all material respects the financial condition, financial performance and cash flows of the issuer, as of the date of and for the periods presented in the interim filings.</font></div></td></tr></table><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:0px;"><font style="font-family:inherit;font-size:9pt;">4. </font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;font-weight:bold;">Responsibility: </font><font style="font-family:inherit;font-size:9pt;">&#32;The issuer&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (DC&amp;P) and internal control over financial reporting (ICFR), as those terms are defined in National Instrument 52-109 </font><font style="font-family:inherit;font-size:9pt;font-style:italic;">Certification of Disclosure in Issuers&#8217; Annual and Interim Filings</font><font style="font-family:inherit;font-size:9pt;">, for the issuer.</font></div></td></tr></table><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:0px;"><font style="font-family:inherit;font-size:9pt;">5. </font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;font-weight:bold;">Design:</font><font style="font-family:inherit;font-size:9pt;">&#32;Subject to the limitations, if any, described in paragraphs 5.2 and 5.3, the issuer&#8217;s other certifying officer(s) and I have, as at the end of the period covered by the interim filings</font></div></td></tr></table><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:48px;"><font style="font-family:inherit;font-size:9pt;">(a)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">designed DC&amp;P, or caused it to be designed under our supervision, to provide reasonable assurance that </font></div></td></tr></table><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:72px;"><font style="font-family:inherit;font-size:9pt;">(i)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">material information relating to the issuer is made known to us by others, particularly during the period in which the interim filings are being prepared; and</font></div></td></tr></table><div style="line-height:120%;text-align:justify;padding-left:96px;text-indent:-24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:72px;"><font style="font-family:inherit;font-size:9pt;">(ii)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">information required to be disclosed by the issuer in its annual filings, interim filings or other reports filed or submitted by it under securities legislation is recorded, processed, summarized and reported within the time periods specified in securities legislation; and</font></div></td></tr></table><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:48px;"><font style="font-family:inherit;font-size:9pt;">(b)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">designed ICFR, or caused it to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with the issuer&#8217;s GAAP.</font></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:0px;"><font style="font-family:inherit;font-size:9pt;">5.1 </font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;font-weight:bold;">Control framework:</font><font style="font-family:inherit;font-size:9pt;">&#32;The control framework the issuer&#8217;s other certifying officer(s) and I used to design the issuer&#8217;s ICFR is the COSO </font><font style="font-family:inherit;font-size:9pt;font-style:italic;">Internal Control -</font><font style="font-family:inherit;font-size:9pt;">&#32;</font><font style="font-family:inherit;font-size:9pt;font-style:italic;">Integrated Framework (2013) </font><font style="font-family:inherit;font-size:9pt;">published by the Committee of Sponsoring Organizations of the Treadway Commission.</font></div></td></tr></table><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5.2 &#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:9pt;font-style:italic;font-weight:bold;">ICFR - material weakness related to design:</font><font style="font-family:inherit;font-size:9pt;">&#32;&#32;N/A</font></div><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5.3 &#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:9pt;font-style:italic;font-weight:bold;">Limitation on scope of design:</font><font style="font-family:inherit;font-size:9pt;">&#32;&#32;N/A </font></div><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:0px;"><font style="font-family:inherit;font-size:9pt;">6. </font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;font-weight:bold;">Reporting changes in ICFR:</font><font style="font-family:inherit;font-size:9pt;">&#32;&#32;The issuer has disclosed in its interim MD&amp;A any change in the issuer&#8217;s ICFR that occurred during the period beginning on </font><font style="font-family:inherit;font-size:9pt;font-weight:bold;">April  1, 2019 </font><font style="font-family:inherit;font-size:9pt;">and ended on </font><font style="font-family:inherit;font-size:9pt;font-weight:bold;">June 30, 2019 </font><font style="font-family:inherit;font-size:9pt;">that has materially affected, or is reasonably likely to materially affect, the issuer&#8217;s ICFR. </font></div></td></tr></table><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Date: &#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:9pt;font-weight:bold;">August 6, 2019</font></div><div style="line-height:120%;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">/s/ Peter Greenleaf</font><font style="font-family:inherit;font-size:9pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Peter Greenleaf</font></div><div style="line-height:120%;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Chief Executive Officer </font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:16px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.5
<SEQUENCE>5
<FILENAME>exhibit994-20190630certifi.htm
<DESCRIPTION>EXHIBIT 99.5
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2019 Workiva -->
		<title>Exhibit</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="sC59B05DB480455A4864D59728C886EB3"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Exhibit 99.4</font></div><div style="line-height:120%;text-align:center;"><img src="auroralogoa01.jpg" alt="auroralogoa01.jpg" style="height:60px;width:154px;"></div><div style="line-height:120%;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">FORM 52-109F2</font></div><div style="line-height:120%;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">CERTIFICATION OF INTERIM FILINGS</font></div><div style="line-height:120%;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">FULL CERTIFICATE</font></div><div style="line-height:120%;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">I, DENNIS BOURGEAULT, </font><font style="font-family:inherit;font-size:9pt;font-style:italic;">Chief Financial Officer of AURINIA PHARMACEUTICALS Inc.</font><font style="font-family:inherit;font-size:9pt;">, certify the following:</font></div><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:0px;"><font style="font-family:inherit;font-size:9pt;">1.</font><font style="font-family:inherit;font-size:9pt;font-style:italic;font-weight:bold;">&#32;&#32;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;font-weight:bold;">Review:  </font><font style="font-family:inherit;font-size:9pt;">I have reviewed the interim financial report and interim MD&amp;A, (together, the &#8220;interim filings&#8221;) of </font><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Aurinia Pharmaceuticals Inc.</font><font style="font-family:inherit;font-size:9pt;">&#32;(the &#8220;issuer&#8221;) for the interim period ended </font><font style="font-family:inherit;font-size:9pt;font-weight:bold;">June 30, 2019</font><font style="font-family:inherit;font-size:9pt;">.</font></div></td></tr></table><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:0px;"><font style="font-family:inherit;font-size:9pt;">2.  </font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;font-weight:bold;">No misrepresentations:</font><font style="font-family:inherit;font-size:9pt;">&#32;&#32;Based on my knowledge, having exercised reasonable diligence, the interim filings do not contain any untrue statement of a material fact or omit to state a material fact required to be stated or that is necessary to make a statement not misleading in light of the circumstances under which it was made, with respect to the period covered by the interim filings.</font></div></td></tr></table><div style="line-height:120%;text-align:justify;padding-left:48px;text-indent:-48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:0px;"><font style="font-family:inherit;font-size:9pt;">3. </font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;font-weight:bold;">Fair presentation:</font><font style="font-family:inherit;font-size:9pt;">&#32;&#32;Based on my knowledge, having exercised reasonable diligence, the interim financial report together with the other financial information included in the interim filings fairly present in all material respects the financial condition, financial performance and cash flows of the issuer, as of the date of and for the periods presented in the interim filings.</font></div></td></tr></table><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:0px;"><font style="font-family:inherit;font-size:9pt;">4. </font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;font-weight:bold;">Responsibility: </font><font style="font-family:inherit;font-size:9pt;">&#32;The issuer&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (DC&amp;P) and internal control over financial reporting (ICFR), as those terms are defined in National Instrument 52-109 </font><font style="font-family:inherit;font-size:9pt;font-style:italic;">Certification of Disclosure in Issuers&#8217; Annual and Interim Filings</font><font style="font-family:inherit;font-size:9pt;">, for the issuer.</font></div></td></tr></table><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:0px;"><font style="font-family:inherit;font-size:9pt;">5. </font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;font-weight:bold;">Design:</font><font style="font-family:inherit;font-size:9pt;">&#32;Subject to the limitations, if any, described in paragraphs 5.2 and 5.3, the issuer&#8217;s other certifying officer(s) and I have, as at the end of the period covered by the interim filings</font></div></td></tr></table><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:48px;"><font style="font-family:inherit;font-size:9pt;">(a)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">designed DC&amp;P, or caused it to be designed under our supervision, to provide reasonable assurance that </font></div></td></tr></table><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:72px;"><font style="font-family:inherit;font-size:9pt;">(i)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">material information relating to the issuer is made known to us by others, particularly during the period in which the interim filings are being prepared; and</font></div></td></tr></table><div style="line-height:120%;text-align:justify;padding-left:96px;text-indent:-24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:72px;"><font style="font-family:inherit;font-size:9pt;">(ii)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">information required to be disclosed by the issuer in its annual filings, interim filings or other reports filed or submitted by it under securities legislation is recorded, processed, summarized and reported within the time periods specified in securities legislation; and</font></div></td></tr></table><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:48px;"><font style="font-family:inherit;font-size:9pt;">(b)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">designed ICFR, or caused it to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with the issuer&#8217;s GAAP.</font></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:48px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:0px;"><font style="font-family:inherit;font-size:9pt;">5.1 </font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;font-weight:bold;">Control framework:</font><font style="font-family:inherit;font-size:9pt;">&#32;The control framework the issuer&#8217;s other certifying officer(s) and I used to design the issuer&#8217;s ICFR is the COSO </font><font style="font-family:inherit;font-size:9pt;font-style:italic;">Internal Control -</font><font style="font-family:inherit;font-size:9pt;">&#32;</font><font style="font-family:inherit;font-size:9pt;font-style:italic;">Integrated Framework (2013) </font><font style="font-family:inherit;font-size:9pt;">published by the Committee of Sponsoring Organizations of the Treadway Commission.</font></div></td></tr></table><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5.2 &#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:9pt;font-style:italic;font-weight:bold;">ICFR - material weakness related to design:</font><font style="font-family:inherit;font-size:9pt;">&#32;&#32;N/A</font></div><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5.3 &#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:9pt;font-style:italic;font-weight:bold;">Limitation on scope of design:</font><font style="font-family:inherit;font-size:9pt;">&#32;&#32;N/A </font></div><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:0px;"><font style="font-family:inherit;font-size:9pt;">6. </font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;font-weight:bold;">Reporting changes in ICFR:</font><font style="font-family:inherit;font-size:9pt;">&#32;&#32;The issuer has disclosed in its interim MD&amp;A any change in the issuer&#8217;s ICFR that occurred during the period beginning on </font><font style="font-family:inherit;font-size:9pt;font-weight:bold;">April 1, 2019 </font><font style="font-family:inherit;font-size:9pt;">and ended on </font><font style="font-family:inherit;font-size:9pt;font-weight:bold;">June 30, 2019 </font><font style="font-family:inherit;font-size:9pt;">that has materially affected, or is reasonably likely to materially affect, the issuer&#8217;s ICFR. </font></div></td></tr></table><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Date: &#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:9pt;font-weight:bold;">August 6, 2019</font></div><div style="line-height:120%;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;text-decoration:underline;">/s/ Dennis Bourgeault</font><font style="font-family:inherit;font-size:9pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Dennis Bourgeault</font></div><div style="line-height:120%;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Chief Financial Officer </font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>aurinialogoweb700pxa06.jpg
<TEXT>
begin 644 aurinialogoweb700pxa06.jpg
M_]C_X0[-17AI9@  34T *@    @ !P$2  ,    !  $   $:  4    !
M8@$;  4    !    :@$H  ,    !  (   $Q  (    D    <@$R  (    4
M    EH=I  0    !    K    -@ "OR    G$  *_(   "<0061O8F4@4&AO
M=&]S:&]P($-#(#(P,3@@*$UA8VEN=&]S:"D ,C Q.#HQ,#HQ." Q,SHT-SHS
M-P     #H $  P    $  0  H ( !     $   *\H , !     $   $2
M      8! P #     0 &   !&@ %     0   28!&P %     0   2X!*  #
M     0 "   " 0 $     0   38" @ $     0  #8\         2     $
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MGO&][7_O,]+8Q=+B9->7C59-7T+6AP'<3^:?ZJX?KC7-ZQEAW/J3\BUKF_\
M15+J?UBR*>D5]%Q7FLDO=E6-T(K<=[,>MP_TFYSKG?Z/]'_A%?/+>Y#$(:&A
M9_JGU2+D_#\^7)SW,8B28R,I?W/:E[?_ $7I.M?7OIW3['8V$S[?DL,/V.#:
M6GNU]\/W/;^Y2RS_ (3TU4^J_P!:.M=:ZUZ%_HUXM=+[7LJ89F65U@V6/?\
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M9=9>#4&DAKQ_.[?WUEW_ .,CZMUW>E6;\CMOKK 'W7OIL_\  TE/5+GOJ_\
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M/_,^HC]WEKKH /KQ?*(JX&_T?ZL-Z5UC/ZE7>'UYVC,85A@K$[]K7A[M[?\
MK;%N+&Z(_-&3?3E>M?M:)R[!8QCW;G?0QLBJGT7._P"ZK\C'_P"+_1^ILJ+)
M PEPE!%&E))))B'_V?_M%L90:&]T;W-H;W @,RXP #A"24T$)0      $
M                   X0DE-!#H      .4    0     0      "W!R:6YT
M3W5T<'5T    !0    !0<W138F]O; $     26YT965N=6T     26YT90
M  !#;')M    #W!R:6YT4VEX=&5E;D)I=&)O;VP     "W!R:6YT97).86UE
M5$585     $       ]P<FEN=%!R;V]F4V5T=7!/8FIC    # !0 '( ;P!O
M &8 ( !3 &4 = !U '        IP<F]O9E-E='5P     0    !";'1N96YU
M;0    QB=6EL=&EN4')O;V8    )<')O;V9#35E+ #A"24T$.P     "+0
M !     !       2<')I;G1/=71P=71/<'1I;VYS    %P    !#<'1N8F]O
M;       0VQB<F)O;VP      %)G<TUB;V]L      !#<FY#8F]O;
M0VYT0V)O;VP      $QB;'-B;V]L      !.9W1V8F]O;       16UL1&)O
M;VP      $EN=')B;V]L      !"8VMG3V)J8P    $       !21T)#
M P    !29" @9&]U8D!OX            $=R;B!D;W5B0&_@
M0FP@(&1O=6) ;^            !"<F1456YT1B-2;'0               !"
M;&0@56YT1B-2;'0               !2<VQT56YT1B-0>&Q 4@
M  IV96-T;W)$871A8F]O; $     4&=0<V5N=6T     4&=0<P    !09U!#
M     $QE9G15;G1&(U)L=                %1O<"!5;G1&(U)L=
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M!!D       0    >.$))30/S       )           ! #A"24TG$
M"@ !          $X0DE- _4      $@ +V9F  $ ;&9F  8       $ +V9F
M  $ H9F:  8       $ ,@    $ 6@    8       $ -0    $ +0    8
M      $X0DE- _@      '   /____________________________\#Z
M  #_____________________________ ^@     ____________________
M_________P/H     /____________________________\#Z   .$))300
M       "   X0DE-! (       (  #A"24T$,        0$ .$))300M
M   &  $    ".$))300(       0     0   D    )      #A"24T$'@
M    !      X0DE-!!H      TD    &              $2   "O     H
M50!N '0 :0!T &P 90!D "T ,0    $                          0
M           "O    1(                      0
M       0     0       &YU;&P    "    !F)O=6YD<T]B:F,    !
M    4F-T,0    0     5&]P(&QO;F<          $QE9G1L;VYG
M  !"=&]M;&]N9P   1(     4F=H=&QO;F<   *\    !G-L:6-E<U9L3',
M   !3V)J8P    $       5S;&EC90   !(    '<VQI8V5)1&QO;F<
M    !V=R;W5P241L;VYG          9O<FEG:6YE;G5M    #$53;&EC94]R
M:6=I;@    UA=71O1V5N97)A=&5D     %1Y<&5E;G5M    "D53;&EC951Y
M<&4     26UG(     9B;W5N9'-/8FIC     0       %)C=#$    $
M %1O<"!L;VYG          !,969T;&]N9P          0G1O;6QO;F<   $2
M     %)G:'1L;VYG   "O     -U<FQ415A4     0       &YU;&Q415A4
M     0       $US9V5415A4     0      !F%L=%1A9U1%6%0    !
M   .8V5L;%1E>'1)<TA434QB;V]L 0    AC96QL5&5X=%1%6%0    !
M   ):&]R>D%L:6=N96YU;0    ]%4VQI8V5(;W)Z06QI9VX    '9&5F875L
M=     EV97)T06QI9VYE;G5M    #T53;&EC959E<G1!;&EG;@    =D969A
M=6QT    "V)G0V]L;W)4>7!E96YU;0   !%%4VQI8V5"1T-O;&]R5'EP90
M  !.;VYE    "71O<$]U='-E=&QO;F<         "FQE9G1/=71S971L;VYG
M          QB;W1T;VU/=71S971L;VYG          MR:6=H=$]U='-E=&QO
M;F<      #A"24T$*       #     (_\        #A"24T$%       !
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M+/\ A/353ZK_ %HZUUKK7H7^C7BUTOM>RIAF9976#98]_P"<]<'[6M[-:T?
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MN8,C&?E>L<5N3C.I]5MA=O?7EU7MJ;D5U9;]KO1W_H?T;/T_\SZB/W>6NN@
M^O%\HBK@;_1_JPWI76,_J5=X?7G:,QA6&"L3OVM>'NWM_P"ML6XL;HC\T9-]
M.5ZU^UHG+L%C&/=N=]#&R*J?1<[_ +JOR,?_ (O]'ZFRHLD#"7"4$4:4DDDF
M(?_9 #A"24T$(0      70    $!    #P!! &0 ;P!B &4 ( !0 &@ ;P!T
M &\ <P!H &\ <    !< 00!D &\ 8@!E "  4 !H &\ = !O ', : !O '
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M4D]&24Q%  $!   ,2$QI;F\"$   ;6YT<E)'0B!865H@!\X  @ )  8 ,0
M86-S<$U31E0     245#('-21T(               $  /;6  $     TRU(
M4" @
M       18W!R=    5     S9&5S8P   80   !L=W1P=    ?     48FMP
M=    @0    4<EA96@   A@    49UA96@   BP    48EA96@   D     4
M9&UN9    E0   !P9&UD9    L0   "(=G5E9    TP   "&=FEE=P   ]0
M   D;'5M:0   _@    4;65A<P  ! P    D=&5C:   !#     ,<E120P
M!#P   @,9U120P  !#P   @,8E120P  !#P   @,=&5X=     !#;W!Y<FEG
M:'0@*&,I(#$Y.3@@2&5W;&5T="U086-K87)D($-O;7!A;GD  &1E<V,
M    $G-21T(@245#-C$Y-C8M,BXQ               2<U)'0B!)14,V,3DV
M-BTR+C$
M             %A96B        #S40 !     1;,6%E:(
M      !865H@        ;Z(  #CU   #D%A96B        !BF0  MX4  !C:
M6%E:(        "2@   /A   ML]D97-C         !9)14,@:'1T<#HO+W=W
M=RYI96,N8V@              !9)14,@:'1T<#HO+W=W=RYI96,N8V@
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M"58 4    %<?YVUE87,          0                        */
M G-I9R      0U)4(&-U<G8        $      4 "@ / !0 &0 > ", *  M
M #( -P [ $  10!* $\ 5 !9 %X 8P!H &T <@!W 'P @0"& (L D "5 )H
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M :(    & @,!              <(!@4$"0,* @$ "P$   8# 0$!
M    !@4$ P<"" $)  H+$  " 0,$ 0,# @,# P(&"74! @,$$042!B$'$R(
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M4V0WUL'$5&YA!H$5/O;$"3;V^J.-4L%BH]X8FMB3A3H4&PO;V7.NEF7I4#4
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M=!@HDRLL:$^-:G)R0R9.ILU^9)6)/^/OG5[O_>W^]=[]?5VONS[T<S;MMLX
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M'O[Y?W)RO]XONOX-]]_#:O\ NE]SX_\ B^_>V_X Z_3X-5_N?VM=O7[[O?\
M)Q#G;_@3?]=W_6=W/^OOU/[O^H^DG_<GC:?^2E]1_P HVKL^FUZOJ_\ %O&T
M_J]8J?ZSVV?U_P#ZO?UC@_=.CQM'B+]5IK_8Z/XZ9UTIX??IKV]?_];?X]^Z
M]U[W[KW7O?NO=>]^Z]U\_P _G&_(#_9@/GMV]4T%;]YM;J::EZ3VIID\D24^
MP9:N#=#PNI,4L-7V!79B:-TX>%TY-KE="NE!ZGI.YJQZJY]N]4ZWL/Y$_0O^
MAWX)[:WCDJ+[;<W?>Y\YVC7M-'IJX]NAX]K;*I6>PUT51@\",I .;#*,?J2
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MHN(BL<M.+03#5!<)_P ,@DD3^EUD3LV_[+S!;"[V7<X;F'ST-4K7R9<,A^3
M'Y=)OW'G1QU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]TNMF]:[WW_4"':VW
MJ[(Q:]$N19!38FF(/J^XR=28J-'4<Z YD8#TJ3Q[FKVC^[O[S>^=^EG[:<AW
MM_:Z]+W17P;*'U\6\F*6ZL!4^&',K '1&QQT&>8><>6^5HC)O>ZQ1/2HCKJE
M;_2QK5R/G32/,CH\?6?Q,V]@&I\KO^JAW1E(RDB8:F$D>WJ:06-J@R+'59@J
MP^CK#"1<-&XY]]HONZ_W6W(?(TMCS/[Y;E%S+S(A5UL(@Z[7$PS276%FOJ$5
MI(L$!%4DMY1GK&KG'WUW;=%EL>5H6LK(U!E:AG8?T:56+\BSCB'4]&W^QHOL
M_P"'?:4O\/\ M_M/L?MXOL_M?'XOMOM='@^W\7IT:=.GBUO?4_\ <VT?NG]P
M_NJV_<7@>!]-X2>!X.G1X/@Z?#\+1V>'IT:>VE,=0/\ 4W'U'U?U#_5:]6O4
M=>JM=6JM=5<UK6N>O__7W^/?NO=>]^Z]U[W[KW1=_EKWC1?&OXT]U]Y5CP++
MUWL#.9C"15.GP5V[:B 8K9>*EU>G1E]W9"BI3]?\]]#]/=E74P7K3&@)Z^:3
M7U];E:ZMRF2JIZ[(Y*KJ:^OK:J1IJFLK:R9ZBJJJB5R7EGJ)Y&=V)NS$D^S'
MI+TM>INN<[W!VAUUU1MB/R;A[)WMM?8^&]#2)'D-T9JCPU-43JI!%-2R5@DE
M8D*D:,Q( )&B: D^76P*D#KZ;NPMEX+K?8VS.O-K4PHML[#VKM[9NWJ,:?\
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M>8I:&F-56U,DTFB-=<LC.UV8DK8E4QJ2!7_9Z8<G4<]5@_[-#\E_^\B.]/\
MT;>__P#[(/;FE?X1U2I]>MO+_A/IO_??8GQ.[:R_8&]=V[ZRU'\A\YC:3*;Q
MW)F-SY&EQT?6W6=4E!3UN;K*ZI@HDJ:J601*P0/(S6NQ)23@!Q0>73T?PG[>
MKX_;/3G7O?NO=>]^Z]U[W[KW7O?NO=:XG_"B/LKL;KC8/Q@J.O-_[VV'497>
M'9<.4GV9NK.[7FR4-+A=I/315\N#KZ%ZR.G>9S&LA8(7)%KGVHMP"6J.FY.
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M+EMH/LF7'?9MN6CRF+IHZFDW/*=+4LFMH2;V%O;\**^K4.'3;L5I3K6,WO\
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M^_\ LO\ A_\ $+=D_P#N1MGVS/\ V?Y].1_%^76\;[1=/]>]^Z]UHI?SZ_\
MMXCO+_Q&O5W_ +SWM;!_9C[>D\GQ'JF/V]U3KWOW7NCZ_%+^6G\O/F'+19#J
M[K.KQ&PJJ11)VMV U1M+KR*'5HDGQ^4JJ2?([I\+^EX\-29&6,_K51R&VD1.
M)SU8*QX#K93^+_\ PGT^,_6,>/S_ ,B=R9WY!;NB\51+@('K-C=8T=0MI!",
M7B:X[IW!]M-QY*K)0TU2@_<HE#%/:=IV/PB@Z=$8''/5X?775/6/4& BVMU5
MU[LKK?;D6@KA-C[9PVU\:\B+H$\]+AJ.CBJ:EA?5+(&D<DEF))/MDDGB>K@
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M]1Z]>_TS]/?\_7ZU_P#0ZVO_ /73W[2WH>O5'KU[_3/T]_S]?K7_ -#K:_\
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M^SJR_$/MZ^E7[+NE/7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]UHI?SZ_^WB.\O\
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MK7UZ]_P]E_+&_P"\F/\ V#/R!_\ M4^_>#)_#_@Z]K7UZ]_P]E_+&_[R8_\
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M]U[W[KW6@E_.Y_[>9_(K_J%Z<_\ ?%]:>UT/]FO^KSZ3O\1ZJC]N]4ZW.?\
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M[]U[KWOW7NM%+^?7_P!O$=Y?^(UZN_\ >>]K8/[,?;TGD^(]4Q^WNJ=;?/\
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M*;(;ZV#B*C<P@T"*GWMB!)M[?5'&J6"Q4>\,36Q)PIT*#87M[+G72S+TJ!J
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M;-4LRWU15.*V)GJZ"1=/JNDL (MSQ[VOQ+]O6CP/7S)/9ETEZ][]U[KZ._\
M+KZIPO3/P@^,>R\-1PTC2]0[.W?G3"BJU7NS?^(I][;JJY9 -=0SY[/3JCM<
MB%$4650H+Y#5V/SZ4J**.CI>Z=6Z][]U[KWOW7NO>_=>Z][]U[K1\_X4&_\
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M_P"W8WR8_P#*,_\ P0/5/MV'^T7_ %>75'^$]:!'M=TGZ,]\(_\ LL_XB_\
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MS\V^BH_DM\3^^.E!3)5Y3>G7V87:T<@4JN^,"(]S;%F;5^E(=X8:B9B"#H!
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M[KW55O\ .R_[=C?)C_RC/_P0/5/MV'^T7_5Y=4?X3UH$>UW2?HSWPC_[+/\
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M^\C-[27'Q+]G3T7 ];*'M/T[U[W[KW7O?NO=>]^Z]U[W[KW7O?NO= 5\HO\
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M-?3R4M73N\3I*JS4\K*2K!@#P0??NO=5C?\ #+/\LS_O&2E_]&QWI_\ ;/\
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M&;MPE'E1CZF1/&:[#U<T?W^$R8CX6JHY8*A!^EQ[V&*FH-#UH@'B.J=>T?\
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M^Y/.EAMUI%!8Q7\BI'&JHB*#A510%4#R  '15OD<<.\;C%%&JQK*0    /0
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MXI\M3I5-54M70""EDIZ:4%&)CD<M]ZO9GE;ECE?:>?\ D'<))>7;EXPR._B
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ML-LC-$A(.GQ9#6AHYI3H=S['RKLP2/=+UWN2*TJ?VZ4!*CTU'\^CJ_'?<_\
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M?_\ E3ME_P";/_5INMHWWA#U&_6KE_+Z_P"WY?S<_P!?Y*?^_AV9[S>]V/\
MQ&/VT_ZEW_:)-U)&^?\ *F;/_P VO^.-TGO^%!LM1NCY"_#[KNLJ98L'/MW/
M2J Q2."HWCO? 8/*5*,;HLOVF!I[FQL$'M7]TU4L>4O<+=XT!N1,@^9$,,CJ
M/LJ[?MZOR*!'8;K.!WZA_P 94D?X3UM/XK%X["8S'87$4=/CL3B*"CQ>+Q])
M&(J6AQV/IXZ2BHZ:)?3%3TM-$J(HX55 ]X-SSS7,\US<2%YY'+,QR69C4DGS
M)))/4;,S.S.YJQ-2?4GJ?[:ZKU39\Z/YL;?&KN_#_%[HWI/+?(#OK(0X1LGA
M*2OKZ2@PM?N6DBR>W]NT6+PN(S.?W1N3(8B>&LD@A6EAIZ:IA?S2,9(XLB?;
M#V&'.?+-QSOS/S+'M/*R%]+E5+.L9*R2%G=$BC5P4#'4696&E10L+-EY8_>%
MF^Y7MX(+$5H<5(&"220  <5S4@X'F#H_F"?S9B ?^&PZOD7YK-T@\_U!F!!]
MB'_6G]AO_"UK_O,?^;I7^X^5_P#IH_\ CO1!_P"6_N[L'?7\Y[LC>':FPSU;
MV)N7!=LY+>/7^J<_W8S%1AL0]1C'-23.Y!1927))9[^Y4]XMOVG:_NY;-M^Q
M[K]=M$,MJL,^/U$#O1L8^6/3H\Y@B@AY1MXK:?Q+=2@5O45.>C9?\*.?^9*_
M&_\ \2CNO_WDXO8#^Y]_RLG./_/#%_U=Z*^0/]R]P_YIK_Q[J^GHW_F2G3__
M (BWK_\ ]Y/$>\6>9O\ E9.8/^>Z?_JZ_0)O?]S+O_FJW_'CUK>=L='?.K^7
M9\\^[OES\<>D9_D)U;W=D=[9?+46#P^7W54T^)[$W30;]W-MW+[?VM,V[MNY
M3;^Z:(-1Y**FJJ!J)5+EBT\$68FP\S>V'N][6\M<@<X<RC:=\VQ(45G=(@6M
MXF@CD224>%(LD1H\997#UI2BLT@6MYLN_;)9[7N%YX%S"% J0N4!4$%NT@KQ
M%0:_D28+8O\ PH-ZCI\HNW/D-\<NX.FMP0R)3Y&/#SXS>=/CIB=+3Y*@SL'7
MFXZ*GL"Q2.CJIE_2 _U]A/=/NF[^\'UG*7.&W[C:$576&A+#T5D-Q&Q^9=0>
M..D$W(MT5\2POXID\JU6OV$:A_,=79]&=^=1_)/KW&]I=*;UQF^MEY.>>C7(
MT"U5+58[*4JQ/68;.8C(P4>6P69HTJ(WDI:N&&81RQR!3'(CMC9S/RKO_)N[
M3;'S)MKVNY( =+4(936CHZDHZ&A 9214$5J" $+VQNMOG:VO(2DP\CYCU!&"
M/F.A@]A[I)U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=?_T-_CW[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=:J?RP_P"W_O0'_:_Z%_\ =0_O.CD/_P 12YK_ .:5
M]_Q_J2]L_P"5'OO]+)_AZVK/>"_4:=>]^Z]U21_/[_[(/I?_ !./7G_NHWC[
MR5^ZG_T])_\ I67'_'X>ACR/_P EH_\ -%O\*]'A_EP_]D'?$W_Q!^Q?_=3%
M[C/WA_Z>ESY_TLYO^/'HFY@_Y+6Z?\UF_P /1 /^%"?_ &0_LO\ \6/V)_[P
M/:ON5ONE_P#3S-R_Z4\__5^UZ/.1?^2S-_SSM_QY.C']7[0SW8'\F_;NQ-JT
M<V1W/O+^7_5;7V[CJ=2T^2SF=Z/J\9B<="J^II*^OJ8X0!?E_H?I[!^][A:[
M3]XB[W2^D"65MS6)9&/!42]#,Q_TJ@G\NB^YE2#FR2:4TC2^J3Z 25)_(=5'
M?R2_G?\ %_XT=']K=0=]=@4G5V[*KMVOW_BZS/87/S4.:P^3V?L_;4N.CK\1
MB<DE-D<'D=J2M)3U/A=EK%,0DM+HGW[RGM=SMSGS-L7,'*VTM?6"[>L#!'C#
M(ZRRR!M+LM5=90 RU T'53MJ*.<-EW+<;RVNK* R1"(*:$5!#,:T)&"&XCTS
MY=&!^=?\T+8?RAZ9[H^-?POZ^WOW]79OK?=&3[)[*BP&6VSL3K[KO;M#-G=T
M[B49VEQN:R-9!08F6*#[J#'TDD\D8@DJYG2FD"?M?[);KR3S'RYSE[C[M;;5
M%%>1+;VYD22>>XD8)%'V%D4%F!;2SL%!U"-07"'9>7)MMN[/<-WG2!1( B5!
M9G.%&*@9.:5/K09Z,3_(-_[()B_\3-V-_P"XVVO80^]3_P!/4;_I76_^&3I!
MSO\ \EL_\TD_R]$>^.?_ '$&][?Z_:'_ +P&$]R;SA_XB;RO_P!0W_5]^CF_
M_P"5%LO]I_QX];1WO"'J-^M8?_A25_Q9?A__ -K3O/\ ]Q.I?>:_W./]R?<'
M_267^&ZZD;V_^/=?LC_Y_P"MF3!_\67#_P#:KQ__ +B0^\+[G_<FX_T[?X3U
M';_&_P!IZUFOYBO_ &_ ^ W_ &J_CC_[_P [+]YH>T/_ (C/[J?Z?</^T&WZ
MD/8?^5.WS[9?^K2=;//O"CJ.NM7SI/\ [B'NXO\ J%WM_P"^7P'O-KF7_P 1
M'Y=_TT/_ &F2=2->?\J):?:O_5P]-?\ /VQN6V7\B_AQW?DL'69386%I'QM9
M+!#Y::;+;0WSC]W5V#FEDM2P5F6PU>#3I*5\ZPRD7$3Z7_NJS0;ERA[B<LPW
M2INLC:@":$++ T2N!Q(5U[B*Z:K7XA6_)#+-8;M9JX$Y-?R92M?R/'\O7JU#
M/?SF?Y=N#V?'NV+O8YZ6HHDJJ3:6!V/OJJWA43O%Y?X9)C:O;U#18RM4W0M6
MU-+3!Q_G;$$P;:_=T]W;K<#8-ROX2AJ&5YH!$!6FK4)&+#S[%9J?AZ#2<I;\
M\IB^BTBOQ%ET_;6M2/L!/RZH0[O[\W[\K_YG'\OWY%Y[IC<W3G6^ZNV?CWLW
MI2/=S*N=WQL?9WR"H\S-O*N@!6.%LCEM\2!/MU>B\"QK#/4Z'G?*CEGE7:N1
M/97W8Y0M>8X=QWB"POYKSPO@AFEL"@A4^>E81751]52RI4*!M9V,&V<N[Y8)
M=K+<+%*TFG@K-%32/L"^>?4#AU>Q_.@Z!W1W]\&MW4NR\55Y[<_56[-N]PX_
M!8^"2IR.4HMM4>;P.Y8Z&GB#25-30;3W57U@B0-)**8H@9V53B_]W+FNRY4]
MSMO?<IUBLKZ"2T9V-%4R%'CU$\ TL2)4X&JI( )Z!G*-]'8[S$9F"QRJ8R3P
M%:$5^UE _/HG/\KC^;#\8,%\8NMNC>_>Q*;JOL3J?$/LZDK=S8[+_P!V-U;6
MQM54-MG(8W/XZAR&/QU3CL)+!15%/6R4\C2TYDBUH]DD/WO]A^=KKG7>>9^5
M=H-]M%_)XQ6-D\2*5@/$5D9E9@SAG5D# !J-0C)KS)RQN+[C<7EC 98)3JP1
M52>((-":G((KQSU:!B/YE?P4W!NC:VR\!\E=@9W<^]-R83:.V<3A?X[E9<GN
M'<>2I<1AJ#S4&&J*2C%9D:V*/S5$D4$>K5(ZJ&(A.X]F?="TL;[<KKDV[BLK
M:%Y9&?0H6.-2[M1G!-%!-%!8\ ":=!QN7MZ2.29]O=8T4L2:"@ J3D^@\L]5
M#?\ "@/IO?..R?QU^7FR,=4UM)UC52[.W=D8*:2JBVS50[AH=U]=9;(1Q!C%
MB:O-R9"EEFDT1)4O31:M=0@]S_\ =0YBVR:'F_V_W.95DO5$T2DT,@,;17"K
M7BP3PV %25#M2B'H4\C7<++?[5,P!D&I1ZXTN!\Z4/V5/EU8=TQ_-W^ O:FQ
ML%N//=O;6ZMW14XRCEW+L;?V/R6&R6WLRT$9K\=#DI<2<-GJ2&H+>&IHJB9)
M8M)81OJC2).8_8#W5V/<[JSM>7Y[ZQ5R(YH&5UD2O:Q4-K0D<5=00:TJ*$D-
MWRMO=M,\:6C21@X9:$$>1I6H^PCH<-C_ ,QKX/=@[_VIU3U_\@-G;GWSO;)?
MPG:^ V_C-T5B9/)-3SU0IOXE3[>_@M$[PT[D&HJ(59@%!+$ AG<_9_W,VG:K
M_?=VY3N(-LMDURR2-$-*U KI,FMLD?"I]>%>DDVP;S!!+<SV+K"@J22N!]E:
M_L'1!?\ A0EM[,9CX3;*RN-H9ZNAVG\A]EYG<$\,;.F,Q5;L?LK;=/7U3*"L
M5,^=SE'2AC8&6IC7ZM[E7[I=W;V_N5N4$TH66?:)DC!_$PFMY"H]3H1V^Q2?
M+H[Y%=$WB96:C- P'S.I#3]@)_+I9_$'^:A\%]J?#SH7%[X[TPFSMT=;=,=>
M;#W=L_*X;=-3N:CS^QMHXK;.27'XK%8*OJ,W25U1BC-2RT8G1X94U%9 Z*6^
MX'L;[GW_ +A<U3[9RQ+<65YN-Q/%*KQ",I-*TBZF9U"%0U&#Z2"#2HH2SNO+
M6\R[K?-#9,\<DS,K BE&8D5)(I2N:]4D_P VKYP_[/3@.N]T]9=.[\V]\>NI
MM[;BVMB.XMX43T%/OG?6\,135DN%H:*!)\;CA18G9DU0D(K:FL,3AZB.E)2-
MLE?83VS_ -;"ZW>QWKF&UFYMO[:.5[2(ZC!#$Y&MB:,VIY@I.A4J*(TF2!CR
MOLW[E>>*XNT:_E0,8U-=*J>)\SEJ< /2O6YGL;_CR=G_ /AK;?\ _=32>^=.
MZ?\ )2W'_FO)_P ?/423?VTO^F/^'K4UZ<[ZZ\^$/\Z/Y=;L^1E=D=C[3WGF
MNZ,1!GSA,SF(<7%V-O;;79FSLQ78["4&2S$V)S&$H8E66GIYM#U4;L!$'=<\
MN8N5MW]R_NX\@6')\27-_;1V;F/6B%C;PR6TJ*SLJ!T=B2&85"D#NH#)]W93
M[QRCM<5@ \J+&:5 KH4HP!) J#ZGR]>MFGX^?++X\_*JAW/D>@.RL?V+1[-J
ML91;FEH<1N7#MB:G,PUD^+CFAW+A<+/*M9%CYRK1*Z?ML"01;WA=S;R'S;R+
M+90\U[,]G)<JS1AGC?4$(#4,;N!0L*@D'(ZCN^VR_P!L,:WUN8RX-*D&M./
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MOGT6[O\ \E.^^/\ M#\?Q<?Q?/UZ*/\ S?O^R7=M?]D^?\SGVK_V4I_QX/\
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M/4H\M?\ )*A_W-^'\?#_ )M_T?X>KY?@9_V05VO_ -D,?\>)O3_LG'_CP_\
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MQ?\  A_^9A?]G_\ \[+_ *;-?OJ#['_\JKM?_*S_ -FO_)1_L^'^@?\ "/\
M??\ 0IU-'+?^X,/^YO ?VW#_ &O]'T^74?\ EF?\SYZQ_P"R%_\ C^ML?]E%
M_P#'R_\ %[I?^9?_ /9^_P#.D_ZN?@]V]Z/^56WK_E9_]Q9/^2?_ &?P'^W_
M .$?[^_X7JZWS%_N%<?[F_ W]EPX?B_H_P 7RKUNZ=N_\RN[!_YEW_QZ&>_Y
MF[_S*[_BW3_\S!_[-#_E?_Z9M7OFGL'_ "6]I_W,_P!R$_W%_P!R?B']A_PW
M^#^E3J'K3_<F#^T^,?V?Q\?P_P!+T^?7STODY_S,[/?]DK_\7:;_ +)C_P"9
M8_YZ7_BP_P#5I_U'^T:??6ODK_DBVO\ R7?[,?\ )2_W)X?C_I>OSZG7;O\
M<9/]R>'^C?'^?SZLV_E _P#90G6?_9!G_%]H_P#F8_\ S/C]$G_,G_\ L_\
M_E7_ ,-?N%OO!?\ *I;U_P K3_9'_<?_ '!_ZB_^$?Q?ET'>:O\ <&X_W-X?
M@_L_]O\ T?7K:O\ ES_V3-W9_P R:_X\',_]E"?\R8_S:?\ '_\ _5H_U/\
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MY6;^UC_Z5G]HO]O\_P#?/_#='01YQ_W#?_<SXA_S1X_B_P"??Z5.K!/YX?\
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!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>auroralogoa01.jpg
<TEXT>
begin 644 auroralogoa01.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" "7 8,# 2(  A$! Q$!_\0
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MI+Y+^OF=-7!PI4W*^I]\T445^?'DA1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 UFXS7P;\<-3.K?%;Q%.3G9<>2/8(JIQ^7ZFOO&3[I^E?G[\4HS
M'\2/$RMU_M"8_P#CYQ^AKZSAU+ZQ-^7ZGX_XE3DLOHQ6SG^C.6KU7]FKQ(=!
M^*5E S%;?4HWM7&2!G&]3CN<K@?[U>55M>"KXZ9XRT*[!P8;Z!_J XR/Q%?;
M8RFJV'G3MNC\-R;%2P>84*\7:TE^>OX'Z%W5W#86LMS<RI!;PJ9))9&"JBCD
ML2>@ _E7P+^TW^V5>^,)KOPQX%N9+#0E)CN-6C)6:\ZY5.Z1GU'+>H'!M?MK
M?M(RZ_J%S\/?#MR5TRT?9JUS&?\ CXE4\P@_W5(^;U88Z#GY%KRN'\ABHK%X
MI7?1?JS^Z\)AE95)B4M%%?HIZX5^E_[$'@&3P7\#[*]N$V7>O3/J1#)@K&P"
MQ#W!1 __  ,U\&_ WX677QB^)6D>'8%86;OYU],H.(;92#(2<'!/"C/\3+7Z
MV6-E!IME!:6L2P6T$:Q11(,*BJ   /0 5^=<68U*$,'%ZO5_H>3CZEDJ9:HH
MHK\R/%"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M"ZE;7:0:YILVDK,&466E6U\EV;8<'Y@QD0=BL<()&/E]PI:* "BBB@ HHHH
M**** ,[7];L_#.A:CJ^H3"WL+"WDNIY2"=D:*68X]@#7XR>,/$UWXT\5ZQX@
MOBOVS4[N6[E"\ ,[EL#V&?7L*_1W]O'XA'P;\#Y]+MYC%?>(+A;%0IPWDCYY
M3]"%"'_KI7Y[_"?P3+\1_B3X;\-1J6&HWL<4NT\K$#ND;\$#'\*N/<3/;O"/
M[ ?COQ=X6TG7(M9T*RBU*UCNXX+F6;S4610RA@(B V",X/'2MC_AW#X__P"A
MC\-_]_;C_P",U^A=O#':PQPQ(L<4:A$11@*H&  /05-2YF%C\[O^'</C_P#Z
M&/PW_P!_;C_XS1_P[A\?_P#0Q^&_^_MQ_P#&:_1&BB["Q^+/CSP7J7PZ\9:O
MX:U9%34--N&@D*9VO@Y5UR,[64JPR.C#-?I+^P_X_P#^$V^ ^EVLL@>]T*5]
M+E&X$[%PT1QV'ELJ_P# #7S9_P %$/ 0T/XG:3XH@B*P:Y9^7.^20;B#"D^W
M[MHN/]D^]1?\$\_B!_PC_P 5-3\,3RHEMK]IF,,#DW$&YU ]C&TWX@4WJKAU
M/T9K\/6^\WUK]P:_#YOO'ZT1Z@S]??V=_P#DA'@#_L"6G_HI:]%KS?\ 9RE2
M;X#> &1@X&C6JY'J(P"/S!_*O2*@85\<?\%*/^1+\&?]A";_ -%"OL>OB+_@
MH_XITBZTOPKH4&I6T^L6UW+//912!I84,:A6<#[N<C&<9&::W$SP?]BS_DYC
MP9_O7?\ Z235^JM?E5^Q9_R<QX,_WKO_ -))J_56G($?DM^U?_R<5XY_Z_O_
M &FE?77_  3C_P"2-Z__ -A^7_TGMZ^1?VK_ /DXKQS_ -?W_M-*^NO^"<?_
M "1O7_\ L/R_^D]O0]A(^KZ***DH*^)?^"EW_(/^'W_76^_]!@K[:KXE_P""
MEW_(/^'W_76^_P#08*:W$SR[_@GS_P E\?\ [ ]Q_P"AQU^E=?FI_P $^?\
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M 4444 %%%% !1110!^;7_!0'X@_\)1\8H/#T$CM9^';18F0_=^T2@2.R_P#
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M>M1P5)5JM=-III[Z:I/7R.A4XJ4I(^ZO#T-Y;Z%I\6HS+<:A';QI<RKT>4*
B[#CH3DUI445^<RW;/&>X4444A!1110 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>consolidatedfinancialstate01.jpg
<TEXT>
begin 644 consolidatedfinancialstate01.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_X2-R17AI9@  34T *@    @ !@ +  (
M   F   (8@$2  ,    !  $   $Q  (    F   (B $R  (    4   (KH=I
M  0    !   (PNH<  <   @,    5@  $48<Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                     %=I;F1O=W,@4&AO=&\@161I=&]R(#$P+C N,3 P
M,3$N,38S.#0 5VEN9&]W<R!0:&]T;R!%9&ET;W(@,3 N,"XQ,# Q,2XQ-C,X
M-  R,#$Y.C W.C U(#$R.C(S.C0R   &D ,  @   !0  !$<D 0  @   !0
M !$PDI$  @    ,T,   DI(  @    ,T,   H $  P    $  0  ZAP !P
M" P   D0     !SJ    "
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M,C Q.3HP-SHP-2 Q,CHQ-SHT-@ R,#$Y.C W.C U(#$R.C$W.C0V      8!
M P #     0 &   !&@ %     0  $90!&P %     0  $9P!*  #     0 "
M   " 0 $     0  $:0" @ $     0  $<4         8     $   !@
M ?_8_]L 0P (!@8'!@4(!P<'"0D("@P4#0P+"PP9$A,/%!T:'QX=&AP<("0N
M)R B+",<'"@W*2PP,30T-!\G.3TX,CPN,S0R_]L 0P$)"0D,"PP8#0T8,B$<
M(3(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R_\  $0@ B@$  P$A  (1 0,1 ?_$ !\   $% 0$! 0$!
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M_9,]G_6*AV%_L2X_YZ1_F:/[$N/^>D?YFCV3(?$%'L+_ &)<?WX_UH_L6?\
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M1[-D_6HE"BMCSPHH ** "B@ HH ** "B@ HH ** "B@ HH ** "B@ HH **
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M%!04%!04%/_  !$(!3D)L ,!(@ "$0$#$0'_Q  ?   !!0$! 0$! 0
M     0(#! 4&!P@)"@O_Q "U$  " 0,# @0#!04$!    7T! @, !!$%$B$Q
M008346$'(G$4,H&1H0@C0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I*C0U-C<X
M.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H.$A8:'B(F*DI.4
ME9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:X>+C
MY.7FY^CIZO'R\_3U]O?X^?K_Q  ? 0 # 0$! 0$! 0$!         0(#! 4&
M!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<  0(#$00%(3$&$D%1!V%Q$R(R
M@0@40I&AL<$)(S-2\!5B<M$*%B0TX27Q%Q@9&B8G*"DJ-38W.#DZ0T1%1D=(
M24I35%565UA96F-D969G:&EJ<W1U=G=X>7J"@X2%AH>(B8J2DY25EI>8F9JB
MHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KBX^3EYN?HZ>KR
M\_3U]O?X^?K_V@ , P$  A$#$0 _ ,F,'TJR@.>E0Q=!5F/M7Z4MCU29<[:>
MO6F?C3E^M,C4>W6G+]WK3#UJ14RH-9 &?>EY]:7RO:G*I48Q2 %4[>E2*#MH
M7.VGKTK5!J-P:,&GT4PU&8-'/K3Z:W(K(!N?>F,?FZTG3K37(QUH,V)))@=:
MIS3#GD4Z:3"XK/F<\\5HA"S7 !//ZUGW%YAB,C\Z2XD.XU0F.YB:8"75UN)Y
MK.FFW#KS5ETW57: %C09%7EN<4UE..AJUY>WBCR_:D!36([>12^3[5;\OVH\
MNF!66/BGQQ\]*F\NI8H^E!(V.WW8.*L1V_M4T,?2K,<=9/<1'#;<#BK*6_/2
MIHH^E68XZ1F1Q0D8X-6XH^E*BD=JD4'=TIB)HAMXJ5ZC2I&SFM$9&5JB9C-<
M=?*5=^*[?4E_=G-<?J:XD;CC_P"M3-%L9%-;KUIQIC=>M PY]:.?6C\:.?6@
MR8<^M'/K1SZT<^M!HM@Y]:.?6CGUHY]:#-CEZ4C=>M*O2FMUZT .7I2TB]*6
M@ HHHH()%^Z.:7GUIJ_=ZTOXUD QOO&DI6^\:2M%L!(OW1S2\^M-7[O6G?C3
M .?6CGUHY]:.?6@ Y]:.?6CGUHY]:#(.?6G+TIO/K3EZ4 +1110 4444 %%%
M%! 5(OW1S4=/7[O6@!W/K2?C2_C4;?>- $J$9ZU/&QJHG6IU;!Q63W*YB_%)
MTJ99/FK/60[JGC<UFXFBF7XW.^KL;GTK-A<[JNQR^]24:4,N%&35V&0-@9%9
M,;!L<U<B.U0: EL:B%5;&1^=6(V-9UNQ9@QJ[')CBB.YSRV+JN=HIZR<U"IR
MHYI?QK4R+.[=SFG+TJ&/WJ?-!D]QK YI,&GYHS6JV$,P:9(=O'KUJ:HY$W4P
M.0\9Z$)(O/C4R9Y.T9KAMI7CI7L,D(N(7B;@8XS7G'B;23I\V41B">H%(F1D
M+TI:4TE,Q"BBB@ HHHH,V-;KUI5Z4C=>M*O2@0M%%%5$ HHHIO< HHHJ "BB
MB@D****!$B_='-,;[QIZ_='-,;[QH,WN)1110(D7[HYIC?>-/7[HYIC?>- "
M5(OW1S4=2+]T<T +SZT<^M'/K1SZU0!SZT<^M'/K1SZU4MB Y]:.?6CGUHY]
M:R .?6G+TIO/K3EZ58"T444 %%%%29A1110(**** "BBBJ,@J1?NCFHZD7[H
MYJ0&-]XTE*WWC250$B_='-,;[QIZ_='-,;[QHCN ]?NCFEY]:1?NCFEY]:;W
M(#GUHY]:.?6CGUI%!SZT<^M'/K1SZT$ASZT<^M'/K1SZT '/K3EZ4WGUIR]*
MD!:*7!]*-I]*#)[CU^Z.:7GUI%SMI<&@ P:<O2A>E+0 5(OW1S3,'TIZYVT
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M1TZ5W5I;F.%5((Q6#W+>Q/%$ N[O3SG-)DKP*.30<;O<7GUHY]:.?6CGUK1
M.7I2TB]*6F!!=?\ 'O+]*\]O ?M4G'>O0KQA]FEY[5Y_<\W#X/>@")0=M*WW
M:>JG;TI)/NT 4;CO6>WWC5^8';TJBP.X\50M0C!]*N1_=%5X@>.*MQ @=*"#
MF%DXP*FBD/%9<<Y)XJY%(>*A;']:%_<#WJ5<[156,YYJW%VID:CE!S5A?NBD
MC4&GLO/%9 /7[HYI>?6D7.VEP:0!@TY>E"]*6F 4445H@U%/W:A:3;Q3I'QQ
M4#\UF DDF>AJO(Q]*DVGTIC@^E:(S*\C54D[U<=,CWJ)H_EIB,N>,LQ.#55[
M?(SBM>2.J[Q\4&1E?9P.M,: 9SFM%K?=VJ)K;Y<8H SV@&[CFD\G':KZV_S=
M*<UN,UDR3.\GVIC1'/2M/[.*:]N,5HMA&9Y=.12#TJPT.UCQ0D?-,!\?:K</
M056V^G-2QL5XK)[F;W+L8/I5E <]*J0N<"K,;'TI"+:@[13EX/-1K(=HIP.[
MO6J G##UJ1>G6JZ]:E'UIF16U%=T9KD]2C^]FNPNEW1^]<MJ\?WZ#1;'-R=Z
MB;[M2S?+D5$>5XYH&(OW1S2\^M(N=M+SZT&3#GUHY]:.?6CGUH-%L'/K1SZT
M<^M'/K09L.?6CGUHY]:.?6@!R]*6D7I2T %%%%! 4Y.M-IR5D 2??--ITGWC
M3:T6P!4B_='-,P?2GKG;3 7GUHY]:.?6CGUH,@Y]:.?6CGUHY]: #GUIR]*;
MSZTY>E "T444 %%%% !11100%%%% $B_='-,;[QIR_=ZTC_G0 1]:E'WJACX
MJ;</6@"4=.M2QMMXJ%?N]:D7K6<BBU')5A)*H*V&JPLGRBL!\QHPR<U>6XP
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MYNM04 *K8.*D/S<YJ$?>J4=.M9,D7!HP:<O2EK1;"$7I2,FXYI^#Z4]8\K3
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ME2K]T<U'C'%2+]T<T (7*\4@D^:A@=U+&G-9O<">,YYJ?!]*@7Y35E.5&#2
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M#GUHY]:.?6CGUH,V'/K1SZT<^M'/K0 Y>E+2+TI: "BBB@@*>OW>M,IR=:R
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MY]:.?6CGUH,PY]:.?6CGUHY]:!!SZT<^M'/K1SZT@$_&EY]::,[C3FZ]:S8
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MZ'FI0?FJN/O5*N<4 6 ?>E_&H5Z5*OW1S09O<>O2EI%Z4M @IZ_=ZTRG)UH
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M-%L'/K1SZT<^M'/K09L.?6CGUHY]:.?6@!R]*6D7I2T %%%%! 4444 %%%%
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MY?J1(_%4U!Q0 O/K1SZT<^M'/K0:+8.?6CGUHY]:.?6@S8<^M'/K1SZT<^M
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M>?6D7[HYI>?6F]R Y]:.?6CGUHY]:10<^M'/K1SZT<^M!(<^M'/K1SZT<^M
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M36J;G%0X-6+,'S!03(UHU(C J1>E"?=%+72HZ',%%%+@^E4 E-8'-/VGTI*
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M#ZTV2A*63G.*!$+?=JM,H*]:M-]W'>H'3(H RYAM)%0_C5R>/YC4#1_+6;W
MIW$<5QE'3/OBL'5-!6,-+%&Q!Z8&:Z7RZ8T9[G*?W:D#SV2&2-B&5E^HI@5F
MZ<_A7::EIT5VIV+M)[UR]]I,MGNP_2M5L!47(;:W'UI[8!XZ5'']T;VRW?FG
M_2F 4444$!1110 4444 %%%%!D%%%% !1110 4444 %%%%! 5(OW1S4=2+]T
M<T /7I2TSGUIR]* %J1?NCFHZ>O3K0 [GUHY]:,&CGUH .?6CGUHY]:.?6@
MY]:,&CGUIR]* !>E+110 4444 2+]T<TO/K35^[UIWXUF]Q!SZT<^M'/K1SZ
MU)F'/K1@T<^M.7I0 W!HP:?10 B]*6EP?2DH -QHW'THHH,WN20_>!J_'RHP
M:HQGI5J&3:U9EHL*"IYJ=6VJ"*B8[ES1$V>.U(U18CDWGGBK"-M.!R*K[3T
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M,AGD^8U!RW.:?+R:8N=M8/<U0O/K3&3+9I_/K1SZT@(]I':C:?2I.?6CGUH
M@<'TJ+RZLL#NI-F:#)E?:1VIC=>M7#'\M0214 09]Z59-K=:7R3Z4>3[58"M
M)SUI/-'J*C92K'BHVZ]: )FE^;K3"VXU'SZTJ\'F@@?@^E)2LWRX'-1<^N*
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MM'/K1@T .7I2.1CK2<^M,<'%$M@*]V?W-><^,6'V@\^G\J]#O/\ 5UYQXO\
M^/H_4?RK&G\1F]S ;K24II*[1$B_='-+SZTB_='-+SZT$!SZT<^M'/K1SZT
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M\<5&OWJL+]WK6)8^.I5!W=*C7K5A?NB@T0NX]A4L;'@'BF+QUXIY.3P:!D_
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MYI?QI@/WFI%.5'-,5,K3E&&Q60#^?6G+UI&!S2KTH E'3K2\^M(OW1S2\^M
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MUHY]:.?6@ Y]:3\:/QIC?>J21_XTOXU%N-/7)44"&M]XT8/I2L#NI5X7DXH
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M<U'4B_='- A>?6F,#NI_/K1SZT&;W(]I]*>N=M+SZT<^M @Y]:.?6C!HY]:
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M:K4:9H$/C!]*N1*.*KH-IQ5B,T 6$XJ8 XJJK$-5A9/E% #\&C!IRG*@TM9
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M P.ZDP:E8'=3:S>XM1%Z4^/K4; YH5BK5:&6J9)'YBXIOF&CS#3 S;JQVL6
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MTBYVTO/K3,@Y]:C;.ZI.?6HF?#'F@ J-F(:E>2H?,H <[<5%GWILLG6JTDQ
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M1SZT<^M !SZT<^M&#1SZT$ASZTY>E-Y]:<O2@0M%%% !1136!S09#LT9J/\
M&E_&@!P^]4H/O5?\:>O2@"7/O39FVQYS3:HZA=>6"N>E %:]NMQ;FLN26B6?
M?DY%4YI>O-<TY'93@++)UJE<3B/))Q]:>TGS&J=X#)D5D;!'>^:^ P-6<'_(
MJC9VFQ@V,5HT (O2EHHH 7!]*>N=M"_='-+@T .7I2TB]*6@S'K]WK2_C4=.
M0UD(1B58TFZIF4,O6HO+K5; )2X/I3UC&VEQCO09O<CVGTHVGTI_XTO/K0$M
MB*F-UZU+(#357(H,Q%4;>32]*.E% !N-.3/6FU(OW1S0 Y^E,5B%Z4YONBFK
M]T<T&0O)IZL0*;SZTY>E "T444 "_>J=?NBHDZU-09/<***7!]* $HI=I]*-
MI]*"!Z_='--8'=3E!VTO/K3 8G6IJC .XU)5 -;KUI.?6E;KUIOXT +@TFXC
MCFGK]VG;,\T -4Y'O4JYVU&%(;I5A$RHH,AF#3U3*TNWM3U4[:"!$CYJ7:/6
MA5..F:E6(L.G/TIF4I#8X\GBKUM;YQQ2VMJVT$J1^%:$<2Q@'(S71")S2EH,
M6$1\]ZE'/>FN<L33E^Z.:T,A=O<T8]#Q0WW::O"\G%29B_C2X/7M4;'GK36F
MVK@&@0Z1\<579SN-#R$BH?,H-5L*TAW&HVDYIDLOO5:28>HK*<A\I+-+UYJI
M-<?+@'-1S7&%ZU1DN/>L3> LTYR:A:;*]:BFD)S4'F4#9,S;JB9]IQ2>93&;
M<<T"%9LG-)FC />EVB@D8V<TF#3^E% #/QI=^T8-*JC=G-$B@]#0 H;=S3,'
MS#Q2Q_+BG9S)Q6B,F-8'-1L#FK#*<=#4;*=O2F(B\O=S1MQQ3E8J,8--9FST
M-!FQNX#J<4*?FI&7)R>*;[ T")3Z]J;YG84+G&#TIK*%.01F@ =CZ5'R>U/!
M+<TO/K02-7IUQ36/S=:&^\:C8_-UK5;&3!NO6CGUH_&CGUIB#GUHY]:.?6CG
MUH \M##UIZGGK4" YJ10=W2DMC^K2R#[TY&(/J*AIZL0O2F1J6/,-'F5!N/H
M:3S#60%CS*/,JOYE*#N[T@)_,H\RF+G%2+'E>G- #U;*@T]#S35CXQBI$A.>
MAK5;&8XYSQ2>7FIUC^44OETQ$*1\U-Y=.2/FIO+K)[@0I'S5B..A(^:LK'\H
MK1;&;&8QWJ:/.P<TWRZ>JX7%,0NW-&,=Z.?6CGUH <O2FMUZT<^M'/K02'/K
M4;?>-2<^M,8'=0(;4T?W14:=:FH D4':*>O6DC^Z*=0!(/K1^-1[C2>90!+^
M-'XU%YE.C;- $G/K3&!W4]CSUI,^]!F]R.G*^T8I&/S=:;N'K0(<QW'-,;KU
MI&8YXY%)N]3BL@#\::V<^M/V[N>M/6/C%:+8R*]/7[HYJ?R >:<EN,TP(/+W
M5(MO\O-6%APW2I/*]J *GV<4Y+<9JUY)]*<L)STH ;%%C J?RZ=''3V4YZ4$
M$6TBC!J3:?2C:?2@"/!IR]*=M/I1M/I0 E-8'-/VGTI*#(9@T8-28/I1M/I0
M! RG=TIM6-H[TUHQF@"+!]*8P.ZI]N.,TQ@=U!!%@T8-2;3Z4;3Z4 1\^M'/
MK4FW/UH\N@"/GUIC [JG\OVH\OVH K[3Z4;3Z58\OVH\N@R97VGTIC1ECG%6
M_+H\N@"GY=->/BK;1_-3'CXH H-E.12>:3S5AX^*B\GVH 9NQ\U*MPK<2+N7
MTI64;<9&:@93GVK)[@1:AH=MJD;/$FU_3O7'7UG)I<K!E8'U(KMX[AX6PH)S
MUP*GN+&VU2'RI4PX_B/>M$!YR,-R.1[4 AN0<BMS6/#LFELTJ(SQ'IM!(K#7
M$C'8O3JN.13 ****#)[A1110(****"0HHHH *D7[HYJ.I%^Z.: %Y]:.?6CG
MUHY]:#(,&C!IR]*6@0@7"Y[U9M;D\*>*KTF=K9H+C*S-A?F.1S4\:^O%9]C<
M;\#-:>/3D5S2W.I.X_'H:>O2F+G;2\^M2,F4\=:7<1[U$F<U851M&:D!8W(
MS4ADYIA^[BH=Q5S2 F;+'-)2>91N]Z %IK+N%+N'K2T 5I$J#&&JY(FZJKJ5
M8\59D]R-L[C2ABHQ2TOET$$EM)\]:BS+Y8!8#ZFLE4V\XJ>-C)U&-O2I OLH
M3FH99"R\<U'YQ==IH#;>* &+N;@@@?2EV[> :>6RO6H\^] "K)M;%6H9^F*I
M,"6XYI\;%>HQ0!M6\@902>:F-P%.,BL:-7D^99 !]:G&5&"P)]:1D]S4\X,O
M4&ECDQUXK,68J<=J<UT<<<T"-;[4.@9:<9MR]>:QH9MS<G!JYYWO01REEIB%
MJ:UN#Q5.-A(V"1^=3<1_=.:L.4U([@$X)Q^-3;58\$'Z5D1LS\[2?PJ_:L58
M;ACZT&$T6/+Q3#%\Y..*M95S]X9^M1R[E) !/X5JC-$#_N^12Q79Z4FTL<$$
M4QXQ&>*S>Y)<^TGJ:>LVY1S6?')O;!JRF%.,U:D!:SGFA?O4B?=%/3K6US,1
MNM)3I/OFFTQ!12X/I1M/I09";C3UR5%,IZ_=ZT +^-*?NBHV^]2,Q"T$L>J@
MKUYJ1?E&*ABR>:D;KUH$07FG6UXK">/S-W3C.*Y;5?A[YH<V\JJ1R,&NR7I2
MT >-WVAWFF2,)Y"=OK5:.X4J &4GZU[9,J7$?E/!N_VMRC^=86J>#K*\4F-5
MCG/4Y!_E0!YPOW0W>@-DY/%;M[X%O+$LZ[Y4[;036-- T#%)4:(CLXQ_.LWN
M4,,GS<<_2GJ>.>#3?+"\KS]*.3R>*D8-UZTH?:.M-S_M4NT,O7)H$30S'=Q6
MQI]ZR8%8L$)'4$5I6R[6]JB0SJ[&Y\W'-:N_;P*Y[3F/&*V5<XJ%L!,S9.:8
MY&.M)R?:F24R"-R,=:JM)AB*FD[U6?[QH*)5;*]:>K#/455\S'>CS,U))?63
MYN.15B-LXK-CDZ59CDJ@EL:,9'K5A7^7%9T<E6(Y*.8Y2\IRO6I5SBJB25/'
M+[UTK8@DHH+ G.:8QYZU0 W7K3DSGUIGXU+#]ZD9R)E^[2TK=:2F9!1110 4
M444 %2+]T<U'4B_='- #&^\:8P.:D8'=3: &8-&#3Z*#,1>E+12X/I0(>OW1
MS1^-"YVTQOO&@S>X-]ZDHHH$%2+]T<TS!]*>N=M "\^M)^-+SZTT9W&@"1>E
M(P.:=102,Y]:<O2D;KUI5Z4"%HHHH ****#(:R9.:3&.]2'[M1\T -'WC4N:
MB&=QHN&\M<]Z &7D_DQE@>:YV^O3,S$U;OKO=D9K$FD^8UE*1UTH#'GV\9J%
MY=U,D.6--KG.L>K?+UQ2,H9O6FTY#S2,QRJ5&*>O2FG[W!IR]* %HHHH D7[
MHYHW$4+]T<TO/K0 Y>5I:1>E+0 ;0:.E%%9F9(OW1S2\^M-4\=:7/O6B$'XT
M9]Z8WWJ2@S>XK?>I5?:,4VB@);"NYQ358XZ4X_=IHZ4&8M%%+@^E !@^E.7I
MC.#2KG;0J9;- !DGCM2[=O3I4GET-\JXH,B/!IZQ_+S2+UJ4=.M $>,<44Y@
M=U)M/I0 J5-4:YVT]>E!D]QV#Z4]<[:%^Z.:7GUH .?6CGUI/QI?QID#EZ4C
M YI5Z4M4 B]*6BEV9YH 8V<TGEYI^,<5(J;E!H,B)1M&*E7[HYI?+IZQ_+0
MBJ-O)J1>F :58QMI\<?-! )'GFI=@]:7;MJ:&'> >M!E*0D,?2KD,'.32PVW
M(./TJZL85<5TK9'-*0BKM4 'BD8'=3\8[T<^M:&1%3U^[UIK?>-)N- $OXU'
M(?>D:3Y:@DE]ZD82/4/F&FO(2*B:0[:5PY25Y.*KR25%),5XJO)<&LW,T4"6
M23BJ<LO7FF37'%56E^7GK6<M33E'S2?+5/S*<\A(XJNWWC4(T)6.X<<U"01U
M&*56VFED.[)IF;(FZ]:,&CFG+TH$-P:<I.,8S368AB,&I(F[GB@D3GOP:7!V
M]*63[Q/:E7[O6@"$@_2CGUJ5DRU1LNUJ &_C3U7;\W>HUSN]:EH,A_F&FLP(
MZTA/RU S'<:U6PB3\:3\:CW'TI-YH,V$O7UJ)0<]*>6W'K2?C0(D)^6F;0>:
M3\:7!H ,8[T<^M)^-&?>F2->HO+SS4C?>I"?EK1&3&8QWHY]:/QHY]:8@Y]:
M3\:7GUJ-OO&@D\P3K4_E[N:;'%5R./Y16)_5Y L?RTNTBK/D^U'D^U:K8C4K
M8-'EYJQY='ETPU*_ET^./FIO*]JDCCZ5D Q(^:L1QTJQ_-5A8_E'%(S9&L?S
M5+Y=/2/GI4OEUJMA$2QC;2^6*D\NCRZS>X#409ZU*L7S9QQ21Q\]*LJI5<4@
M&>73U7"XI>?6CGUK5;&;#GUHY]:.?6CGUIB#GUI/QH_&F-]Z@!^?>C/O4=%!
M))GWH_&HZ=&#Z4"'!3N/%3)UI,'TIR*?2@"6BBF,PSUH 1GPQJ-G)-*Y]ZB+
M[3B@"3<?2E5SFH?,H\R@"RTG-)YE0;SZ&C<?0T&;W+&[/>F-]ZFJ<CWI:!#U
M/'6G;-U-C3)JQ''S60"1Q]*F6/YJ7:?2GJ#MK1&0OETY(Z%Z5(OW>M,!WET]
M4&*1>G6ES0 =**,T4$#U^[UIWXU%4B_='- "\^M'/K1SZT<^M !SZT<^M'/K
M1SZT '/K3&!W4_GUHY]:#(1<[:7GUHY]:.?6@!C [J3:?2I.?6CGUH CV9IC
M*0U3\^M,8'=001<^M&#4FS-&TCM0!$ =QJ79FD"G=TJ09H 9M([4;3Z5)SZT
M<^M $>T^E,8'=4_/K3&!W4&3(N?6CGUI6!W4F#0 ;<TR1!CK3\&F2 T 5Y.,
MU$WW:LLNY:B\N@"HT>6I&0;:LM'S4;1_-63W K;-O(%/A<AN014OET>72 NQ
M^5<PK'* R5SOB+P>C[[FS81@\[1WXK9C8KQ5V&8;0'0LGTK5;&1Y1-"\+%71
MD/\ M#%-P?2O2]:T"VU2)I(TV,>@KSW4M-GT>X;S5;:3QD&F(J@@\CFBE.#R
M%*CTI* %P?2DJ1>G7%,;[U!(E%%% !4B_='-1U(OW1S0 O/K1SZT<^M'/K09
M#EZ4M(O2EH$%->G4U@<T .MI/*(/2M^TD\ZW1L\G_&N=VG_(K0TVZV.L;$*/
M?BLY%4Y69L<^M&#4K(#R.13>G%8'9N-5BK5+YE,V@T=* '^92A=W-1U(OW1S
M4@+C'>HV8AC4G/K4;?>- "HW/-356'WJG5\+BD -G/I4;J&'6I&RPJ+:?2@R
M>XU4&:<5!;CFC:?2EC^_5B'+%\O(I<8[\5.N&XS3S;_+4DF=(S*Q(&?I2K(S
M*"00?>IY(PK$5!,2I(%4 +(2^,<4YOO4R//%3K&&^M !&PXYJ3'F-BD2WYJ4
MQ^7R!0(%LG895P!Z9J5(Q&H5F!8>]5VN67@@BD\QI<D GZ5)FRRRY'RC(]JB
M:U=OF+A!Z,<4D4SC@*2/I1,[LQRK ?2@0J*(_P"-6/J#5A9AMZC\ZSF8(OO1
M%-GKUH UX6&X'-7%8-T.:Q%F*^PJU!=$L,<CVI :BPS??5L+5J&1@!N.6[UF
M"2:3H^T>E6X-R(-W/O01(O13E9CVK1602 '<*QE<;LY%689MK<=/6KC(YB^T
M>YJAFBZ\8J2.8-W%3,HD'-:F9G>7CD#-,\UE;D$5H&$)QVJ%X0S$T $=P=H%
M6(9"<55,93H*1965L8- C0)W&DJNDWJ<5)N#<AA6J()U^Z.:=SZTR,_*.:?^
M-,Q&,#NI-I]*DY]:.?6@"*C^&G/3%^]02R1,[13N?6DP?I2\^M9O<0<^M.5B
M!BF\^M'/K5H!3ECFDVXYZFG+TI:8 H+*"QRO]VJ]WI-GJ*%;B!1&.C8Y-6*4
MMN7;0+F.0U+P!;R;IM/F9"W19#C':N;NO"E_9LQF.]AU\L9%>G[=O&:5HXI$
MVNF3ZXK-[AS'CSQ^7*5<;&]&X-3K#M^:O1K_ ,*V6J!@ L<O]YN*Y;4/!\^G
M%R)/-5?[O-(#%5CNX&:OV:EF ((JEQ#RWR_[W%:%BWF8(Y^E9R-T]#>T^(+M
M':ME(^:R=/=<*-PS]?>M>-CT%1$F0V12KD5%)5AUW,2:@E7K3,RG,Q!-578'
MO5N901[U0D^5C041R/M%1K,0>.E)<,<' R*A20A14C+T<V3UYJPDQ4XK)$A5
MLBK4,K,H)&/K2 U([CGK5B.X]ZQO..\XY%3),=U!'*;'VCW%30W!(K%%P=^#
MTJU%/MXS5\QGR&TLVY1S3\YYK/ADW &K*R\=:U,6K%E.M3Q_?JFDG-6$DYH,
M9EP]:2FHVY0:=6JV,0HHHI@%%%%!FPJ1?NCFHZD7[HYH+0?C3&^]0WWC24$,
M*7!]*2I%^Z.:!#-I]*>N=M'XT9]Z %Y]:8P.ZG9]Z,^]!F]QFT^E&T^E/S[T
M9]Z! H.VEY]:<I^7K36Z]: #GUHY]:.?6D_&@D>O2EI%Z4M AK=>M*O2D;KU
MI5Z4 +1136Z]: '9HIG/K3EZ4&8M&T&BAL*F<C- ADA\OFLS4+S@X.:??WF%
M(S6+<7),=92D=$(E>XN"<U1DEI9I"2:K.P-8G5J(TGS&@9;G-1U(OW1S4ECU
MSCUI<$-R,4L?UI9.](@5?O5-@^E5XZM+]WK0 REP?2AOO4Y?N]: %7.VEY]:
M/QHY]: '+THW#UIGXT@^\: ):***#,%^]3BIST-"]:<TF&ZT"(^G6C-*S;A4
M>#09O<?FBF8-.#%1B@0M%)O-+G-!(N#Z4]<[:%^Z.:7GUH$&#3EZT+TI: )
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MSF0XYJ4@[>E*8/+<GO2/)Q7.;#1TIZ'FF*V5S0/O4"+.X]J-Q]*:OW13J #
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M$YR*MPS#CD5<96.:4"]MW>]'EU )B&J43;JUN8V$;*L0!Q3ESM]*!EJ7:?\
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M/S&K,\VY<YJBS!N]24(\Q7@<U+;W!&,\56IZ*WH?RI :*W9W5<M[W&,G%92
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MY*$ ]*YN\NS(S-W-<\Y&T(CI[K<#S6?++NS2/(6J+=[XK([EL-<YJ+\:E?\
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MH 5<[:7GUI/QHS[T&3#\:3S,=Z:Y]ZC_ !H G#;N]2*#M]:ABCZ$U97A0,T
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MFW.TJ6^7ZT&KU1U,C%UQCBJ<D?85+#>1,B@RH/\ @0J22/C*_,/:@XWN9%Y
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M'G8.W;%2+TKX.]]3VTK*PM-8'-.HH&>#_M->"UFT^U\2V\;&6W_=7.U<_*>
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M=S1M([4"(]I%&S/UI]/C3/- #%4@8Q2[,U/M%&T>M $/DGT/Y4]83MZ5,O3
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M$MY,8;/-:%M*6<&LGH:E@6,EQSNV@= :DBMI8#YDF2OTJQ&QV@CDU/\ -)"
MX*CWJ '6VH 8V\+Z5N6=QOA5LC_)K"C:"WC P&([BM"SD\R)65<*>GYU1$B_
MJ%G%J5G*D@RV/D->;26TNFW#P39W*>K<=>1^AKTZV(90&./K6%XR\._;+?[3
M "67EBHSG%!B<W;3#CFM6WC\X"N;@NB>2I3M@\=*W--NN%Y'YT^4U6QOVMH(
MXE]:?.NV/=3+>XWL!FKTT7FPA1S]*1FSE[[5)(9&502!Z52BUZ?=@HP'J0:Z
MFVT=/M!:6,D>A%6KSP[:W0/EJ(Z"><R]!UK[1.L189],UU,F%<C..G'X5Q4O
MAV72=062)MP)'*\UUR?-"KLP+D<\UJMC*>I9A^]5ENM4;=R#5T'=S6J.8***
M*8@HHHH,V%2+]T<U'4B_='-!:%Y]:C;[QJ3GUJ-OO&@8]?NCFF-]XT]?NCFF
M-]XT&8E%%% @J1?NCFHZD'^K%( _&FS2>7'FG'"1!B<5D:A?8W!3GZ&LG+4?
M)<@O[QF9A61/)U]:EDN-W).#5*:3YCBHD==.!#)(:8C9YH?FF+TZXK(U)F^[
M4?/TIRL,=:1Z"")OO4E%% !10OWJ5E.>E !@^E.5BHQ@TJYVTO/K09/<1I#M
M]Z%7<N:7;FC&.] @V]A1M/\ D4Y>M.;I0!%^-,;[U2;,\T>703J-C3/-2].*
M11M-./6@0E%%% !112X/I0 ]?NCFGKTIBYVT]>E #MF>:-I':GK]T<TO/K69
MF(N=M !W&EY]:<O6D(6BE;K24 -8'-*O6EIT:@FM5L9O<< <4Y>#S3O:EVYH
M$/7V-31IT)J.*.K2Q_**" VCUJ11\O!IFTCM3U!VT +@TX*-O)H7I3EC:1L;
M21]*O4SF)].:G@MRQSM/Y58M[+ID8JZL*QJ,&M8PZG+*972W]JG4;5QFEY^E
M,D/O6QD/W#^\*C:0;NH-,8_+459.6I/*.D8[B>U0M(<T22!>,BJ\DP]167-J
M6+++[U#YE12R9SBHUDXJ#11)Y)/EJ#SAZC\Z1I-W&:CV"D,D9PW0@FHRIV]*
M3;M;-/#;N^#0!"S%1CO2+DJ#3Y$W,30HVK0 W!I^T>6,GFBEVAEZ\T 5V4;B
M1R?:G!R!R"/K3BFWD=:C)9FY!H =YA/3FEY-/CC 44C#!ZT&3$Y]::#\QYIL
MC'H.::O2@"9F&>M)N']X5'364Y_^M0 YF&[K3#][@U&Y*L>*6/)YJP)=P"8)
MYJ%N6XYITH/)QQ42OVH($9B&(P:<O*TC9SZ4J]*!"L?EJ!OO&I7IJI\O- $0
M^]5A?NBF^6*</E6@S$8'-)SZT_(]:8W7K0 <^M'/K1SZT<^M!D'/K1SZT<^M
M'/K0 R3OS4/\1J9DRV:C92#[4$#LT;0:9SZTY>E:(!WETF,<5(OW1S2[<UF
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M-VE?;\*/QH,B38*8T?-"R8&,TN\T 1-'\W2HVC^:K5-9-QS0!6V[>]-9&+#
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M=ZT>9B@R>Y+148.[O3UZ4"%HHS10!(OW1S1(PA4,[!%;H6X!I%^[UKU[X)?
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M3@5GQR!N<BK:<J,&LS1&A R,V2RY^M7X\K@KR/:L#<8V)%/^US=FVCTH&=3
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MZU#(#SQ21@CM0!:SGG-)OQQ3-QHJ0%9SFF@_-S2TUNO6J('MRO%$?'7BFJQ
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MQ4-_L]*3=GO3&^]610_/O3&^]244#'K]WK4BGY>M04]?N]:!"7%I;7T,L-Q
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M=.CTZQMK&&X-O#G:2Q.<9))ZFC#YC#%3Y(*P2CH<]8>,+2_6-#MC<@?>(%;
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M]Y*AP%;'TH ZNWOM[#]P^/\ =-6U?S'^Z5'H:Y:WOIWF(#;1Z5MV<,TA#,^
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MQ_G%,5]-2\OW1S2\^M-13M%.P:U1@]PY]:.?6CGUHY]:8@Y]:<O2F\^M&#0
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MS-X@30_B=:12)N2_0VI;LH///Y"O)L^]='\.?$D/A'QMH^MW(E:VLIF,D<!
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MN<@CZBH"^Y<&K0QXD\R3D\5+YD*?*5!-55^4^U7(6CVC<F3ZU$@(O.3S"%(
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M42-43-EF(QQ3U?R5 %0>=CJ:$D\Q\9S4#+*K+==&PM78=-$: L<MZU7A_=@
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M&TOED]J<JD'D$5+D>M!!$D?-3>72+]ZI.:!#/+I,8XJ=5&.33FB39NW#/UH
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M1?NCFEY]::OW>N*=^-(R&C[QJ6HAG<:EI@%%%%! 444UNO6@!V:*9SZTY>E
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M93_'9$MCQ]?NCZ4M(OW1]*6OL2#[L_X)W?\ (F^+?^O^#_T U]>K]T5\A?\
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MYIC'YNM'/K4;?>-!D#?>I***!!NQ2;S2-UZTW\:R8$FZGJ?EZU!GWIZGY>M
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MJG&'=UT^%6'(X#EQ['.,^QKXHA5I+B.(?,\BMY:CKN/& /6OUB_9[\$K\/\
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MH/DW\S,[=OW8!'\Z^BZ^7?VWF LO"JD@,TLV!W/RK7FX&/\ M$33$?PSY9Y
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M-9^5#D_O&.58@=A@\]LU\\V]QTYKH?#FNS:3K%E>VDK6]W:R!TEC/(P02?P
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MT_\ 1:5[>3_QGZ$2V/.&CIC0[A4S'GKVH_&OL#E/K#]BI=GA3Q&/^GV/_P!
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M"CSKV9/ESV"^G&!^%>RQQB.,* 1R>ISWK/UW6[3PWI-SJ-_=1VMK;KNEDD(
M _&L[P+X\TKXB:#'J^CSM<6+LZ"1AM.58J01VZ9^A![U\Y.=6LW5F=L4HZ(Z
M05\F_P#!0C_D4/"'_83<_P#D.OK(9[U\V?ML:?#?^'?"_G+N5+YSC_@%:X/_
M 'B)G6^!GP)8Z+<ZB558I%4]&VG%=/IO@V&S53<E7D7D^M=%'#$D*+%&8R!C
MD8I/+;^([CZU]LY:GD**(80D2CRTV*.BTZ20MSBG^7374XX!J!D'6FL#FG[3
MZ4;3Z4"&A@.">:7 ;G--://-*ORK2 7I1110!(H.T4O/K3 Y48IPRW.:S>YF
MR:,_*/FIWXU7_&GABHQ2 ES[TR1AZBHV<[NE,8Y^M @<YZ5!(#Z5*.E-;GIS
M6B RKY,YK$NE(SQ717D?RG/!K&NH_E-7$F42C;2;>,UI0R'-9'*,2*O6LI9%
MSUJY$1-4S#9UJM)(6SCGZ4S=NX/%2*%4<$$U!J,2/<?F&WZUIV:PHB@KN/K6
M>K%FP0<5<M\H0!2 U4DD3_5)'M[;NM2>9*_)3G_9'%00MP,U?M_N"D!7\J:3
MN5'H:7R2G#')]:N=3QS2-!N&2.:#,R]0A#0\<U@1YBG*XQBNJN(<)C%8%[;A
M)&?O0#V'JV[O22+ZGFH+>0L1ZU/)G<<T'.0/'56:$\\&M#!]*:\9*YQ5Q$93
M1_+46,<9K7^RAE!JE<6IC)(4_E6O.1RE7GUI/QIS*=O0U&E%S,?SZTY>E-;K
MUHY]:!$J&IUDQ55>E2+]WK3E'0OF+L<GS=:N*=P!!K,C]ZO0R84<UB,F;(7F
MB-B,>E(7W-@]*7;CH>*DT)5<[JM1R8QDXJBK%34P.[O2)U-.&48'-65PW.:R
MH7V@ U9CF/;I0(NL@V]:S[Y=P*U;\W<M5+CN: .=O(!'(Q%53DJ*U[J'?EJS
M9%V.15G.XZD*@[?2EP:5NO6E7K6JV,ANT_Y%.7I3FZTE !4D<FVHZ* -&WFZ
M<U># \YK'MV(Q5])/E%8O<W6Q9\P#C-&^JX^]4H^M2,FC.:L+*5&*K1U-N'J
M*#)EN-MR YP:DAE*R8[52CD^; YJ96.[I0!O6LP.#D?G5Y6W#.:PK5CM%:4<
MPV@9Y]*")1,CQ9HHNH?M*C>_4[>>E<;OQP_RMTPW!KT[;]HC=&X&.,UQ/B'1
M&MSYJQL1GJ%.*LY6K&1TIROM&*:K>9T.3WQ1F@0_S"W%30PJ[?,<?6H(^M3J
MPW=:#5&UI:VEO(#(@D^G-=/;WEJ<-'%M7LN*XNW<+@YK4M+PC%',/E.L%UYG
MW1CVJQ"I90Q&*P[6\#,/F&?K6I'=[CC(Q]:TN8S@+K&F"_L3GG8.*X;RW5C&
M48;3CI7H<;]/G#(W\(-<WXJT9YI_-M&VC@D#OP*F4;BIRY68*KL;%./6E97'
M+*P/N*;FN:QUW'K]WK2_C4/F%6P>%]34BLN<A@1ZYI#'X-.7I0&#=#FG8/I0
M9,<J@KUYJ54&*B1&_NG\JEH .E*?NTY5!7J*1EYXY% ABJ<]*E&:%!VTN#09
MASZT<^M'/K1SZT"#GUIC [J><KU.*3KT.: !0=H[5+#"T[;=I8>PJ[8::\^W
M<C >I4UN6^EQVZC!&:TC$PG+E,BST$)()'Z'^$UO0PQ1Q+Y:[&]:9)\K'G%+
MO_=CO71&'+J<<ISF2[C_ !-DTK$;>M5?,ILDQ JI2)BF2,>>M032=<'-0R7'
MO5=[@XK*4]#;E)9)*KO)Q43S?+433#;U%<W,'(2-* O6H_,W=.:B9MU)&Q7M
M06B=I#MIJR';36<$=1FD5MW':@9*&W=Z3?CBH\;6Q3C09CO,-'F&F;L4!MW%
M B9&# <\T-G=3=GEKF@,6&<T &XBC=ZG%+SZU&V=Q[T 3*PQUI:B53Z&I-P]
M:#-[BT@8AO:FGD\&CGUH$2$[N:3<1VXJ/<13U;=P: $*[N:51@8IS#:N*:.E
M ",#FDP:?2;AZT ,Z=3BC:&[@TK;6'4?G3%X:@!_EBFA<,?2GMUZTF#02#=>
MM.7I3=I_R*0L5XP:T0B2EVYIBN=M'F8:H9FQ^W'%)2-)SUHW#U%(0M%,9CGC
MD4Y6.WI3 6GK]WK3,T9I&3W%;[U)110 ]?N]::WWJ,'THVGTH 2I%!V^E-4'
M/2GMUZUJB P:,&G+]VEH 9SZTY>E.\O/.*-I':@ P?2C:?2GJ#MI<&@R$4';
M3O++<XIRJ=O2I%!VU8$:Q\4JQ_-4F#3E4^E! WRZ<L8S4NT=SBE$>[IS0(3:
M/44NTCZ5)';LQX5C]!5R*S9L!E(^HK91T.><BFD98< G\*L1618 E2/PJ]';
M)%CD U*/8T1AJ8\Q7CM0H![U84':.U+SZT<^M:D!SZTGXTO/K4;?>-!B2?C1
MSZTU?N]:7/O0 O/K1SZTF?>E_&J .?6CGUHY]:.?6@ Y]:.?6CGUHY]: #GU
MI/QI>?6HV^\:DD5LY]:<N=M"_='-+SZT"&,#NI-I]*DY]:.?6@!%SMI>?6D_
M&E_&D9CEZ4M(O2EIB"BBB@ IK=>M.IK=>M "8-&#3EZ4M #.?6C!I6Z]:5>E
M9O<C4;@T<^M/IK=>M2+43GUHY]:3\:/QH#4FC/RCYJ=N_P!JJ_XT]>M:H@F_
M&CGUI/QHS[T"&-]XTY?N]::WWJ2B.YD?&FTBC!I]%,_KH9SZT<^M*W7K2<^M
M !SZT<^M'/K1SZT '/K1@T8-.7I01J-P:<O2EHH#4**** U"BBB@S"GPP@R)
MM+&0MD;ON@XQ_0_D:973?"W^S_\ A9'A<ZH(X].75K5KR61P%\GS4W[L] %#
MYS_>K.;M&4O(4MC]0?V>? \7P^^$^@Z7L5+IH1<W#*/O.Y+8/N 0/PKTE,A>
M3GD_SKAH?C1X!6%!'XRT54VC 6^BP!CIUIQ^-7@/'_(YZ/\ ^!L7^-?G\X5)
M2<N5Z^1R.]S,_:'\=+\/?A1XAU8,OG_9C#;ID;F=_ER!WP#G\*_*3D%MS MN
M8D^IR<FOKW]NSXQ:#XHTOP[X>T74X=9C$[75U)93JZJN,*A*GKGG%?'RD%5P
MS,,#EEP?RKZG*Z')0;:U;-8$GF8H\RF45[8Q_F4HRW.:%C^7FEVXXS0 Y>E2
M*?EZU!^-&XCW%422M]ZE1B#4'F4Y).:!&C;R8QDXK2MKQ1E5X;E=W^\,5B1L
M&P<U:A;#4&9^AG[''CG_ (27X9C29+E);K2)?+\@$%A"00O'INR:^A(UVQH
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MRC@<LJY('N:N,9U-D*ZCU.X8JF23@#O7(>/OBCH7PYL&N=3N!O+?);PD-(_
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MRK<TPVZGIUJ&%@P'-6HU![\UF=)+&I]*LP_*W/%,B7:*G5<MFH LQU<CE(4
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MC6;W 2G)3:D7[HYI 244B]*7-:(S8Y>M$GWC3:*8@IK YIU% "+TI:*:P.:
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M;X7#57CCSS4N2O I 6VNB!@<U7:Z+,5/%,W'T-,V[G)- $VX>M+3,8[TY>E
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M%E^;K5'S*>LG&*0C0-QA<9J/[3SU%5-YI5SNS@T 6EE);-3QR^]4MQI5D.:
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M#[U("['&)%!J*1"KD4L4Q7 [4K-N8F@""0&HL&K,AJ&@!F#3E4^E+4B_='-
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M-+DYS5=I.:8SG=TH M>9[TQI/FJMYAI1EN<T 2-)S2;S3>?6CGUH,WN68<L
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MIZ_=ZU&I^7K2TP),^]&?>HZ7!]*"23\:<O2HUZ=<4[\: 'YIK9S2<^M.7I0
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M_C2_C09$JR8&*7S*C7I2YH DSGG-,9CN/>DW&HVD.XU($RR'%+YE1J=R@TM
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M\Y-2[<\=JDVBF2'8N13 JZEJ4.EPY;&ZN4OO%T]RS+#E1VJ?Q=,749Z5S:*
M@(ZUE*1I&)/+?7LQ)EEW#TS4#?O.M+DMSTI>?6LS08N8U"CH*=R:7GUHY]:
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M-U-Y]:.?6J$.WFC>:;SZT<^M #]U(/O4WGUIR]*#)CCUIZ_='-,P?2GKG;0
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MZC\:8TR[C\P/XT$70M/7[O6J[3#=U'YTGG>] 71:9AMZBFK)M&*@#;N]+^-
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M2EI%Z5*J;E% $=%/:([NE-*E3C%2 8/I25(H.WTIC?>-4 E+@^E)4B_='-!
M+G;2\^M'/K1SZT&;#GUI/QI>?6FC[QJ2T31\=:N0MT*\GVJE4T$GEXQ2%'<U
M[5FX+ CZBM.%0WF'VKGY+YE\G_:-=):JGD'<P!([F@U.:F0?;G^O]*LMF(9Q
MBKJZ:)I&D(X'?%4+^0*6&1^=!!FZE,9F4#GZ4+]T<TQFW,33USMH,Y"\^M,8
M'=3^?6CGUH,2*GK]WK36^\:2@0K?>I*** )%^Z.:7!I%^Z.:>O2@!N#1@T^B
M@!F#3EZ4M%!(4Y7VC%-HH L1S$8%7+>Z\MLYK-3K4NXJU9O<#>CU'W_6IO[1
M]ZYY93NZ'%3QS&M%L!JRWDLC$*^!Z9J,EI/E/S'UJFLAW9J_8CS)!Q6;W K2
M:>9.=I)^E0MI\D(SY;8_W3786Z11H R9/KBGSV<=PN5P >U:*)DY:G#A6W<J
M?RJ9(^YXKHI-&5>0*HS6&TD8/Y5G8M-%..,'I5N&/I2PVNU0,59CA([<4AB)
M'5B-*58_E%2+'\M!F]P6/YLU+Y=(JG&!4B@XK5;'/,%08HQZ5(L>1[T](^:L
MQ&*#BI$C/4BI%C^:I.G% Y;#/+%)TX!J7R]W- B^;I6JV.8:B9-6%0;10D8I
MS=:U0"=****9D*?NU6N&Q'BK)^[52Z^[64I&D#D?%#;L"L-5V@#-;/B3[PK'
M.:YKG2'/K1SZT<^M'/K0 <^M'/K1SZT<^M !SZTQ@=U/Y]:.?6@D1<[:7GUH
MY]:.?6@08-.7I0O2EH,QK YI5Z4M%9O<04445HM@"G'GR\<X//YTVEC^_09L
M[;PXP:+@YXK:AZ5SGAB0*O)QZ5T<3>M5 PF6E^[UI<^]1T5UK8Q),^]&?>HZ
M*8$OXT<^M-7[O6ES[T&8O/K1@TF?]JGK]V@ 7I2TU@<TJ]*#(6FMUZTZFMUZ
MT"$Y]:.?6CGUHY]: '+TI:1>E+0 UNO6DY]:5NO6DY]: #GUHP:,&G+TH)!>
ME+110 449HS0 449HH,GN%-8'-.HH$,\O-.4;1BEHH **** "BBEP?2@R$HI
M=I]*2@ IZ_=ZTREP?2@"3\:3\:%SMIC?>- #\^]-;.?6FU(OW1S02,VGTHVG
MTJ3GUHY]:!"+G;3&^\:DY]:C;[QK)[@)4B_='-1U(OW1S0 O/K1SZT<^M'/K
M6B <O6G'K35Z4M,R"FLFXYIU% #-I%'/K3Z:W7K0 G/K1SZT<^M'/K6;W(U#
MGUHY]:.?6CGUJT!&WWC2;0:5OO&DI@+Y=/5<+BA?NCFEY]:#-[AMS1C'>CGU
MHY]:R>X@Y]:<O2F\^M.7I6B,SXT7[HYI>?6D7[HYI>?6F?UR'/K1SZT<^M'/
MK0 <^M'/K1SZT<^M!&HY>E+FF<^M'/K0&H_-,;KUHY]:.?6@-0Y]:.?6CGUH
MY]:#,<O2EI%Z4M @7[U68N!4"]:E\P>M %C</6FL>>M0^9[TQI/FH G\S%'F
M5!O/H:-Q]#0!/YE'FU!N]3BC/O09D_FT]9/EZU6_&G+TH$6-V>::[#UIJGY>
MM-;[U "4UNO6G4QNO6@ Y]:3\:7GUJ-OO&@D?GWI?QJ*I%^Z.:!#UZ4].M,7
MI3T-!F]R:FOTI&Z]:&(V]:!$5%%% !1110 @^]4\?:H!]ZIX^U!DRQ&:F!]Z
MK*#NZ5+0 ,PW'FH9&'/-+)WJ%ONT 1M]XTE%% !4BYVU$/O5*/K0 O/K1@T<
M^M.7I00-P:,&GT4 ,P:5>#S3J8W7K5&1,&'K2_C42]:D7[U #L&I8U/I1&H)
MJ?:>U #U4%0::ZX%21J-HS1)P*""LWW:@;KUJP_2J[=>M A.?6CGUHY]:.?6
M@!5ZU(KX:HN?6E4_-UH,RTL^TU:AN.!S6:QYJ2.3;@4 ;,-U\W45>5MZ@YKG
MXY?GZUIP7&% S09O<T0>.31YF.]4S<<]:8]P:9)>63+<<U;A[>M9%O<'BKL4
MYW5HB35A^\*NQL/6LV"7YN:MJVYLU$BBZOWJE'UJ"+M4X^M9 +SZTY>E-Y]:
M<O2K =@^E/7.VD7[O6ES[U)(O/K1SZT?C1SZT '/K3EZ4WGUHY]: '#[U2@^
M]0<^M.7I09$WXT<^M-7[O6G?C0(.?6G+TIO/K3EZ4 +36Z]:=36Z]: $Y]:4
MKN6DY]:<O2@"K+!FJS6W/0UI,NX5&T?RT!S&5+;U3F@&WK6U)#NX/%4[BV S
MCD5GR&BF8,UNHRV:JLFZM2]C6.+.<&N=NKXPNV.16?(:<Y<$)V]*1V6-<%@/
MJ:QWUJ3H 35>34)9LY5ORI<H^<V/M4:\>8O_ 'T*BEO$Z!U/XBLC<6Y/6FMU
MZU:@9\Y?:\^8@'/XTR34&7@54&%&<C-*,/SGFGRF?,3?;G9>AJ/[4Y[&DVXX
MQ24C(?Y['L:/,-,HH$2;SZ&D\QO0TJ_='-+SZT$@LS9Z&I?M'O47/K4;9W'O
M0+F+T=STYJRMP-H^8?G66H.WTIZL0,4^4OF-02*W.X?G2[A_>%97G$<8J6.X
M.T4@YC0VANXHV#U%4!=$-4\=P&Y)K,"SY=+Y)_NG\J;',/4?G5E9AM'S#\Z0
M$'ELO8C\*3!J228<\BH?,H =M/\ D4R3O4BR?+4<C@YY%! P=*6H\^]#287&
M: EL*W7K2;O]JHMYIK9)S09$^?\ :IC?>IJ]*6@@*0?>I:* %/6GK]T<U'4B
M_='- !^-&?>F-]XT8/I0!)^-'/K2+G;2\^M !SZT8-'/K3EZ4&8+TI:*:W7K
M0(&SFDP:<O2EH 1>E+110 4]?N]:910!)GWI?QJ*I%^Z.:#)B\^M'/K1SZT8
M- !SZT<^M'/K1@T .7K4\?:JZ\'FK$?:@"S&F[FFW$84EN]20TRZ4\G'%2:=
M"KGWQ3&^]244C%[A3U^[UIE%6(DS[T9]ZCHJ0),^](/O4RI%^Z.:0$E2Q*,
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MDW9[T9]Z %Y]:C;[QI^?>F-]Z@D,'TIZYVT+]T<TO/K0(.?6G+TIO/K1SZT
M.W4NZF<^M'/K09O<?12+TI:!!111F@!!]ZIX^U0U(OW1S09,M1]J>W2JT;[:
M>TO/6@!K\,:8W(XYHD8-WIB_=ZT -VGTI*DS[TQOO4 (OWJDYIJ=:D;KUH 3
MGUIR]*;SZT<^M! _-&:9SZT<^M  W7K1SZT<^M'/K09"KUJ12-W6HN?6G+UJ
M@+:$9ZU95AM'-9RL=W%3QL?2@C4NJPQUI'88ZU%UH8_+0(:Y&.M5FZ]:E>HN
M: #GUHY]:3\:,^] "\^M-&=QI<^]&?>@S%;KUIR]:;^-.7I0 Y6(D/I5N.<C
MZ53S3EDP,4 :'VBCSL]ZIK)Q4B-SS6JV,B[#)\U:$$GS5F0?>%:%O]X4Q&I
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M]*4TU@<U9RCMQI-]*N<5)'!NYQ6JV ="IDP,596((<=*2./R\4\MNYK5$ V
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M*6D7I2T"&MUZTG/K2MUZTG/K0 Y>E2+]WK4:]*6@R9+SZTGXTU7VC%(QW'-
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MW&I>M9L!T?6K"]:@4$'I4M( ER7)'2D7I3F^[4._#&@R>Y+3U^[UJ/S*-YH
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M44N#Z4 )4B_='-,VGTIZYVT&0@^\:EJ(9W&I/,QQF@0C9W4G/K0S9.<T?C0
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MXTN#2!3N/%24&3&8-.7I2T4 .3K4U0I4U!(4U@<TZB@0SGUHY]:5NO6DY]:
M#GUHY]:.?6CGUH .?6C!HY]:<O2@R&X-&#3Z* $7I2T44 %%%% !112X/I00
M)4B_='-,VGTIZ_='- #&^\:2E;[QI* "I%^Z.:CJ1?NCF@R9+#]ZK\)XJA#]
MZKL?:J"6QHVY''-:,)&!67; \<5HQ< 4&);S3EDP,5 &'K4B_=J0+,39JQFJ
MD9Z5./K0 \?>J4?6H5//6I@?>J)%Y]:<O2F9]Z/QH$29IC=>M)GWH_&@S9-'
M]T<U(A&>M0+TIZ5(BT#[T9]ZCS1F@"=3\O6EJ)?NCFI%Z4 +3U^[UIF:* )?
MQHY]::OW>M+^-!F/7I2TSGUIR]*!"U(OW1S4=/7[O6@!W/K1SZTF?>C/O0 O
M/K1SZT?C1SZT &W-))&-E+SZT-]VJ'+8S+JT$BG/%<QJVD#<[ 9^@]J[1HP_
M!JK<:>LBXH,H[GF4UN8&/RD?A5<MN.:[K4/#X;<0N?PKFK[1VMV8!&P/:L7N
M:&6?NTU>E/DC,8P01]:8O2D!*OW1S2\^M-4\=:=^-( Y]:.?6CGUHY]: '+T
MI:1>E+02%.3K28/I2J#GI0434UNO6G9IC=>M #EZ5(OW>M1KTI\8/I60 RG=
MTI-I]*E;.ZC:QZ9/X4$D3?=J/!J63Y<@]:8&'K0 W!IR]*-P]11O7^\/SK1&
M3W%HIOF)_>7\Z>JEAE1D>U,0E%.V-_=/Y4FUO[I_*L@$I<'THVM_=/Y4X?*O
M)Q]: &[3Z4;3Z4\'=T;-&X X+#-! *#MI>?6G)\W Y/M2^3(S8",3Z!: (65
MLYP2/I28<?PG\JOPZ/=S8(20*?\ 9-7H?#-P^,AA^!J.9BY3$5FQC!J9(F=0
M=I_*NE@\,%5 923ZXJW'H(7 VG\J.9ARHY1;8[>0<_2GI:C/-=>-!4\XJ:+1
MXD #1DGUQ1S,T3@<@MCELX)'TJ3[+MXP:ZUM'0L2JD#TQ43:*F<FL^9A>!S*
MI$HPR9;Z5((4V[EX]JWWT6/;D$9J'^R\=C^5&H71D*HVT]=H'WA^=:G]E_[)
M_*F-I//W3^5(S* : ?> )]:<#&1E2H'IFK+:2=WW3^5.72R!]T_E0!7!AQR
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M4&9+^-'/K35^[UIWXT$!SZT<^M'/K1SZT"'+TI:1>E(P.: '9IC=>M&#1@T
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MUJ4]:[4[JYY;T=@;[U)12X/I5"#!]*-I]*>N=M+SZUDP$7.VEY]:.?6CGUH
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M*** "I%^Z.:9@^E/7.V@R%Y]:.?6CGUHY]:"1R]*6D7I2T""C--;KUI.?6@
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MI ?3U^[UJ->E+0!)GWIC?>I**"1K=>M)@T-][K3?,QQFJ$+^-&?>HV;<<T4
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M:?2GKG;2\^M'/K2)#GUHY]:.?6CGUIB#GUHP:.?6G+TH,V-P:.?6GYIC=>M
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MM'/K09CEZ4N:9SZT<^M!8_-&:9SZT<^M!F/HI%Z4UNO6@!]%(O2EH ****"
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MTZT 2K]WKBGK]:B;K3E^[UH,B8TY?N]:C4_+UI:!$RL,=14J<J,&JE21R;:
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M68[<><<<BDM+/<P(&:V[+3CN!*D?A6BB1*1:TR#9$AQS_P#7K2.?I3(X?)
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MU(OW1S09"\^M'/K1SZT<^M4 <^M'/K1SZT<^M !SZTY>E-Y]:<O2I 6BBBJ
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MZ4@''K2444&844N#Z4;3Z5H9L2BBBF(*D7[HYJ.GK]WK60#6^\:<I^7K2/\
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M Y]:.?6CGUHY]:!!SZT<^M'/K1SZT&8<^M'/K1SZT<^M !SZT<^M'/K1SZT
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M 6BC-&:R>Y 4UNO6G9IC=>M:( Y]:.?6CGUHY]:8#EZ4M(O2EH,@HHI<'TH
M2BEVGTHVGTH >OW1S3UZ4Q0=M/7I0 M"_>HIR4$#P#3EZ4N:.M #6!S28-/H
MH 9@T8-/HH 1>E.P?2C!]*>N=M!F(@.>E2TU>M/- A**** "BBB@!K=>M)@T
MK YI5Z4&;W!>E2K]T<TS!]*>H.V@DECJ>H(^.M2'D\&@!]%(O2ES02/7[O6G
MH1GK4-.3K0!97[U65^Z.:JIUJROW>M $B]:E'UJ)>M2CZT&0]>E2K]T<U$O2
MI5^Z.:!"\^M#?=HY]:CD?'% $4WW35&0U9FD^6LZ5SS5&;'5(J;E%5%D.ZK$
M<E A)(?F/%-\GVJ<G/.:3/O0!6DBXZ5#M*U=?\ZKR=Z"2+!J2.FK]ZI%^]0!
M87[O6FR'WIN['TJ*63K0 R9ACK5%OO&I99.34/6L'N4%%+@^E.0'/2D ZWC)
MDSBNATV, +61:IE@:W;"/D5I$DUXU.T8J55R/>DC'R@"IXH^F:U.=WN+%%TX
MJPD?-(@VG%2K]ZD42*-JXI:*,U) 5(OW1S4=2+]T<T +SZT<^M)^-&?>@!>?
M6G+TIOXTY>E A:*** "GJ>.M,I!]ZB6P#VS]::*D'UIC?>-8C$HHHH :W7K3
M!]XT]NO6F#[QH,R6BBB@04444 /7[O6ES[U'160"M]ZDHHH **** "BBB@S8
M4]?N]:910(DS[TOXU%3U^[UH D7I3C]VH_QIR]*"!O-.7I2,#FE7I0 C=>M*
MO2D8'-*O2M8 +4B_='-1U(OW1S5/<SD,;[QIT<$<G,@W+364,QYR:FC4[1P:
MM& JVT4/,(VIV6GK)YA(/;K2JI*G';K[5DZYXD@TVUV)M:3NP-)^[J->]H3Z
MMK4&DP'>!(>V.<5Q&H^)+N^W#+",]/2J-Y>3ZE.\KR@1GHN?:H5;,84\5SRK
M<VAK&CRZCXF) +')]:>3S4:K@8!I>?6N=FXX,0WM4R257Y]:3<12&:*S#:.1
M^=2QMNYK,5CMZ5*EPRJ!S0',:T:@\YJS''NQCFL1;YE&*GAU0QJ.>: -Z.W+
M'!! ^E6DLT5=[$+CIFN=_MV2D_M"XN^-Q5*TYN57(Y>8U=0U8.IB3[P_BK*C
MA:3YG^9CUJ2.W/<[CZU>M[;IQ^E1)\VH6MH5X82K=*T(8N!3UM_FZ59CC"\4
M*)E*011]*F^[2A3T'-3PVI<#<"/J*WA RE/0J;2TAP"?I5N&U+@;E(^HJY'9
MI& <C-28V\5TQB<\ID4=N(NE6%SM%,J1?NCFJ,Q>?6CGUHY]:3\:#,8WWC24
MYLY]:;0(*D7[HYJ.I%^Z.: %Y]:.?6CGUHP: #GUHY]:,&C!H,WN.7I2TB]*
M6J$%%%% !1114DC6Z]:5>E(W7K2KTJA"T48/I2[3Z4 )11109!1110 @^]4H
M^M1#[U2CIUJ0%Y]:.?6CGUHY]:#(.?6CGUHY]:.?6J .?6CGUHY]:.?6@ Y]
M:<O2F\^M.7I4@+1115 -;KUI.?6E;KUI.?6@@.?6G+TIO/K3EZ4 +36Z]:=3
M6Z]: $Y]:<O2F\^M.7I0 M%%%!DPHHHH **** "BBB@"1?NCFEY]:1?NCFEY
M]:" Y]:.?6CGUHY]:!!SZT<^M'/K1SZT&8<^M'/K1SZT<^M !SZT<^M'/K1S
MZT .7I2TB]*6@ IK=>M.IK=>M!D)SZT<^M'/K1SZT"'+TI:1>E+02%%%% !1
M110 4444 2+]T<TO/K2+]T<TO/K0 <^M'/K1SZT<^M!DPY]:.?6CGUHY]:!!
MSZT<^M'/K1SZT '/K1SZT<^M'/K09L.?6G+TIO/K3EZ5(A&Z]:3GUI6Z]:3G
MUJ@#GUHY]:.?6CGUH .?6CGUHY]:.?6@!R]*6D7I2T$A1110(****#-A4B_=
M'-1T]?N]:!#6^\:2E;[U)0 5(OW1S4=2+]T<T +SZU&WWC4G/K4;?>-!&H]?
MNCFF-]XT]?NCFF-]XT"U$HHHH#4D7[HYIC?>-/7[HYIC?>- :B4444$!1110
M(D7[HYI>?6D7[HYH_&@!K [JK3@[CQ5O/O5>?[QH,WN?&=%%%8/<_KDD7[HY
MI>?6D7[HYI>?6M%L <^M'/K1SZT<^M, Y]:.?6CGUHY]: #GUIR]*;SZT<^M
M!&H_-%,Y]:<O2@-1:*** U"BBB@-0HHHH,PJ1?NCFHZ>OW>M AW/K4;?>-2?
MC4;?>- "IUJ1NO6HTI[=>M!D'/K1SZT<^M'/K0 <^M'/K1SZT<^M !SZT<^M
M'/K1SZT$ASZTY>E-Y]:<O2@0M%%% !11109O<****!!1110 4444&3"BBB@T
M6P4444&;"BBB@"1?NCFEY]:1?NCFEP:"0Y]:.?6CGUI/QH$+SZT<^M)GWI?Q
MH .?6CGUHY]:.?6@!R]*6D7I2T&05(OW1S4=2+]T<T +@T8-.7I2T (O2EHH
MH 0?>J4'WJ.B@@DS[TY6(-0T]?N]: )2V3FC-1Y]Z7\: 'T4B]*6@"1?NCFE
MY]::OW>M+^- "\^M.7I3?QHY]:#)CZ*1>E+0 N#Z4;3Z4]?NCFEY]: (J*<P
M.ZDVGTH >OW1S3UZ4Q<[:>O2@R>XM/7[O6F44")?QHY]:1?NCFEP:"1R]*>G
M6F+TI\8/I0!83K5A#S5=.M2C[U %A?O5* <5#'VJ7S,<4&1*N<5(N=H[5"LG
MRTYI/EH$+))M'6J<TY&?2G32?+6=<3$#%4!)--N7K51IAMQD9J"2X-5VD+'-
M!F6A)\U3QR5GK(<U822I$7O,HW#UJOYGO1YE4!9J*7J:19>.M122?,: '+UI
M68YJ/>?0TGF5($K2';4$DOO0\G%0-EFSB@!&.YLTE+M/I25DP)%^Z.:>O6HU
M/'6GIUH)+EK]ZMVQ8<<US\+[6K7L9>0>U;+8SD=!&Q["K<1]>#5&&8;1S5N/
MYL&F0BROWJD7[U11U,/K4C%;KUHY]:.?6CGUH('+TJ1?N]:C7I2T *WWJ2EP
M?2DH D7[HYIZ]*8OW1S2\^M!F/HI%Z4M @I!]ZEHH D'UIC?>-*G6ED!W'BL
MGN:(91112&-;KUI@^\:>W7K3!G<:#,EI3]VDI3]V@1$7VG%)YE(P.X\4VLC1
M$F[/>G*PQU%0T4$<I8R/6C-1+]WK2_C0(DS1FH\^]+^- #\T9J/\:7\: 'YH
MS3.?6CGUH,V/S13.?6G+TH$2+]WK4B]*C0'/2I:U6Q 4444&0444@^]0 [!]
M*?TC%'XTQFW,16JV$+$NYLU:R1P!FH8UVXJ56"I*Q( 4=33,^IGZQJ@TZWD.
M]0[#[I/->>7%TUY([R'Y<\*:T-<U0WU_.I/RJ1@YX/ K'_BKBG/F=CHA3Y=0
MW!N0NT>E+@^E#4Y3\O6L345<[:7GUH_&CGUH .?6CGUHY]:.?6@!R]*6D7I3
ML'TH)&,#FE1,FEJ:&/?C')]J!#XX RCUK0M;;$:@@_Y-1V\)5QD$?A6K#'\H
MH*$M[?I6C#".!4<,7S=*T8;<\$@_E6D8&$YD*PG=T-68[,MSM/Y5:C@%3KA5
M S73&!QRD55M0G/>IEX6G-]ZC!]*V,I:H2BBBJ,@J1?NCFHZD7[HYJ31"\^M
M1M]XU)SZU&WWC0,>OW1S36!W4Y?NCFEY]:HS(JD7[HYIK [J<N=M2(7GUIR]
M*;SZTY>E "T49HS09O<**,T9JA!1110 4445)(UNO6DY]:5NO6DY]:!$L?W1
MS3L^]1+TI: %;[U)115&04444 %/7[O6F45($F?>E_&HJD7[HYH,A>?6CGUH
MY]:.?6J .?6CGUHY]:3\: %Y]:<O2F_C3E/;/-2 M%%%4 UNO6DY]:5NO6DY
M]:" Y]:<O2F\^M.7I0 M-;KUIU-;KUH 3GUIR]*;SZTY>E "T444&3"BBB@
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MYKW/0(R#MZ4@4XZ5+SZT<^M(R>XBYVTO/K1@T]4RM #.?6C!J3RZ>D)ZX.*
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MH$2_C1SZTB_='-+SZT&8<^M'/K1SZT<^M !SZT<^M'/K1SZT .7I2TB]*6@
MIK=>M.IK=>M!D)SZT<^M'/K1SZT"'+TI:1>E+0 ;0:.E&:,T$A1110 4444
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M:,&G+TI:! JG;TJ1<[:%^Z.:7GUH,QR]*:W7K1SZT<^M !SZT<^M'/K1SZT
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M?EZU#SZTY>E $WXT8-(OW1S3UZ4 "]:E'3K4=2+]T<T"%Y]:.?6CGUHY]:"
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MR$Y]:.?6CGUHY]:!#EZ4UNO6CGUHP: #GUHY]:,&C!H)'+TI:1>E+0 4444
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M)::P.:;N/H:3S#09CN?6CGUI,YYS2_C0*X<^M'/K1@T8- 7'+TI:9SZTY>E
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MC0(**-Q]*-Q]* "EP?2DW'TIZGY>3B@SU&[3Z4E29]Z8WWJ!"4Y*;4B_='-
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MV_[\BCZG(/\ B*5'_H&?WGSYO7^\/SHWK_>'YU]!_8X?^?>V_P"_(H^QP_\
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M)]P]:-P]:@W'THW'TH^HON'^O5/_ )\O[R?</44;AZU!1N-9?49=P_UZI?\
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MY\O[SLL^]&?>N-\P_P#/:6CS#_SVEH^J2[A_K)#_ )\O[SLL^]&?>N-\P_\
M/:6CS#_SVEH^J2[A_K)#_GR_O.RS[TF]1U<"N.\P_P#/:6E^TSKPLC%>V[K1
M]4EW#_62'_/E_>=AYB_WU_.EW ]&!KCOM=Q_?I/.=N6ED#=]O2CZI+N1_K)3
M_P"?+^\[+/O2;U'5P*X[S#_SVEI?M,Z\+(Q7MNZT?5)=Q?ZR4_\ GR_O.QW
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
@ !1110 4444 %%%% !1110 4444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>consolidatedfinancialstate02.jpg
<TEXT>
begin 644 consolidatedfinancialstate02.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_X2-R17AI9@  34T *@    @ !@ +  (
M   F   (8@$2  ,    !  $   $Q  (    F   (B $R  (    4   (KH=I
M  0    !   (PNH<  <   @,    5@  $48<Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                     %=I;F1O=W,@4&AO=&\@161I=&]R(#$P+C N,3 P
M,3$N,38S.#0 5VEN9&]W<R!0:&]T;R!%9&ET;W(@,3 N,"XQ,# Q,2XQ-C,X
M-  R,#$Y.C W.C U(#$R.C(S.C0R   &D ,  @   !0  !$<D 0  @   !0
M !$PDI$  @    ,T,   DI(  @    ,T,   H $  P    $  0  ZAP !P
M" P   D0     !SJ    "
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M,C Q.3HP-SHP-2 Q,CHQ-SHT-@ R,#$Y.C W.C U(#$R.C$W.C0V      8!
M P #     0 &   !&@ %     0  $90!&P %     0  $9P!*  #     0 "
M   " 0 $     0  $:0" @ $     0  $<4         8     $   !@
M ?_8_]L 0P (!@8'!@4(!P<'"0D("@P4#0P+"PP9$A,/%!T:'QX=&AP<("0N
M)R B+",<'"@W*2PP,30T-!\G.3TX,CPN,S0R_]L 0P$)"0D,"PP8#0T8,B$<
M(3(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R_\  $0@ B@$  P$A  (1 0,1 ?_$ !\   $% 0$! 0$!
M   ! @,$!08'" D*"__$ +40  (! P,"! ,%!00$   !?0$" P $$042(3%!
M!A-180<B<10R@9&A""-"L<$54M'P)#-B<H()"A87&!D:)28G*"DJ-#4V-S@Y
M.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@X2%AH>(B8J2DY25
MEI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KAXN/D
MY>;GZ.GJ\?+S]/7V]_CY^O_$ !\!  ,! 0$! 0$! 0$        ! @,$!08'
M" D*"__$ +41  (! @0$ P0'!00$  $"=P ! @,1! 4A,08205$'87$3(C*!
M"!1"D:&QP0DC,U+P%6)RT0H6)#3A)?$7&!D:)B<H*2HU-C<X.3I#1$5&1TA)
M2E-455976%E:8V1E9F=H:6IS='5V=WAY>H*#A(6&AXB)BI*3E)66EYB9FJ*C
MI*6FIZBIJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN+CY.7FY^CIZO+S
M]/7V]_CY^O_:  P# 0 "$0,1 #\ CMY 5 /)J:0;EQTKV#9F>UNI8\<U.(_W
M++ZB@RD8AZTZF0Q13@<&@@T+2X*-@GBM&6-+J J>_0^AJ43(PI(VBD*.,$4V
MJ,&**=00PIU,S)5J>-:EBL:EL,)5R+[GXTD9S)12XIF#(;S_ (\Y?]TUS@Z4
MT0Q\?,BCW%;]U+LC"+UQ29%M3/ [FD;I4H4B%CS30I)XJS&1T%A;?9X.1\[<
MFJ]^NZ7\J2,F85GD)5SJ*#[AE5HR),BI(P<\TS.1AS+MF=?1C3:"&.%.%!#'
MJ<&K]O<LO?-2Q%B:-+Y/EPLH'!]:RGC>)RCJ0P[&FC&2&BG4S)A3J9F3(,FK
MD2'<,U# T4&U<5<C&$%",ICQ2U1BR&[_ ./27_=-<V.E",V7["W!/GR#Y5^Z
M/4U<?+MN-3)B2(7XJ+&:2)8A7FKFG6WF2^8P^5>GUJC&1L8-4;H9E/X4&)SU
MFP:($5<&:#[E@<"D&">E,R92O;$2.73ACU]ZRWC>-L.I%!#&@XIXYH()!4B$
M@^U)DFA!D$,.M6IK9+R+#<..C5*9$T8DD;PR,CC# TE68,*=3,RQ .:TH@,B
MLWN'0MJ,D"KG IHQD**7FJ,F177_ !ZR_P"Z:YZWA,\JH.!W/H*2,V;1 "A$
M&%48 J-R5ZU'4'H5V;-.09%,ABE/:M:TC\JW4=SR::,9EFJLB9E8G 'J:HQ.
M1TTD(<UHAJ1]PQ<$FG#"]33,V*Q!J"2W$H.X<'M2(9G3V!3F++#T[U5Z4S-D
MBG/UJ5!DXJ6!?MW"$!NGK5GSECD4 Y!J29#[BVCO(NH#C[K5B2Q/#(4D4@BK
M1SR&4X51D:%M$&7-7HX@"*R&]BY$OS@U/5HPD.P*6F8LBN3_ *-+W^4UF6L7
MD1X/WVZ^WM4L26I:!XIKC(J12*YCP<BI4Y[4S-EB"'S)1GH.36ETJD8SW*T]
MXL0PO)K-EG>4_,W'I2,[&%;,$3%6TG7ZTS[9CVE8CY>*6,,/F8Y-,S9-YB^G
M-*&8]100Q"%STJA>6F[]Y'][N/6@S9GD$'!X(J6.7GYOSI,F]F74(<4W!##V
MJ 9:MW=#PWX&KK+%=1[94_\ K4TS*:,^?274YA8,OH>M5&@EB/[R-E^HJS N
MVG+8!&:T8OO8-0$BVHYJ3M5G/(6EH,F5[F<1KM!^8U2'K42945H.#4[J:1$A
MP7BGQPDG@4&3T+R(L*=>>]5;B[SE4-4]##=W*+<\GFHVH1,C)2 $"K*1@=J9
M]JQ^,')I Y)ZTR&2JZCM4ZNIH,V*=O4D4T[7X'/TH,V59[-9F"[2#_>%9LMO
M) ^'4CT/8T&;)8).-O<58ZC.,U#W&GH$<R _,&'TJY;R#/R2!AW!'-*QFW<O
M(<KE>?:G_*PP<<]C5IF,B![6%'655V'/..E0RLZ38Z5+)1=MI&88;\ZM=JI;
M&$MPIDTRPQECU["AF=KF49#)(6/.:D!XJ"V.49J55YH,I%B.(L:G+I GO5(P
MEKH4I;AI#[5 :1+V(V-1DU2,I&;'>0]""*L+<1[&<9(49IGVK*R7\<C$.-H[
M&K"X894@CU%!#'*,<FG[B>E!FQZ(.K'-64 QP,"@S8\@$4TJK+L=0RGL109L
MGA\(2W.DW.IVLF!"W$1'WAWP?RJ/1/#&J:YEK6'$(.#+(<+G^M8RJ)7;Z#C%
MF;J6GMIVHSVCNLC0N49EZ$TV/ ;<#M8#BJ3NKD-69(EXRDD'!/:K*W)GA;:,
M2+S]:9G)(@COI=V&P0.H-7/-3<$=<JW*Y[4&3+5N1DA3D58[52V,);B,P1"S
M'@5DSS-.^3T["E)BBNI&.*F7FH!DH&>!5J&//)X%-&,WH2R3!%VK5)W9SSS3
M;,K$9(II/%!#&&F;3TJD92,F&PED7) 7ZU7G\V F)E*@_K3/MF6;;0=3N],E
MU&"T=[2+<7D'08&3^54HI7B.48BI4D]C-EZ+4 >)E_X$*N(R2#<C U1FR[%8
MW4MG)>!";:)@C-Z$]J U)-,S9;L[.XOI&CMHS(ZH7('8#J:K-TXHNKV,V=WX
M&N(;S3)M/<C>K'<N>2I[UTVH7<.CZ/,+-%W0Q'RXD7.#VX%>?53]I8VC\-SP
MV9I+B:21V)D=BS9[FJZN5;:W!%=R6ASR>I8\II!E!S20RE'P<JP-!F]RQ/ L
MH\Z _./O+ZTL$B2Q;&.&'W2>QH,F7K25"VW)#]"IJ]VJD8RW*%W/N/EJ>!UJ
MH%J&]0MH."U*BD\ 4B67$B"#+G%#S'&$&!5;&#U(2<\DTPGT-(ED=&WF@S8\
M1$U9CLCC<PP*I:F,G8YH:JQX" 5+'*ETH24;B3P".]4?:R.]!71-7T/21&WV
M6. Q7( ."TWWL_3(-<E9^%0^OZEIURSHMK%*ZLO?:,BN:,N5-HSN4?#>DQ:S
MJ$UO,[HL=M),"O7*C(K2M=%TFVT#3]8U"_N(A.9!Y,"9=RK$<'H!@<YJY3:=
MD2RS T#^&M2OX9KE;:*[2..)SU4CJP'!-;&HZ5HNCWGE7-Q<SL5#"*)0"H([
MD_TI<\KV1#2)UT*.WU^:U@NYTB-F;A&4X;&/NFLFQ73&M\W,%]++DY\G&W%"
MFVKHAI$FH6D&BC3]8L+FXMTN-ZD3+EE(QP1W!S4B?$:XA#1)8V\I'1TRH;\*
MGD]JKL7-RZ(YO4-4EU&^>ZEBBCD<\K&N!_\ KJI=)]V0=^.E:Q5M#*3N@BG9
M4 !QBI)#YR;P/G7J1WI[&;U0L4Q'1B#4L@WJ9U7'.' _G09ON7+';(P<@&0<
M9[XJQ=7'EC8I^8]?:B^ADU=E,#/-+BH&R>.!FY/RKZFIP5C&$'/K3V,9.XTD
MGJ:8:1FQA6D\L]JHACA&35B*T9AD\"FC*3L78H40=,GWJ0\J1ZU2.>3N>: D
M&MOPN+>;Q%9B]GBAMHW\R1Y&"C"C..>YQBE._*['W+-:Y\>ZW)J$TL=Z5@:0
ME$\M>%SP.E=/%?Z==ZS;Z@;ZV234=/:*3=(!LEVX^;TSQ6$J?*O=,F9VAZ98
M:'?S2WFIV0GEMI8UCAE##E>[=!TX'>L_4K>WG\(:+:Q7"-)"\Q90P++EB1D=
MJI7E.]B'L+:6T2^!=0LOM$8FDNXW5"1N( ]*9XVF<^(WN;2598?*C!:-@RY"
M\]*:3Y_O_0AO0Z==9TY_$V?MMOM.E; XE7:7Q]W.>OM3;5Y9O#-E#IFI064T
M3/\ :0\HC9LG@Y[C%96TU783,[Q/B_T'2X6U);R>&63S7SSSC'7G'O7-K;")
M<!,"M*=U&QG*URM,JQ2*XZ'@U*V)8,$C(YQ5DLJ-$R'<!Q5F"50.1P>M-F1"
MP\N4XZ9XJY!,NTHWW6&#29#[! 6MKD*3\O8CG(J=HRTA8.ISR,GFAF8]86SC
MC\ZE7RHNX=OT%(B3%,I>DS2,V@HQF@ACU0GM4Z6Q/7BJ2N8R=BRD2)VR:?5[
M'.W<7&* 109L\WVC=C-/,6WJ13/N62NO[L#%/ACS$3W%,S8J(Y'M6[;:C%;6
MT4$MLKJ%PSXY)WY_]!XH:N9,LO?Z9&4VV\C?*,EO7GT/TJ47>E2(RB&3>QXR
M 0.OO]*CED2VB=7TQ"K1VS+C'&T<],YY^M*L^G[E,D<A &&  Y/KUJ6I$NQ#
M>7%JX4PHRMD[LC Q5%Y5QP:.A+11G,<@()P:BMYUC#*Z;\T(B1;0(R\]^U5I
M8?);(.5-),S9*D1N(C@ $'CWJ$ HY4CD&F0S26.0(L@*MM_"HKM9)'#A,*!U
M'-!DR!0WJ2:FA!(J6265S4@0GM09R)-@4C<P&>F:L);CO5I&,I$RHJ]!3JLP
M84H%!FQU)09L\USDYIRG)Y-!]TR1GRN-V:!(VW&>*#-CUD81GFI!=R>7L[4S
M)DIN!M7*U925792AQ3N9LTT;BG$!A4D%*<R19W?=]:IFXY^]6=AMJPPL'[T8
M IF;)!+CI2F5F&#2,VQ4=U/RG%+N);)/4T&;)Y)&"[%;Y2*2.:2/[K$>U(AE
MA=LV-@"OW]#5F&W(Z]:+7(;L6UA"C)%9CW<K' .T>U-Z&-[C8LFX0L2?F&36
M\*<693'459BP%.H,V%(<D]:1FSS8 8YHIGW3%IV.*#-AGC%.H,V.+$@5/:8,
MHS3,V;*/\M3JW%(R8YU62,JPR"*Y^1&CD*,",&DR0 IP%(ECT4EAP3]!5EX0
M44JK;NX(J62 !V$>601WIF*1#)!@CIBGI&6;"@FD0R_!9<9:KR($'%7%&$WT
M'=C6&1\Q^M*1FB2+_7(?<5N"G BH.HJS!BYI<\TFS-A3J#-GF?:EIGW3%%+0
M9L*=F@S8X<U8APC9H,V7HI<CK5R-^*#)DN_"U#,L<P42#"DXSW%,AEB*TMXP
M-L8/N>:F$48_Y9K^522V/ 4= !]!2X%!FQK1J>U02VT9C8D 8&<U#1-RJBQF
M%B6&[''-30KA%_>; Q.3BDA2-*)%2-0"2/4U)6J1S2#;D50;3I,G:ZFI<;D)
MV&K93+(IP" >QK4I131$W<*<*I&+%SCK2<=:1FQPI<\'FA,AGFE+5'W+'"EH
M,V+Q2X%!FQZ]*>O6@AD\3<U>C.1UH,F)-+R%S4<TY:W"YYS3Z&;-6V8M"N[K
MCFIQ29 G.:<#4$L45FW-TTORJ"J?SI-Z$6NR)58?PU?MHC(/WB_*O04EJQ2T
M1H  # I:U.9CA2TS)AWIU!#%H H,V+@4;:5C-AL/7-!4X-3RLS9YH.E.JC[I
MCA2T&;"G9H,V/%2*?:@ADB]:L),$Z\F@S9&969SQ0%8NN1T[4&;-N$_(O:IQ
M09L0G%(KY.!6;)9+V.!FL@B6:4D_>].E.6Q"-*VMB%!DY/:K@  P.*<58RF[
ML=15&+%S3J#-AWIU,ABTHH,F+2T&;%[44$,X;^PKC_GI'^M+_8=Q_P ](_UJ
M_9,]G_6*AV%_L2X_YZ1_F:/[$N/^>D?YFCV3(?$%'L+_ &)<?WX_UH_L6?\
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M1[-D_6HE"BMCSPHH ** "B@ HH ** "B@ HH ** "B@ HH ** "B@ HH **
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M%!04%!04%/_  !$(!3D)L ,!(@ "$0$#$0'_Q  ?   !!0$! 0$! 0
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MD!:*7!]*-I]*#)[CU^Z.:7GUI%SMI<&@ P:<O2A>E+0 5(OW1S3,'TIZYVT
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M1TZ5W5I;F.%5((Q6#W+>Q/%$ N[O3SG-)DKP*.30<;O<7GUHY]:.?6CGUK1
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MJ;</6@"4=.M2QMMXJ%?N]:D7K6<BBU')5A)*H*V&JPLGRBL!\QHPR<U>6XP
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MYNM04 *K8.*D/S<YJ$?>J4=.M9,D7!HP:<O2EK1;"$7I2,FXYI^#Z4]8\K3
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ME2K]T<U'C'%2+]T<T (7*\4@D^:A@=U+&G-9O<">,YYJ?!]*@7Y35E.5&#2
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M#GUHY]:.?6CGUH,V'/K1SZT<^M'/K0 Y>E+2+TI: "BBB@@*>OW>M,IR=:R
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MY]:.?6CGUH,PY]:.?6CGUHY]:!!SZT<^M'/K1SZT@$_&EY]::,[C3FZ]:S8
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MZ'FI0?FJN/O5*N<4 6 ?>E_&H5Z5*OW1S09O<>O2EI%Z4M @IZ_=ZTRG)UH
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M-%L'/K1SZT<^M'/K09L.?6CGUHY]:.?6@!R]*6D7I2T %%%%! 4444 %%%%
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MY?J1(_%4U!Q0 O/K1SZT<^M'/K0:+8.?6CGUHY]:.?6@S8<^M'/K1SZT<^M
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M>?6D7[HYI>?6F]R Y]:.?6CGUHY]:10<^M'/K1SZT<^M!(<^M'/K1SZT<^M
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M36J;G%0X-6+,'S!03(UHU(C J1>E"?=%+72HZ',%%%+@^E4 E-8'-/VGTI*
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M#ZTV2A*63G.*!$+?=JM,H*]:M-]W'>H'3(H RYAM)%0_C5R>/YC4#1_+6;W
MIW$<5QE'3/OBL'5-!6,-+%&Q!Z8&:Z7RZ8T9[G*?W:D#SV2&2-B&5E^HI@5F
MZ<_A7::EIT5VIV+M)[UR]]I,MGNP_2M5L!47(;:W'UI[8!XZ5'']T;VRW?FG
M_2F 4444$!1110 4444 %%%%!D%%%% !1110 4444 %%%%! 5(OW1S4=2+]T
M<T /7I2TSGUIR]* %J1?NCFHZ>O3K0 [GUHY]:,&CGUH .?6CGUHY]:.?6@
MY]:,&CGUIR]* !>E+110 4444 2+]T<TO/K35^[UIWXUF]Q!SZT<^M'/K1SZ
MU)F'/K1@T<^M.7I0 W!HP:?10 B]*6EP?2DH -QHW'THHH,WN20_>!J_'RHP
M:HQGI5J&3:U9EHL*"IYJ=6VJ"*B8[ES1$V>.U(U18CDWGGBK"-M.!R*K[3T
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M,AGD^8U!RW.:?+R:8N=M8/<U0O/K3&3+9I_/K1SZT@(]I':C:?2I.?6CGUH
M@<'TJ+RZLL#NI-F:#)E?:1VIC=>M7#'\M0214 09]Z59-K=:7R3Z4>3[58"M
M)SUI/-'J*C92K'BHVZ]: )FE^;K3"VXU'SZTJ\'F@@?@^E)2LWRX'-1<^N*
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MM'/K1@T .7I2.1CK2<^M,<'%$M@*]V?W-><^,6'V@\^G\J]#O/\ 5UYQXO\
M^/H_4?RK&G\1F]S ;K24II*[1$B_='-+SZTB_='-+SZT$!SZT<^M'/K1SZT
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M\<5&OWJL+]WK6)8^.I5!W=*C7K5A?NB@T0NX]A4L;'@'BF+QUXIY.3P:!D_
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MYI?QI@/WFI%.5'-,5,K3E&&Q60#^?6G+UI&!S2KTH E'3K2\^M(OW1S2\^M
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MUHY]:.?6@ Y]:3\:/QIC?>J21_XTOXU%N-/7)44"&M]XT8/I2L#NI5X7DXH
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M<U'4B_='- A>?6F,#NI_/K1SZT&;W(]I]*>N=M+SZT<^M @Y]:.?6C!HY]:
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M:K4:9H$/C!]*N1*.*KH-IQ5B,T 6$XJ8 XJJK$-5A9/E% #\&C!IRG*@TM9
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M P.ZDP:E8'=3:S>XM1%Z4^/K4; YH5BK5:&6J9)'YBXIOF&CS#3 S;JQVL6
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MTBYVTO/K3,@Y]:C;.ZI.?6HF?#'F@ J-F(:E>2H?,H <[<5%GWILLG6JTDQ
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M1SZT<^M !SZT<^M&#1SZT$ASZTY>E-Y]:<O2@0M%%% !1136!S09#LT9J/\
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M;\#-:>/3D5S2W.I.X_'H:>O2F+G;2\^M2,F4\=:7<1[U$F<U851M&:D!8W(
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M YI5Z4M4 B]*6BEV9YH 8V<TGEYI^,<5(J;E!H,B)1M&*E7[HYI?+IZQ_+0
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M>#09O<?FBF8-.#%1B@0M%)O-+G-!(N#Z4]<[:%^Z.:7GUH$&#3EZT+TI: )
M?>HI,[CS2T4&0B]*D7[O6F44 29]Z7\:CP?2GJ#MH 7!IZJ=O2D7I4J_='-!
MD]Q%Z=<4[\:8P.ZE7IUQ3 =LSS1MQQFF^9BE!W=ZH@>O2G8/I35ZU*.G6@!F
MT^E/7.VEP:,&@ V9YIRC:,4JJ=O2EVGTH,A*D7[HYH6/*U(L?% N815!'7FG
MH,'%.2/YNE68[<MC@_E6JV,)S&QQ^8V*OPP[% [4R.WV ''-6%^[3.:4B1>%
M S3OQJ*I%^Z.:T1D+SZT<^M)^-,D? ]:8 S#<>:B:3!]JC:0EC3))#0,D9LC
MK5>1ASR*BDF*\5!)+D9K)[FB)FE 7&14$DP]15668\X&:@\P]^#6)IRD\TG7
MFJSRY[TR:3Y>M5UDXZT&@]CDDU#)WI7D]Z@9SN/% Q&?:<4PY8YQ4FW=R:3[
MO&<4 ,VGTI"Q6I,_[5(R;AGK09,A9LG.:5?K2>73UC^6@0I4'FD]A2MPN*:O
M!YH)%;[M-63#4LG-1*#GI0!:&6&<TCKGOS0I^7K36;YCWH :HVM3CUI-U&:#
M(:W7K43?>-2,?FZU&W6M4(2FOTI&Z]:&/R]:#-C%ZT2?>--HH$.7K3FD^;BH
MZ>J@KUI@-8[CFDI6X:DK1$A36Z]:=36Z]:9B)SZT<^M'/K1SZT '/K3&!W4_
MGUHY]: //(8^!5E(^:9#]T587[U9/<_JL7RZ/+]JD -.7I6BV%J5VA.>E)Y)
M]*M4N#Z4PU*ZQ<=*>D?/2I=I]*50<]*R 5(^:EZ<4@^]3B#Z4C-BI3VZ]:1<
M[:7!K5;"#!HP:<O2G8/I4/<!8\T]NO6D4';2X-( Y]:.?6C!HP:T1FPY]:.?
M6CGUHY]:8AC [J;4O/K4;?>- "44N#Z4;3Z4$A@^E2Q]J8O3K4BJ?2@1*/K3
MUZ4P9I>?6@!6Y%0T\R;>,U#)(=QH &Z]<5&Q^;K0QR*CYH ?12+TI: 'K]WK
M3OQJ*GK]WK09O<D7K4BJ"U1KUJ1?O4")54[NG%3)3%/RCFE_&@"P#[TY6&.H
MJ!?NTM!DRQD>M&XU$OW>M'F8H L*WR\G%+^-5\YYS3E? Q0!-GWIZGY>M09S
MS3U^[UH()<T]?NCFH/QIRO@8H F_&C/O4>XT4 2_C1SZTU?N]:=SZT '/K1S
MZT<^M'/K09!SZT8-'/K3EZ4 -P:,&GT4 ,Y]:.?6E;KUI.?6@@.?6CGUHY]:
M.?6@ Y]:.?6CGUHY]: #GUHY]:.?6CGUH .?6CGUHY]:.?6@R8Q@=U-J7GUI
MC*=W3- #::W2G[3Z&C:?2@"OM/H:7RB><'\JGVGTIR_=ZXH J/"<=#47DM_=
M/Y5>;[U)63 H^41U!'X4GEU==0146T4&3W*K(<]\?2D\YT& "1]*L28'>JTC
MXK1")DNR%&>*9=6]KJ4)CGCW/V;TJKYH]1^=-^U!7(W#\Z8SG=4\'36[-)$Q
MF7LJ<G]*Y^:&:U<B:)X3_P!-%*_SKT^UF$F!D?G4E_HUIJD9210)/[Q[T"/*
M]Q;E1D>HI%.[IS6WKFAR:)<281C%QCY3Z"LCC;O4;<]J"1FT^AI*DW;N2<4Q
MOO>M "5(OW1S4=2+]T<T +SZT<^M'/K1SZT&0Y>E+2+TI:!!1110 ;C36)$B
M-@]:=2G[M '2V$AN(UV_-@<[>:64?O#@YK,T&^,$QCS@-Q6S/"8\G!]>E<\S
MKID(X'-2*H*]14&[/).*3S,<9K-%LL[ >A!I=I7CI5:.8AZL;]W.:8A<&F,I
MW=*E7[M-=ATSS09D(^]4\:CJ3BH1]ZI ?>I-%L2,P#8R*8S#/WA4;?>HV9YI
M&;W'Y_VJ%SNSUJ/VIPDVC%,1/&P#\G%7%D7RQ\R_G64TO/6FM<^6O!Y^M!)H
MR1J[DY%026_S'BJ*Z@<\U-_:!H%<LI:GT_2K<%GN;I5*.\+(#4T>H&/FD,UH
M]/SV/Y5))IN!T/Y5G0ZQ(#WQ5^W\0(S;''/K5F3W(3I/F'E3CZ4UM/\ L_"*
M2#Z"MV'5+9U"_+^=3K##=<AE /;-/E,G+4Y:33&#%E< >F:HW=O*K$>9^M=M
M)I:9('-9]UHRL23UI"YSCUA8*-WS'UI=NWD=:WY-+VY 4D?2JTNG&,9VD?A0
M:7,J-R[;&! ]ZM)B'@&G_9#C=@_E32@'7CZU(R5;F0MPK$>PJ]:SNN&<\?W3
MUK'D613E'POUJ:WG?:-QRW>@#HEO$8<1,?H*G1MZAMI7V(K$M[QEP.:TH+II
M,"D8/<N*S)R 3^%6(;IMV&X^M5U<JHIK.2:OF,Y1-<,DBC# GV-#0X7/>LN.
M9HVSBKD5X9#S6J,B54R,GK3)(?X@,U/2G[M!F9^UNX/Y4JDKVJQ)WJ)ONT"'
MI,!W%6DD#*#N%9WEY[4OF^7\OI0'*:6X?WA2_C5*&7(!JTC;E'-:K8S:'[<T
M;=O(ZT?C1SZTR!,EN>E+SZT<^M'/K0(3\:/QI=N:-NWD=: '+TI:B\PT]9#M
MH =11R>:*#)[C6!S2KTI:* $'WJ<\SQKCRHY$/KUI*4_=H S]0T.QU)2#$L<
MIY '?Z5RMYX:N[&1Y;99)8_[L:EL?E6MJVJ2:;K4#,<0GUZ5OZ;>+=*Y7A7K
M)FEN57.'T^:1) &1E;NI&#7103-P2"![BK]UHL)4F,9<_P 0K/\ )EM_W;*Q
M"_Q8X]:R"]R:2X^8G/%,:8,O6HY%/E\ U3:1D)&/TI#)YB-N<\UG2,6D((P*
MG:0LN:@;YA06,D V8'-4I-RL>#^56BQ7J,5#(V[)H 2+FIVDVKBJJL5:IN&0
M'/-2 JS$<X./6I?/[@Y-5U8'Y<\5*D?Y4A$T<Q<YQS5B-BK\@BH57;S4H;=S
MG%!)I6\PVCD5;C8'G-8T+X;K6A#)P*OF,Y&E'4H^]5>W8%1S5@?>K2YS2+<6
M?+%2KTIEO]T5(W6MEL<X4444Q!11109L*D7[HYJ.I%^Z.:"T-8'=3:EY]:C;
M[QH(#!]*>N=M"_='-+SZT"(V^\:2E;[QI* "BBB@S8444@^]0(E7.VC\:!TZ
MTQOO&@!^?>D!^8\TRB@DL9'K1FHU^Z.:7GUH$*V<TJ]*%Z4M !36!S3J* &8
M-.7I2T@^]2 6JE]<"-#\PS]:FN9O+!YK U*Z+%O6LY2%3CJ5KJZW$G-9TUQQ
M3+B8\U4:0[?>L3T5'0627/UJ+.::V2:5>E "T]?N]:9FC-203(1GK3SUJ"/K
M4U(!R]:EW#UJ'!]*50<]* )J*,T4 /7[O6ES[U'10 YLY]:%!STIR_='-+SZ
MT&8_-&:9SZT<^M A^:8W7K1SZT<^M !SZTY>E-Y]:5>M!F]QU-8'-/-)0(9S
MZTY<X]:0J2>/Y4^/C@]:"1ZJ=M+SZT_--;.:!"KTI:1>E.P?2@ P?2C:?2GK
MG;2\^M!D144K?>-(OWJ )%!VBGKTI$I[4 )4B@[14=31_=%!D]Q,&F,IW=#4
MU%6!!M/H:EBCX!(Q3JD7[HYH(%\L4;3VHP:<O2@!54[>E+M/I3U^Z.:7GUH,
MA%SMI<&D_&GIG=0+FL*H.*FB4\<'\JEAAW >M7(K?@9K6!A.9%!#N()XJ\L0
M50<\TBQA3UIS=:V,1****"0IZG"\G%1[L5%)(3G'-!F]Q\T@YP0:@\[/':D;
M[M5V8ANE*XB>214&01^=5)+C--FD^6J#3$,:S<]3=1T+$DW')P:J3W6 0#FF
M2R$YJL[;JR*Y2077J0#44DY+$CI4#?>-(SX7%(L=)(6S3%;BF\GFD_&@8XY)
MXIO3J<4W?AJ'.6)H =N/;FFL<_6G+]T<TQF&X\T -'2I5^Z.:9@^E/4$*.U!
MDQC?>-.7IUQ0JAFSFGL@S0(A/^L/-*WW:5H_FIOW>*"050?K2[128[]Z,D\F
M@!=OI3&SGTJ53\O6HY?SH 9GWHS[TS:?2DK5&3%8_-UI"?EIK9S3?QH$+^-,
M>G_C4;?>-!FQ!THS2G[M1_C0(?1N-(O2EK5;$A1130^&IB'X/I3&SGTIS.<T
MUCN%!D)^-'/K2+G;2\^M "?C1GWIC?>-)0!Q*=:L)UJ! ?2IT/-9/<_JLFIZ
MJ"O7FF4Y.M:+86H_RZ>J#%%% :B^71Y=/7[HYI<&LP(]I':GKG;2X-&#2,V&
M#3EZ4+TIV#Z5JMA!@^E/4';0H.VGKTI@"]*6EP?2C:?2@!*7!]*-I]*>N=M!
MD,V9H\NI,&C!H C\NF-'\U3\^M1M]XT 1[2*,&GTN#Z4$C43)J;;CBF*#GI3
MVZ]:!"?C3)'Q0W7UJ"5CS0 UI#N-)YE-Y/-,8'=0,EW9YIK=>M-7A>3BES_M
M4"'KTI:13\O6EH 7!]*50<]*5?N]:=^-!F]Q]&XTBYVTM ARR'%2+(=M0T]6
M&WKB@"=9#MI?,-5_,QWS3UD^6@S)?,-'F&H_,H\R@1.LGRT[<:K>93UD^6@"
MPLAQ2^95?S*/,-!);63Y:7S*I^8:>LGRT"+BR?+2^9599/EI?,H M))S4^[/
M>J"2'-3>8: +/XT?C4*R?+2[R>E!D3?C3EZ5&OW>N*7\: ),T9J/\:7!H 5L
MYI,&G+TI:"!G/K1SZTK YI,&@ P:,&GKG%% #,&C!I]'- #,&CGUI^1ZTQCS
MUH,F&#3EZ5&9-O&:3SAZT 34QNO7%0M<?-U%,:;<.M %C/\ M4QF^8]Z@67M
MFG [N] #]YIK.=W2C!IZIE: ()&..E1LQV]*M/'Q5:0;>*#)[E:20XJG-<;2
M1FK4Y^4UF7##<>:R>X@,A8YZU'R9#Q3(Y/FP.:G569LX/Y4C5%NQ?:P%;MNH
M?D\8Z5BV4)+ X/Y5MPC:H%:K8S#4M,36K&1&7$BCC(ZUY1=6K6<TD)Y*'FO9
M(9-L<A[C@>]<EXB\%-?-)/ ^UNI [\4R#S_^&FKTK0N-)N;?*O;3)M_O(15%
ME,9P1CZT )4BYVTUD(3..>]$3;HP<T"'\^M'/K1SZT<^M!F.7I2TB]*6@044
M44 %%%%!FPCD,-PC#UKKHKG[9;JP.[CM7'-][K6SH=X(\Q,P7TR<5G(VIRLR
MY)@.<<BHVSFI95*Y&,5&IXK Z[@O6I/,V\5 TF&(H!W=Z#,N1S?*.:-P9\YJ
MLK$<5(F>N*!$QZTE+@^E&T^E "4,QVXI=I]*>L>Y>E2!$F2>E$H(ZC%3&/9S
MCFF-^\X/6J I,QSQTJ-FR*MRP[!Z"J3J=QQR*"9;#?QI0VT8I-I_R*C9B&(K
M5;'*]RW',54"G?:#5-9#MI?,J.4M2+JW1 Q3#>%9"1UJKYE/C7=R>*LCF-"W
MU1U;D$"MBUUTQJ/F_6N:9MK8'-3PGY1GBLQ'96NOF7&6&?K6K%JD3J%8!CZU
MYY]J,,AQ5A=:>/I1S$\IWN(YFW*<9[9IS:>LR<UQ-OXDD5N>*U[7Q)YF,NH_
M$4@-&XTL)E0,XJA+I);G:<?2M2WUN!@%8JQ]<BK1FCN/NLH![9H%=G*R:?MX
MVG\J;'9A>O%=-)9!N1S56XL0BY[T%<YBM'M;Y>?I4]K(ZL 5(_"K'V<*N\\4
M)L^]N7/UJ1EA9BS8/%6D0,HQ56.YC3[R9]ZF2ZC9OE90/3-(DM+ "HIRQ^6>
M*9',,_>'YU9CVMSD?G6\#GF*C'TJ;.:5HP$#9YIB>M48@R\Y-1M&,U890R]:
MBQCO0!%]WBHFA#,34[1[CFDVE>U $(PGR[JEC?&*A:/=(3BK$:C:.12 LHV5
M!S2_C5;?MX!IT<G-',9%CGUHP:0'=WIZ]*UN0-P:3\:DIK1[CF@!-F[FC:13
ME&T8I:8"!BHQ2YS36!S2KTH,GN+1110 4N#Z4E/4\=: .3\=:3+<6L=Q&<E>
M2!VJ+P?JC?90KN,KD$Y]S75W]L+JTD0G/%<':P_V?<7,(&,,,#\ :RF;Q?,K
M'>V\Q90#Q4DMN)"3VK*@O Q7YAG [^U:<-QN4+FI1C)<C*5U;^7D 9%9=U#M
M4GO72-&'XK.U*RVQD@$_A2E&XXS.8:8JQ4\"CS/RIMU\LA!X/O4:L%4*YV_[
MW%8['4G<=*VY>N355BR]B!4\JE1E1D>U0;FD7!!S5F;W$5MW0\U-$I; -,CB
M"\]ZGCYJ0$\G$QQR*L;2.*3;@9[TY6R.>#2(%7I2TTJ2>/Y4JJ=W2@!T9(?I
MQ5Z&3@54'UJ:/- &I;R=*OQMG%8L4VUL9K1@EW $<U9SS-BW(VCFG-]X\U!;
M9\L9%3MG=73'9'$Q5Z4M(O2ES5""BBB@S85(OW1S4=2+]T<T%H7GUJ-OO&I.
M?6HV^\:!CU^Z.:/QH7[HYIC?>-!FP;[U)110(*7!]*2I%^Z.: &;3Z4;3Z5)
MSZT<^M!F]Q%SMIC?>-2<^M,8'=0(;12[3Z4G\5!)(N=M+SZT@Z=:7GUH$'/K
M3EZ4WGUHY]: 'T4U>M/- "9J&:3R\FI),*N[-8^HWQ7<!TK*8H[C;Z^SGFL.
MZN"Q)ITUT64DFL^:;<.O-8G9")'+-DFH<YIK9+9I5Z5)J(P.:3GUH9CNXI.3
M5$"\^M'/K1SZT8- $D?O4RL-W6H%4XZ4Y0<]*D"T/K2_C46XT%SMI 29]Z<K
M#'45 N2.E.VGTH GR/6BHU!VT]>E $J_='-+SZTB_='-+SZT&8<^M'/K1SZT
M<^M9"#GUHY]:.?6CGUK5;&;W#GUHP:.?6G+TH$"]*6BB@!Z_=ZT*H+9S3*=&
M#Z4$DVT>M+M]*,'TIR].N*!#=I]*>N=M&?>E_&@ Y]:.?6CGUHY]:#(8P.ZI
M(EZ9XI.?6G+UH <R\\4-]VGCZTU@=U,!B_>JPOW14<:<U-M/I09/<2EP?2C:
M?2GJ#MJB!FT^E/4';2X-.7I0 +TI:*>@/I09"JIVU+Y?[L$TE/3+ #&10+F&
M1QY/%6X;<Y!Q3[>WZ<5=6/:<5JMC"<PBMPJ@]ZEHI=F>:U1SB44NTCM2;MM,
M IC'YNM(\G'6J[2?,: )9'Q4/F4I;*BJ[/AC2N!+))Q5*:X"D\_K3IIAMZC\
MZS+B7YCS7,]S3E)IKGY>M5?.SSFH9)?>H?,I%D\LG6H=V><TQW.WI4/F4#+.
MT'G(IC*-W6H//[4OF&@![#YN#43,0Q%/W9[TQE!;.: &J<M4RQ[N:B'#5*DF
MV@!64JN,5"L9+9Q5EF#+UIJ]: &[2.*3DG:>E2,>:8W7K09,0+M8XZ4K?>ZT
MA<K4;.2:!$F?>FLNXYZTVGK]WK02,QMH9AMZBG/^=1>7NYH 3<>W2CDTNTCB
MDZ=36J /QILE*"-QYI).]!DQ@Z4C)N.:3GZ4Y3\O6@0W;CC-,8'=3V^]UHY]
M:")$;?=J/!J5Z8*#(%Z4M&:,UJM@&MUZTP9W&G-UZT<^M, ;KUHY]:.?6CGU
MH,@Y]:3\:/QIC?>H &^]2444$''*,#%21IDTJQ_-4Z(,UD]S^KANT^E.0'/2
MGLISQ2KUK1;"U'8/I1M/I3QFEY]:S 10=M/7I0O2EP?2@ HJ14^7FE\N@S9%
M4B_='-+Y=/6/Y:T0A%Z4[!]*-I':GKG;3 %SMI>?6CGUHP: #GUHY]:,&C!H
M,AR]*6D7I2T -;KUJ-@=U2-UZTG/K0!%4B_='-+MS2?=XS02+SZU'(?>B1\5
M$6!7K0 -)\M0224\GY:9M!YH :K?+UQ2Y]Z:R_-P*3:?2@H5OSIHHW$<8HH)
M)%^Z.:>O2F+]T<TO/K0(?3U^[UJ->E+09O<F63 QFG9W<U7IROM&*!$U,;KU
MI-V>]&?>@!"Y7BGK(=M-V@\Y%+CT- #MYHWFF\^M'/K09#MYIZR';47/K3EZ
M4 2>93UDXJ&G)0!-11FC!]*""1?NCFG+UIJYVTN#0!,OWJEJ"/CK3VD^;B@"
M2G(Q!J#S*<DG-!D6O,I=QJN7)IRR'% $N\T]9.*AW9[T?C0!:5@5!S2[AZU3
M,VTXS2?:#006FDPU)YE4VN#NI/M!H T%D^6F-,5:LYKHJQIC7AQUH OM<_-U
M%#7F%QFLO[337N.* +K7WS'G]:C:^^;K^M9S2$M[T<MVH,F7FO>>M N2U55C
MW*..:GBA/'% %A&+*#GFG8-+%'TJ?RZ (43)JQ'%[4L<?-3J-HQ0 WRZ-N.,
MT^FMUZT 1R54F/)JV]598RV>*#)[E"X[U0DMFDR=I/X5L_9-W)%2QV8]*S>X
MC&M=/+,"5(/TK3CL O6KZVH7D4K1\T@(([<1CBI=Q]*7:1VI*T1)+&QP.*F\
MTMQ55)#NV]JF4C=UI@$UG!=+MD7)]:Y[6O!,5XKM 0K=L5TP/O3DZT >/WFC
MW.DR,DBNY'48-5L>@*#T(KV34=.CU*W\J8*T?H%Y_.N&USP,;(/-9J_D]5C^
M\1Z_KF@R.4_&C!H:-X1^\5HSZ,,4#<W*@L/4"@0Y>E+2*WR@FFGGD'B@!]%(
MO2EH ****#-D9_UAI^XQRQN.>:8?]8:DH+1TL;?:K=7'S$CG'-5]I%5M'OO+
M+1,=H[9.,U>=2,\&N66YT+8K-]XTJ4_:#]:>J#;2&"@[LXXJ=?NBHUP%ZT!C
MN]: +*YVTO/K35/RCFE_&@!>?6E5BIIN[_:IZGY>M2 YN>:8R_Q#FCS 6VY'
MYT\\+@4 59F+C!JJR[>,X%763YLU"T/F,1C(JB9%5NGK5=DRV:NO"!PO(]JK
MNI5CVK1'*]R#&VBG/3!TIB)(TSS4N*A63:,4><:8%E%&<GBE9]K8%0K(64&G
M;J0"LW<TW?Z<BFDEFQVIZQX%!)&TQ#$4^.X90#2-&,TC<**!<Q=M]4:/!K3M
M=?9<9.*YY?NCFG!]O&:"^8[BSUTR,!N!_&MR*\CFB7<FX^M><6-T(B#D#\:Z
M73=6#%5WK^=9LCEOJ;\]NDR<?+[5G2V(CR%Y^E:$<@D4$'.:&CRU(#G[JWN#
MG;N"^F*J+!<J<Y;\JZ.X4X.!54)Z\&I J6MQ-&H#*Q/KBM:UNB5!)P:J^7FI
M8X]N,\541RV->.?S% !S4RC"U0A;8H(.:L1S%S@UJ<TMBQ2^7NYIZ("HH)*\
M8K5'*]QFPCL?RIK*?2I6D.WWIJGGFF!6*E>HQ4;,0?:K\D:OSD57>$XX&:S>
MYHBN,MS3E8JW-#JT:\*?RJ 2,S$,"![BI&7HY?>I?.'J/SJHN-HP<TC9SZ4&
M?*7/.'K4BR?**S&FV=^*:M\JMC<OYT!RFOG-%58+D28.X$_6K.X'O00+111M
M%:K8Q8QNO6G+TIVP4F,4 %(/O4M%,!S<*,<[NM<AXKMUL+GSE/W\?R%=;\WH
M:Q?&5K]JTE-J'>N<G'O6<HW*IR:9@V>I?O!\P_.NBL;K<%;/XUY_I);S KG+
M UV-BVW:G85@=$H\VIT4<S,<@$CVJ>3]]&%;CZU0MYMF!D5:\W=6JV.5Z&5J
M&BK('D4;B/2N;N(MV=_RLO9N#7=ECM QPW6LG6-"W*TD:E\_W1FIE&Y49G(I
M<,T87%*IY]*)86MY"&4K_O#%,FRJ[NU9;&Q*>M2QL1CBJMO)O4$FK"D[N!Q2
M L;CZ&A<ELXH3+*/6K$49XR* %7.VGQIDYI_DGT/Y5+%$>.#00-6#+9J3RL5
M.L?RCBK$< *CUIF3D4!%\W2K]EQ@4[[.*6W3;.1CBJ,Y,V8/NBG-]X\T1_ZL
M4[:#72MD<;&8-&#3^E%4(1>E+1109L*D7[HYJ.I%^Z.:"T+SZU&WWC4G/K4;
M?>- QZ_='-,;[QIZ_='-,;[QH,V)2X/I25(OW1S0(9M/I3USMI>?6CGUH .?
M6CGUHY]:.?6@S8<^M'/K1SZT<^M @Y]:8P.ZG\^M'/K0 BYVTO/K1SZT<^M!
M(<^M'/K1SZT<^M @P:&8JM.'W>:J7EQY:G!K)[C*]]>&-2OI6#<77F$@G%3W
MMYYF3GFL6>0LQ-9R.J$1;B3J <_2J#,=QX-222&H^3S61J)N]3BC/O3&^\:2
MK E_&CGUI%^Z.:7GUH(#GUIR]:;@TY>E2!*N<4O/K358A>E+R:0#UZ4[!]*:
MO2I5^Z.: &J#GI3VZ]:,&CGUH <O2ES3-K?Y%&T_Y% $RGY>M.Y]:A7I3U?:
M,4 /Y]:.?6D&6YS2\^M9F0<^M'/K1SZT<^M:+8S8<^M.7I3>?6G+UH$+2X/I
M0>M.7[O6@!E2Q=J-H;G-.4;3022_C3&/S=:#UIC YH$.IZ_=ZTQ<XI=I]* )
M/QHY]:1<[:7GUH,@P:<JGTH7I4JYVT  S1^-+SZT;,\U8"IUJ8 XJ)5([<58
M7[HH,F-P:<O2G8/I1M/I00&#Z4]4^7FA0<4NT_Y%!D'EBGA=HQ3HEZ9/-3K#
MN;!Z4&?,111>9]*O0VX50.E/M[8+CTJPT8!K5;&<I#50(H(YIPRW-&,=Z<O2
MM4<X+TJ1?N]<4RF22=A3 DDDQQFJ[R5'(Q]*BWFJ E9LK59GPQI7DJO)(:PE
M(J(^2<BJ\EQ[TR23WJI+)UK$VY22:7<M4)F.34K2?+5663K0:"$Y6HBQ'&#2
M>92C+<YH,QZMN&#Q4<D8W'%+^-&?>@",1_-4OET?C3EZ4 1,IW<"DVGTJ?--
M;.: (MI]*>L>5IX4;>32\=N:!#-N.,TY>E(V<^E*K#'6@8C=>M)SZTK=>M-_
M&@R8UP?K314F?]JF,?FZT"$HHV@T=*"0I/,VTUC\W6F-GZUJM@%:;YCS36;<
M*:J?-SQ3FP&ZT -7K3FI*4_=H,F,;I35SMI?QHY]:!#1G<:<W7K1SZTQZ")"
M,?FZU&W7K1@T<^M!D'/K1SZT<^M'/K6JV .?6CGUHY]:.?6F9!SZT<^M'/K2
M?C0 QOO&DI6^]24 %&:-H-&T>M!!S21U*L?S44Y*R>Y_5HC#:V*=&N>:>R;C
MFG+'\M:+8-1?+H\NGJN%Q2X-,-2/RZ>JX7%+@T8-!F&#3EZ4JJ=O2EVGTH$&
M#Z4]<[:%SMI>?6@ Y]:.?6CGUHP: #!IR]*%Z4M "X/I1M/I3U^Z.:7GUH,B
M/:?2DJ7GUIC [J (V!S2<^M/IC?>ZT '/K4;?>-/S[TQOO4 ,>H:F;KUJ)OO
M&@!C=>M)^-*W2FJ#M]* %Y]:.?6CGUHY]: &,#NIM2X-,93NZ4$BK]WK3OQJ
M*GK]WK0(=SZTY>E-_&G+TH,WN+1110(**** $\S;Q4BME0<U$R;CFE4;1B@S
M)OQHY]::OW>M._&@08-&#3EZ4M "+TJ5?NCFHZ>O3KB@!V#4L?W1S3%Z4[!]
M*""3\:<O2F+G;2\^M #Z*16(&*7=0 4FZFMUZTGXT&1,LAVTOF57+E:3SO>@
M"SYE)]H]ZK/)\M0^90!9DN/F--^T>]5F<YI* )VN#FD^T&H/,V\4QI#NXH()
M9)S3%D..>M)R?:G1Q[N: %ZT8/I5B.#-2BW^:@"M'#NY(JQ';].*L+"-HJ:.
M/&/2@R9#';BK$=O4BQ_-4N,=Z (UAPWM4GETY>E+0 BC::<:2DW4 +3&^]UI
M^<T*FYLT ,\O-+]GW<XJ?RZ<HVC%!D]R%;<;:/+V\5/36Z]:!$)^6F'D\&IG
M3<*AVE:"0Y]:C;[QI_XTQOO>M "#[U/4'=TIF[%.1CZ4 35+%VJ'>:<LAH M
M@'%#%54!U+@]0!35D^4<T[=GG-!D8NM>%;75@Y1!&>V>.U<1J?A"[TO=(@=X
MS_=4FO4OQILD:2+B5=Z_2@1XA(?+D,;_ "'T;BG;"OTKTW6_"-GJBNT,?ER=
MCBN$U+PK>:7EI-WE]B0<&@#.7[M+40<[MH^]Z=Z=M;N"#[B@!]%(O2FMUZT&
M;!NO6G+TIO/K3EZ4" .4F0@=#721R?:(58'=QVYKG*UM%F^]&3@=JB4;G1 F
MSF0XYJ4@[>E*8/+<GO2/)Q7.;#1TIZ'FF*V5S0/O4"+.X]J-Q]*:OW13J #
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M$YR*MPS#CD5<96.:4"]MW>]'EU )B&J43;JUN8V$;*L0!Q3ESM]*!EJ7:?\
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M/S&K,\VY<YJBS!N]24(\Q7@<U+;W!&,\56IZ*WH?RI :*W9W5<M[W&,G%92
M^E2[CTH)E$W%OLC@\?6IH;H'OS]:YE_.W$AMJT1:@T+;&;)'O2CN)TU8Z]+H
M;L;A^=6%D+#(YKE8;XLVXU>BU;:=H;./>NB,K,QE1-S<=W2G')YS6?;WC3,,
MBK^>.N*V.1Q:T%VYJ)X<L<#-2\]<\4H8 <FH>XBG+F,8Q@54>96RI8?G5ZZP
MQ()XK$O!Y4S$=/7\*RD$0GD"2L-PQ]:K22%?G X]:AGEW+O!S5=KP^2%J$='
M*6QJ.T=1^=2+J(V@A@3[&L*20FDCF*\8ICY3IX-2^4-D9^M7(=4R 2P'XUR:
MW94^U2_;O>@CD.R748I$ 8!CZU4N)4WDH0!Z9KFDU)U.%!(]JN1ZL@0;T^;O
M1S"Y#04W$C9!(3MZ5=M9ECP&D4OWYYKGI+^69B(FVIV6IK60QX,C8?ODT<XY
M0T.MAF,F/2IFC#\9K%L;[>0 <CV-:JR?-6BGS:''-<FIFZOHTLBO+"2Q[JO)
M%8%LSQ_*_P!\=<UW,+8W@\!JPM6TH0JTR#<3SQS2E#E5RZ=3FT*]O<;<<XJ[
M'>^C#\ZYR.Y8R%6!!]ZMB4JV*B,C64;['2V]QYF!FK&XJWM6%97!XK7CD\Q1
MS6D9:G-*!89@R\'-5;C3TO$VE=K_ -XU85=I]J5IB&P.:V;YU8YK\AS]UHK6
MN0H+D=U&:I)&T;9*D'T(KK]OG*,U0O-.&XL!FL)4S6%0Q,LS<@XIXPK>U69+
M<HN""/PJ#RZR-[HFBDQCFK,3 MUJDB$=CCZ59AX;GBJ(D:2GY13X_OU#'RHP
M:EA^]6D#FD7U^Z*6D3[HI:W,0HHHH ****#![A4B_='-1U(OW1S06A>?6HV^
M\:DY]:C;[QH&)12X/I24&;"BBB@0444N#Z4 )12[3Z4;3Z4&;W'J#M%+SZTL
M?W10P.:!"<^M'/K1SZT<^M !SZT<^M'/K0WW:1(GOFLK5+P*S*&!Q[^U2W]W
MY*$ ]*YN\NS(S-W-<\Y&T(CI[K<#S6?++NS2/(6J+=[XK([EL-<YJ+\:E?\
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MH 5<[:7GUI/QHS[T&3#\:3S,=Z:Y]ZC_ !H G#;N]2*#M]:ABCZ$U97A0,T
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MFW.TJ6^7ZT&KU1U,C%UQCBJ<D?85+#>1,B@RH/\ @0J22/C*_,/:@XWN9%Y
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M'G8.W;%2+TKX.]]3VTK*PM-8'-.HH&>#_M->"UFT^U\2V\;&6W_=7.U<_*>
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M=S1M([4"(]I%&S/UI]/C3/- #%4@8Q2[,U/M%&T>M $/DGT/Y4]83MZ5,O3
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M$MY,8;/-:%M*6<&LGH:E@6,EQSNV@= :DBMI8#YDF2OTJQ&QV@CDU/\ -)"
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M'/K0 R3OS4/\1J9DRV:C92#[4$#LT;0:9SZTY>E:(!WETF,<5(OW1S2[<UF
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M-VE?;\*/QH,B38*8T?-"R8&,TN\T 1-'\W2HVC^:K5-9-QS0!6V[>]-9&+#
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M=ZT>9B@R>Y+148.[O3UZ4"%HHS10!(OW1S1(PA4,[!%;H6X!I%^[UKU[X)?
MB3XE))JE[.UCI43&,2PL"\K#J,'H1_A7-6JQPZYJFP0A*;L>1[6_R*,'FOK#
M_AC?P^<G^V]2.23^\6)V_,K69XA_9 LK72;B;1]5O;C4XUS!%+M1#Z@X %<*
MS+#N2CS;FCP\SYA'S<@Y%'XU)<6DMC<36TR[)H7:-UW!L,"0>?K4#?>->M=/
M5;&+5M ;[U)113 >OW>N*:WWO6C!V]*04&0U@<TG/K3Z:W7K0(CDJ)ONU*X/
MUJ-ONX[T 5V!S3"Y7BIF^[4# [CQ0 [=GO2;E8D8PR_Q>M,I=I]* /I[]D?Q
ML]Q8ZGX:N9%,\4@N[4%N2O\ &JCOW/%?1.0<E6#*3D$'(QVK\]O _BB\\&^)
M;+5;23RWBE7<N>63.6'XCBOOW1]<M?$FF6NI614V]T@D0*0<>HX[@Y!]Q7R>
M8T?9U.==3U<-4YH\I=P?2EV[GB7U/-*C!EX-6=.A$]R<GE:\9O6YVFS#$(8U
M1>@J4=*%Z4M8C"BDS1N'K0 M%)F@L%Y)P* #..O%-9@,DG %1S2+&ID9UV#I
MS6#J6L2W"[849%[G'6KC%R8"ZYX@2-6AMV60]"R'(KF<N_+<L:L31JS%E'?!
M'O7F_P 6_B]8_"K2Q-E9M<E.RWMF8< CJ17;3I<TE"".><['G?[37Q:%G8CP
MGHUU%*9T+:F5890=D!]2,''O7RPOR8(4J,<+G) [5=U;5KO6M4N[^];S+JXE
M:1V'(Y/ _ 8%4PP89!S7U>'H>QCRGG3GS:#_ +0S<&D;DYJ-NO6G_P %:VMH
M9AFGJH914/XT^%CN]: +"0GT-2^72K)\HI=P]: &^73)K?<OO4J_>IS=:DR>
MYES0%5Q@_E5%XL,<BMZ:/<N:SYK?DYJHF<C-,(9JAFAVDC!K1\C;S4$R]2>*
MU,)7L4HUV]J>Q^;K2L,'KQ43?>K5;&!/"^UO:K:R!OXA6>OW>M.5\-4/<TYC
M3A/S=:NK,54 <BLJ*3I5E;C QFL;,T4C21MR@YIWEYY-48[CIS5F&?S#C.:1
MH2^6*18QNJ8Q_(*8BG/ R*D!K?*V,T,QV^HJ5HP3DG!INT9VYXI$E<?/P:<+
M56Z<U95XHCM*9([U918Y%#J0"?X>] BHMJ$4'O5>>/YC6PL(*\\&FRV(=<T&
M1S5Q'UXK/9<,1747&GGR_NG'TK#NK?R68XQ6ZEH83*6T^E/7.V@,&[TO/K6R
MV,1RL0,5)#,0U0\^M21_6LWN:+8OQS5.K$MP,UG"3#59CGVX%9\HR\DAS5N*
M3@5GQR!N<BK:<J,&LS1&A R,V2RY^M7X\K@KR/:L#<8V)%/^US=FVCTH&=3
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MZU#(#SQ21@CM0!:SGG-)OQQ3-QHJ0%9SFF@_-S2TUNO6J('MRO%$?'7BFJQ
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MQ4-_L]*3=GO3&^]610_/O3&^]244#'K]WK4BGY>M04]?N]:!"7%I;7T,L-Q
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M=.CTZQMK&&X-O#G:2Q.<9))ZFC#YC#%3Y(*P2CH<]8>,+2_6-#MC<@?>(%;
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M]Y*AP%;'TH ZNWOM[#]P^/\ =-6U?S'^Z5'H:Y:WOIWF(#;1Z5MV<,TA#,^
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MQ_G%,5]-2\OW1S2\^M-13M%.P:U1@]PY]:.?6CGUHY]:8@Y]:<O2F\^M&#0
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MS-X@30_B=:12)N2_0VI;LH///Y"O)L^]='\.?$D/A'QMH^MW(E:VLIF,D<!
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MN<@CZBH"^Y<&K0QXD\R3D\5+YD*?*5!-55^4^U7(6CVC<F3ZU$@(O.3S"%(
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M42-43-EF(QQ3U?R5 %0>=CJ:$D\Q\9S4#+*K+==&PM78=-$: L<MZU7A_=@
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M&TOED]J<JD'D$5+D>M!!$D?-3>72+]ZI.:!#/+I,8XJ=5&.33FB39NW#/UH
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M1?NCFEY]::OW>N*=^-(R&C[QJ6HAG<:EI@%%%%! 444UNO6@!V:*9SZTY>E
M"T444&;W"E/W:2B@M"#I4B_=ZTRBD1(27\ZHW"9SZUH'[M5IDSFKB8GQYSZT
M<^M'/K1SZU)_70-]VD7[HYI6^[2+G;0 ]>E/3K3%ZU(H.[I01J38/I3UCRM"
M_='-/7I0&HGE>U21J5[4Y<[14BYQ0&H5(OW1S4=2+]T<T&8]>E+N-(O2ES0(
M<LAQ2^93**H"5)CFKEO<'BLP28;KQ5F&3YA[]/>F8O<];^ /A-O'?Q.TG3_+
M<P1R":=U4D*J\@GT&>*_2R)!'&JJ" HVC\.*^1OV$O!X6SUSQ+/$P=W%O S*
M1N4 $D>HSD?A7UVN=@SUKXG-:_M,1R]C%B,VU37Q#^UUXVCUOXD0:1%<1S6^
MFQ99HW#!)&&&4XZ,,<CK7V[Y?[QF;D'!Q]*\VUK]GGP9XBU:[U._T[SKNZD:
M61]V,DFN? UJ>&J^TF(_/*.X#*"3@GD_C3))%;^(?G7Z!_\ #,/@'_H$G_OJ
MC_AE_P  ?] D_P#?5>]_;-%ZV _/"5ER>1^=02;<9+ ?C7Z*-^RU\/V.?[*_
M\?IC?LK_  _;C^RO_'JT6<T>P'YQ2LN>&!_&NW^!7C2/P/\ %30M0EGDB@\T
M1SK'_P M(B<;3]21^5?</_#)_P ./XM!\P_WO,QFGV_[*OP[MYDFAT/R)D8,
MLGF9(QR#^=34S>A4A*'+N@/78V\R-&!R" <^M))$9-O.!D$_@<TVUC$-M%&N
M["J -W7I4Z]*^0] /@;]M#P"=#^)RZU;(8[75[0R-[W"MRV/7:!7@7F>9\WF
M;]W.<8Z^U??_ .V!X'3Q5\+KB_6'SKS295N(W'!1#PXK\_3&5R=V_GAL8X[?
MI7W>65O;891[&;W+"PAE![TR2T#4Z!FVC@U/N'<UZXAOARSV^*]%(!_X_(L_
M]]K7ZTKT_'^M?E1X9 ;Q1I'(/^EQ?^AK7ZK+]T_4_P Z^0SSXZ7S-(DHZ5\6
M_P#!1A2T?@G S\]S_P"TZ^T*^.?^"A$?F1^#/]ZY_P#:=>3E_P#'B4?#2Y\M
M".FQ?Y"CGUJ\+7;"@QT4?RJNT)5CP:^]$0\^M'/K2LI!]J3GUH .?6CGUH_&
MCGUH ]L_8Y_Y+YX?_P"!_P J_4*OR]_8Y_Y+YX?_ .!_RK]0J^.S;^/\@(I/
M]:O^ZW\Q7Y<?M<?\G#>*/]\?^BTK]1Y/]:O^ZW\Q7Y<?M<?\G#>*/]\?^BTI
M93_'9$MCQ]?NCZ4M(OW1]*6OL2#[L_X)W?\ (F^+?^O^#_T U]>K]T5\A?\
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MYIC'YNM'/K4;?>-!D#?>I***!!NQ2;S2-UZTW\:R8$FZGJ?EZU!GWIZGY>M
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MJG&'=UT^%6'(X#EQ['.,^QKXHA5I+B.(?,\BMY:CKN/& /6OUB_9[\$K\/\
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MH/DW\S,[=OW8!'\Z^BZ^7?VWF LO"JD@,TLV!W/RK7FX&/\ M$33$?PSY9Y
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M-9^5#D_O&.58@=A@\]LU\\V]QTYKH?#FNS:3K%E>VDK6]W:R!TEC/(P02?P
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MT_\ 1:5[>3_QGZ$2V/.&CIC0[A4S'GKVH_&OL#E/K#]BI=GA3Q&/^GV/_P!
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M"CSKV9/ESV"^G&!^%>RQQB.,* 1R>ISWK/UW6[3PWI-SJ-_=1VMK;KNEDD(
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M&P<U:A;#4&9^AG[''CG_ (27X9C29+E);K2)?+\@$%A"00O'INR:^A(UVQH
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MRC@<LJY('N:N,9U-D*ZCU.X8JF23@#O7(>/OBCH7PYL&N=3N!O+?);PD-(_
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MRK<TPVZGIUJ&%@P'-6HU![\UF=)+&I]*LP_*W/%,B7:*G5<MFH LQU<CE(4
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MC6;W 2G)3:D7[HYI 244B]*7-:(S8Y>M$GWC3:*8@IK YIU% "+TI:*:P.:
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M;X7#57CCSS4N2O I 6VNB!@<U7:Z+,5/%,W'T-,V[G)- $VX>M+3,8[TY>E
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M%E^;K5'S*>LG&*0C0-QA<9J/[3SU%5-YI5SNS@T 6EE);-3QR^]4MQI5D.:
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M#[U("['&)%!J*1"KD4L4Q7 [4K-N8F@""0&HL&K,AJ&@!F#3E4^E+4B_='-
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M-+DYS5=I.:8SG=TH M>9[TQI/FJMYAI1EN<T 2-)S2;S3>?6CGUH,WN68<L
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MIZ_=ZU&I^7K2TP),^]&?>HZ7!]*"23\:<O2HUZ=<4[\: 'YIK9S2<^M.7I0
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M_C2_C09$JR8&*7S*C7I2YH DSGG-,9CN/>DW&HVD.XU($RR'%+YE1J=R@TM
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M\Y-2[<\=JDVBF2'8N13 JZEJ4.EPY;&ZN4OO%T]RS+#E1VJ?Q=,749Z5S:*
M@(ZUE*1I&)/+?7LQ)EEW#TS4#?O.M+DMSTI>?6LS08N8U"CH*=R:7GUHY]:
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M-U-Y]:.?6J$.WFC>:;SZT<^M #]U(/O4WGUIR]*#)CCUIZ_='-,P?2GKG;0
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MZC\:8TR[C\P/XT$70M/7[O6J[3#=U'YTGG>] 71:9AMZBFK)M&*@#;N]+^-
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M2EI%Z5*J;E% $=%/:([NE-*E3C%2 8/I25(H.WTIC?>-4 E+@^E)4B_='-!
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M"KGWQ3&^]244C%[A3U^[UIE%6(DS[T9]ZCHJ0),^](/O4RI%^Z.:0$E2Q*,
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MDW9[T9]Z %Y]:C;[QI^?>F-]Z@D,'TIZYVT+]T<TO/K0(.?6G+TIO/K1SZT
M.W4NZF<^M'/K09O<?12+TI:!!111F@!!]ZIX^U0U(OW1S09,M1]J>W2JT;[:
M>TO/6@!K\,:8W(XYHD8-WIB_=ZT -VGTI*DS[TQOO4 (OWJDYIJ=:D;KUH 3
MGUIR]*;SZT<^M! _-&:9SZT<^M  W7K1SZT<^M'/K09"KUJ12-W6HN?6G+UJ
M@+:$9ZU95AM'-9RL=W%3QL?2@C4NJPQUI'88ZU%UH8_+0(:Y&.M5FZ]:E>HN
M: #GUHY]:3\:,^] "\^M-&=QI<^]&?>@S%;KUIR]:;^-.7I0 Y6(D/I5N.<C
MZ53S3EDP,4 :'VBCSL]ZIK)Q4B-SS6JV,B[#)\U:$$GS5F0?>%:%O]X4Q&I
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M]*4TU@<U9RCMQI-]*N<5)'!NYQ6JV ="IDP,596((<=*2./R\4\MNYK5$ V
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M*6D7I2T"&MUZTG/K2MUZTG/K0 Y>E2+]WK4:]*6@R9+SZTGXTU7VC%(QW'-
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MW&I>M9L!T?6K"]:@4$'I4M( ER7)'2D7I3F^[4._#&@R>Y+3U^[UJ/S*-YH
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M44N#Z4 )4B_='-,VGTIZYVT&0@^\:EJ(9W&I/,QQF@0C9W4G/K0S9.<T?C0
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MXTN#2!3N/%24&3&8-.7I2T4 .3K4U0I4U!(4U@<TZB@0SGUHY]:5NO6DY]:
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M_*F-I//W3^5(S* : ?> )]:<#&1E2H'IFK+:2=WW3^5.72R!]T_E0!7!AQR
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M4&9+^-'/K35^[UIWXT$!SZT<^M'/K1SZT"'+TI:1>E(P.: '9IC=>M&#1@T
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MUJ4]:[4[JYY;T=@;[U)12X/I5"#!]*-I]*>N=M+SZUDP$7.VEY]:.?6CGUH
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M*** "I%^Z.:9@^E/7.V@R%Y]:.?6CGUHY]:"1R]*6D7I2T""C--;KUI.?6@
M;KUHY]:.?6D_&@S>XO/K1SZT?C1SZT"#GUHY]:.?6CGUH <O2EIG/K3EZ4&8
MM%%%!:"BBB@S85(OW1S4=2+]T<T /7I2TSGUIR]* %IC=>M#=>M&#00'/K1S
MZT8-'XT '/K1SZTF?>E_&@ Y]:<O2F\^M.7I09"T444 %-;KUIU-;KUH 3GU
MIR]*;SZTY>E "T444$!4B_='-1U(OW1S0 QOO&DIS [J;0 ^-,\U813FH8ST
MJS'VH,F2H#GI5J+M4$?:K$?:J GB^_5H&JT9'K4P/O0!)FD'WJ9GWHS[U(%@
M=.M/5CCUJNK<>M/63B@R>Y:BD/%6E;Y1S6=')S5E9/E%406J*A60[:E5SB@!
M:<O6F[J* +&1ZTY#S4*_='-/7K4F3W+&X>M2+]WK5=?O5+UH$3K]VEIJ<*,\
M4Z@ J6/M45/7[O6@"8TE1>9BESGG-!FR2GK]WK4:]*6J$2_C3EZ5&OW>M._&
MI ?3U^[UJ->E+0!)GWIC?>I**"1K=>M)@T-][K3?,QQFJ$+^-&?>HV;<<T4
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M:?2GKG;2\^M'/K2)#GUHY]:.?6CGUIB#GUHP:.?6G+TH,V-P:.?6GYIC=>M
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MM'/K09CEZ4N:9SZT<^M!8_-&:9SZT<^M!F/HI%Z4UNO6@!]%(O2EH ****"
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MTZT 2K]WKBGK]:B;K3E^[UH,B8TY?N]:C4_+UI:!$RL,=14J<J,&JE21R;:
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M68[<><<<BDM+/<P(&:V[+3CN!*D?A6BB1*1:TR#9$AQS_P#7K2.?I3(X?)
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MU(OW1S09"\^M'/K1SZT<^M4 <^M'/K1SZT<^M !SZTY>E-Y]:<O2I 6BBBJ
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MZ4@''K2444&844N#Z4;3Z5H9L2BBBF(*D7[HYJ.GK]WK60#6^\:<I^7K2/\
MG3!TH F_&CGUIJ_=ZT[\: #GUHY]:.?6CGUH .?6CGUHP:-I_P B@@.?6G+T
MIO/K3EZ4 +11109L*D7[HYJ.I%^Z.:U$*Q^7K5:^F$-BY) X[U,]9/B"1O[/
MVJ"3CH!5?99/VD<JS><S/ZFF[?3D5'8Z7>W8!6*7:2<?(?6MBW\'W<F"SM&#
MV88KA]G-G;[2*,NG1JK-RP!^M="O@\HJAYE)]<]:@U#PF]K&9-V*U]C/J9^W
MA>R,HE4XR/SJ*1@V<$'\:KR;HY#&3NQWH7Y3635M#6]]1^S=1Y=.5ANZU*%#
M=Z0R'RO:E2/FK*QC;0L?S4&8SRO:I8X^E2JHP!2A3NX% APA#4R5/+%6XDX!
M/%$EN)&QUS3$4K,^9-6Q)9HL(<$9[\U%#IOD*&*D'W%5-0OVCD,2C(Z<?2D2
M5IF#3,5.1[4U?O8[T^&,8%6([<F3.#4 0&/<W2I8XV7^$_E5Z.SSVJRMF-HX
MK11%*6AG*K;ONG\JGCA8\[3^575MPK8J=8PJBM% RYR"WAV88\&KL.9"  2*
M;%#YAQC(K1M[7RE'%:1@83F+;VQ&,@BIV7:<"GC./2EVYKI.8:OW>M-;[U##
M#$4E,S"I%^Z.:CJ1?NCF@0O/K1SZT<^M'/K0 <^M'/K1SZT<^M!F]QR]*6D7
MI2U0@HHHH ****DD:W7K2KUI&Z]:5>M4(<W6DI3UI* "BBB@R"BBB@ HHI<'
MTJ0$J1?NCFF;3Z4]<[:#(7GUHY]:.?6CGUJ@#GUHY]:.?6CGUH .?6G+TIO/
MK3EZ5("T4450#6Z]:3GUI6Z]:3GUH(#GUIR]:;SZTY>M #FZTQNO6GGK3&Z]
M: $Y]:<O2F\^M.7I0 M%%%!DPHHHH **** "BBB@"1?NCFEY]:1?NCFEY]:"
M Y]:.?6CGUHY]:!!SZT<^M'/K1SZT&8<^M'/K1SZT<^M !SZT<^M'/K1SZT
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M 6BC-&:R>Y 4UNO6G9IC=>M:( Y]:.?6CGUHY]:8#EZ4M(O2EH,@HHI<'TH
M2BEVGTHVGTH >OW1S3UZ4Q0=M/7I0 M"_>HIR4$#P#3EZ4N:.M #6!S28-/H
MH 9@T8-/HH 1>E.P?2C!]*>N=M!F(@.>E2TU>M/- A**** "BBB@!K=>M)@T
MK YI5Z4&;W!>E2K]T<TS!]*>H.V@DECJ>H(^.M2'D\&@!]%(O2ES02/7[O6G
MH1GK4-.3K0!97[U65^Z.:JIUJROW>M $B]:E'UJ)>M2CZT&0]>E2K]T<U$O2
MI5^Z.:!"\^M#?=HY]:CD?'% $4WW35&0U9FD^6LZ5SS5&;'5(J;E%5%D.ZK$
M<E A)(?F/%-\GVJ<G/.:3/O0!6DBXZ5#M*U=?\ZKR=Z"2+!J2.FK]ZI%^]0!
M87[O6FR'WIN['TJ*63K0 R9ACK5%OO&I99.34/6L'N4%%+@^E.0'/2D ZWC)
MDSBNATV, +61:IE@:W;"/D5I$DUXU.T8J55R/>DC'R@"IXH^F:U.=WN+%%TX
MJPD?-(@VG%2K]ZD42*-JXI:*,U) 5(OW1S4=2+]T<T +SZT<^M)^-&?>@!>?
M6G+TIOXTY>E A:*** "GJ>.M,I!]ZB6P#VS]::*D'UIC?>-8C$HHHH :W7K3
M!]XT]NO6F#[QH,R6BBB@04444 /7[O6ES[U'160"M]ZDHHH **** "BBB@S8
M4]?N]:910(DS[TOXU%3U^[UH D7I3C]VH_QIR]*"!O-.7I2,#FE7I0 C=>M*
MO2D8'-*O2M8 +4B_='-1U(OW1S5/<SD,;[QIT<$<G,@W+364,QYR:FC4[1P:
MM& JVT4/,(VIV6GK)YA(/;K2JI*G';K[5DZYXD@TVUV)M:3NP-)^[J->]H3Z
MMK4&DP'>!(>V.<5Q&H^)+N^W#+",]/2J-Y>3ZE.\KR@1GHN?:H5;,84\5SRK
M<VAK&CRZCXF) +')]:>3S4:K@8!I>?6N=FXX,0WM4R257Y]:3<12&:*S#:.1
M^=2QMNYK,5CMZ5*EPRJ!S0',:T:@\YJS''NQCFL1;YE&*GAU0QJ.>: -Z.W+
M'!! ^E6DLT5=[$+CIFN=_MV2D_M"XN^-Q5*TYN57(Y>8U=0U8.IB3[P_BK*C
MA:3YG^9CUJ2.W/<[CZU>M[;IQ^E1)\VH6MH5X82K=*T(8N!3UM_FZ59CC"\4
M*)E*011]*F^[2A3T'-3PVI<#<"/J*WA RE/0J;2TAP"?I5N&U+@;E(^HJY'9
MI& <C-28V\5TQB<\ID4=N(NE6%SM%,J1?NCFJ,Q>?6CGUHY]:3\:#,8WWC24
MYLY]:;0(*D7[HYJ.I%^Z.: %Y]:.?6CGUHP: #GUHY]:,&C!H,WN.7I2TB]*
M6J$%%%% !1114DC6Z]:5>E(W7K2KTJA"T48/I2[3Z4 )11109!1110 @^]4H
M^M1#[U2CIUJ0%Y]:.?6CGUHY]:#(.?6CGUHY]:.?6J .?6CGUHY]:.?6@ Y]
M:<O2F\^M.7I4@+1115 -;KUI.?6E;KUI.?6@@.?6G+TIO/K3EZ4 +36Z]:=3
M6Z]: $Y]:<O2F\^M.7I0 M%%%!DPHHHH **** "BBB@"1?NCFEY]:1?NCFEY
M]:" Y]:.?6CGUHY]:!!SZT<^M'/K1SZT&8<^M'/K1SZT<^M !SZT<^M'/K1S
MZT .7I2TB]*6@ IK=>M.IK=>M!D)SZT<^M'/K1SZT"'+TI:1>E+02%%%% !1
M110 4444 2+]T<TO/K2+]T<TO/K0 <^M'/K1SZT<^M!DPY]:.?6CGUHY]:!!
MSZT<^M'/K1SZT '/K1SZT<^M'/K09L.?6G+TIO/K3EZ5(A&Z]:3GUI6Z]:3G
MUJ@#GUHY]:.?6CGUH .?6CGUHY]:.?6@!R]*6D7I2T$A1110(****#-A4B_=
M'-1T]?N]:!#6^\:2E;[U)0 5(OW1S4=2+]T<T +SZU&WWC4G/K4;?>-!&H]?
MNCFF-]XT]?NCFF-]XT"U$HHHH#4D7[HYIC?>-/7[HYIC?>- :B4444$!1110
M(D7[HYI>?6D7[HYH_&@!K [JK3@[CQ5O/O5>?[QH,WN?&=%%%8/<_KDD7[HY
MI>?6D7[HYI>?6M%L <^M'/K1SZT<^M, Y]:.?6CGUHY]: #GUIR]*;SZT<^M
M!&H_-%,Y]:<O2@-1:*** U"BBB@-0HHHH,PJ1?NCFHZ>OW>M AW/K4;?>-2?
MC4;?>- "IUJ1NO6HTI[=>M!D'/K1SZT<^M'/K0 <^M'/K1SZT<^M !SZT<^M
M'/K1SZT$ASZTY>E-Y]:<O2@0M%%% !11109O<****!!1110 4444&3"BBB@T
M6P4444&;"BBB@"1?NCFEY]:1?NCFEP:"0Y]:.?6CGUI/QH$+SZT<^M)GWI?Q
MH .?6CGUHY]:.?6@!R]*6D7I2T&05(OW1S4=2+]T<T +@T8-.7I2T (O2EHH
MH 0?>J4'WJ.B@@DS[TY6(-0T]?N]: )2V3FC-1Y]Z7\: 'T4B]*6@"1?NCFE
MY]::OW>M+^- "\^M.7I3?QHY]:#)CZ*1>E+0 N#Z4;3Z4]?NCFEY]: (J*<P
M.ZDVGTH >OW1S3UZ4Q<[:>O2@R>XM/7[O6F44")?QHY]:1?NCFEP:"1R]*>G
M6F+TI\8/I0!83K5A#S5=.M2C[U %A?O5* <5#'VJ7S,<4&1*N<5(N=H[5"LG
MRTYI/EH$+))M'6J<TY&?2G32?+6=<3$#%4!)--N7K51IAMQD9J"2X-5VD+'-
M!F6A)\U3QR5GK(<U822I$7O,HW#UJOYGO1YE4!9J*7J:19>.M122?,: '+UI
M68YJ/>?0TGF5($K2';4$DOO0\G%0-EFSB@!&.YLTE+M/I25DP)%^Z.:>O6HU
M/'6GIUH)+EK]ZMVQ8<<US\+[6K7L9>0>U;+8SD=!&Q["K<1]>#5&&8;1S5N/
MYL&F0BROWJD7[U11U,/K4C%;KUHY]:.?6CGUH('+TJ1?N]:C7I2T *WWJ2EP
M?2DH D7[HYIZ]*8OW1S2\^M!F/HI%Z4M @I!]ZEHH D'UIC?>-*G6ED!W'BL
MGN:(91112&-;KUI@^\:>W7K3!G<:#,EI3]VDI3]V@1$7VG%)YE(P.X\4VLC1
M$F[/>G*PQU%0T4$<I8R/6C-1+]WK2_C0(DS1FH\^]+^- #\T9J/\:7\: 'YH
MS3.?6CGUH,V/S13.?6G+TH$2+]WK4B]*C0'/2I:U6Q 4444&0444@^]0 [!]
M*?TC%'XTQFW,16JV$+$NYLU:R1P!FH8UVXJ56"I*Q( 4=33,^IGZQJ@TZWD.
M]0[#[I/->>7%TUY([R'Y<\*:T-<U0WU_.I/RJ1@YX/ K'_BKBG/F=CHA3Y=0
MW!N0NT>E+@^E#4Y3\O6L345<[:7GUH_&CGUH .?6CGUHY]:.?6@!R]*6D7I3
ML'TH)&,#FE1,FEJ:&/?C')]J!#XX RCUK0M;;$:@@_Y-1V\)5QD$?A6K#'\H
MH*$M[?I6C#".!4<,7S=*T8;<\$@_E6D8&$YD*PG=T-68[,MSM/Y5:C@%3KA5
M S73&!QRD55M0G/>IEX6G-]ZC!]*V,I:H2BBBJ,@J1?NCFHZD7[HYJ31"\^M
M1M]XU)SZU&WWC0,>OW1S36!W4Y?NCFEY]:HS(JD7[HYIK [J<N=M2(7GUIR]
M*;SZTY>E "T49HS09O<**,T9JA!1110 4445)(UNO6DY]:5NO6DY]:!$L?W1
MS3L^]1+TI: %;[U)115&04444 %/7[O6F45($F?>E_&HJD7[HYH,A>?6CGUH
MY]:.?6J .?6CGUHY]:3\: %Y]:<O2F_C3E/;/-2 M%%%4 UNO6DY]:5NO6DY
M]:" Y]:<O2F\^M.7I0 M-;KUIU-;KUH 3GUIR]*;SZTY>E "T444&3"BBB@
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MYKW/0(R#MZ4@4XZ5+SZT<^M(R>XBYVTO/K1@T]4RM #.?6C!J3RZ>D)ZX.*
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MH$2_C1SZTB_='-+SZT&8<^M'/K1SZT<^M !SZT<^M'/K1SZT .7I2TB]*6@
MIK=>M.IK=>M!D)SZT<^M'/K1SZT"'+TI:1>E+0 ;0:.E&:,T$A1110 4444
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M:,&G+TI:! JG;TJ1<[:%^Z.:7GUH,QR]*:W7K1SZT<^M !SZT<^M'/K1SZT
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M?EZU#SZTY>E $WXT8-(OW1S3UZ4 "]:E'3K4=2+]T<T"%Y]:.?6CGUHY]:"
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MR$Y]:.?6CGUHY]:!#EZ4UNO6CGUHP: #GUHY]:,&C!H)'+TI:1>E+0 4444
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M)::P.:;N/H:3S#09CN?6CGUI,YYS2_C0*X<^M'/K1@T8- 7'+TI:9SZTY>E
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MC0(**-Q]*-Q]* "EP?2DW'TIZGY>3B@SU&[3Z4E29]Z8WWJ!"4Y*;4B_='-
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MV_[\BCZG(/\ B*5'_H&?WGSYO7^\/SHWK_>'YU]!_8X?^?>V_P"_(H^QP_\
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M)]P]:-P]:@W'THW'TH^HON'^O5/_ )\O[R?</44;AZU!1N-9?49=P_UZI?\
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MY\O[SLL^]&?>N-\P_P#/:6CS#_SVEH^J2[A_K)#_ )\O[SLL^]&?>N-\P_\
M/:6CS#_SVEH^J2[A_K)#_GR_O.RS[TF]1U<"N.\P_P#/:6E^TSKPLC%>V[K1
M]4EW#_62'_/E_>=AYB_WU_.EW ]&!KCOM=Q_?I/.=N6ED#=]O2CZI+N1_K)3
M_P"?+^\[+/O2;U'5P*X[S#_SVEI?M,Z\+(Q7MNZT?5)=Q?ZR4_\ GR_O.QW
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
@ !1110 4444 %%%% !1110 4444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
